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“Not only to be receiver,





What is the meaning of  life?
Throughout history, great efforts have been made trying to understand which is 
the significance of  living or existence. Philosophical, scientific, theological and 
metaphysical approaches have proposed multiple answers to questions such as “Why 
are we here?”, “What is life all about?”, or “What is the purpose of  existence?”.
Scientific contributions have focused primarily on describing empirical facts about 
the universe, exploring the context and parameters concerning what life is and 
aiming to describe how it works. Though life definition is still a challenge, from 
the biologist point of  view lifeforms are self-organizing systems that regulate their 
internal environments as to maintain this organized state, also known as homeostasis, 
and reproduce to continue life over multiple generations. 
Importantly, homeostasis maintenance needs the capacity to sense and adapt to the 
external environment. Throughout this thesis, we will focus on a specific subset 
of  mechanisms developed to respond to a certain stimulus. These mechanisms, if  
successful, return life to its homeostatic state but, upon failure, may lead to life-
threating conditions. 
I am afraid we will not provide a new answer to the question “What is the meaning 
of  life?”, however we will further describe its complexity and fragility and, one could 
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As innate immune cells, macrophages sense endogenous and exogenous danger 
signals and respond orchestrating inflammatory processes. For the rapid induction 
and efficient resolution of  inflammatory responses, macrophages induce the 
expression of  pro-inflammatory and anti-inflammatory mediators, which cross-
regulate each other through feedback loops. This process requires tightly controlled 
gene expression at multiple levels. Recently, the regulation of  mRNA deadenylation 
has emerged as a key regulator of  the strength and, critically, the duration of  transient 
inflammatory responses. 
Cytoplasmic Polyadenylation Element Binding (CPEB1-4) family of  RNA-binding 
proteins target mRNAs containing Cytoplasmic Polyadenylation Elements (CPEs) 
in their 3’UTR. CPEBs orchestrate the assembly of  two types of  ribonucleoprotein 
complexes (mRNPs) which can repress or stimulate the translation of  target mRNAs 
by modulating the length of  poly(A) tail. Several inflammatory mediators harbour 
CPEs in their 3’UTRs and are potential CPEB targets. Thus, we hypothesized that 
CPEBs could be an additional checkpoint to control inflammatory responses. 
We find that CPEB4 is a novel player in macrophage response to LPS. Upon LPS 
treatment, CPEB4 is upregulated and its polyadenylation function is activated, a 
process mediated by the MAPK p38α and ERK1/2 and two AU Rich Element 
Binding Proteins (ARE-BPs). Interestingly, the pattern of  CPEB4 expression and 
activity suggests that it participates in late LPS-response, when the resolution of  
inflammation occurs. Indeed, myeloid-specific Cpeb4KO mice display increased 
sensitivity to LPS-induced endotoxic shock. We identify CPEB4 target mRNAs by 
RNA-Immunoprecipitation and Sequencing (RIP-Seq), uncovering that CPEB4 
regulates the expression of  negative regulators of  MAPK signalling, thus creating 
the negative feedback loop needed the resolution of  inflammation. Moreover, we 
also describe how the interplay between CPEB4, HuR and TTP defines mRNA 

























In this thesis we have studied CPEBs contribution to inflammatory responses. 
CPEBs, which stands for Cytoplasmic Polyadenylation Element Binding Proteins, 
are RNA binding proteins that can regulate mRNA translation by modulating the 
poly(A) tail of  mRNAs. In this first part of  the introduction we will summarize 
the process of  protein synthesis, focusing on the lifecycle of  mRNAs and how the 
poly(A) tail,together with other elements, can have an impact on mRNAs fate.
1. Regulation of  protein synthesis
Organisms store biological information in their genomes which, except for certain 
viruses, are made of  DNA. The genome can be divided into genes, DNA regions that 
encode for functional molecules, either proteins or RNAs, and intergenic regions. 
Gene expression comprises a group of  molecular processes by which information 
from a gene is used to synthesize its functional gene product. For instance, protein 
expression is initiated by the transcription of  a gene into an intermediary molecule 
called messenger RNA (mRNA), which is then translated into the sequence of  
amino acids that forms the protein (Crick 1958; Crick 1970). This course of  events 
is known as the central dogma of  molecular biology, and it efficiently explains how 
nucleotides in the DNA store information for protein composition (Fig. 1).
Figure 1. Central dogma of molecular biology. Modified from Barillot et al. 2012.
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However, less than 2% of  the human genome consists of  protein-coding sequences 
(Brown 2011). So, what is the rest of  our genome for? Besides other functions, 
our genome contains thousands of  elements whose function is to regulate protein 
expression at the transcriptional, translational and also, post-translational level (Mayr 
2017).
Since the statement of  the Central Dogma, the elements that govern gene 
transcription have been widely studied. To date, we know that cis-regulatory elements 
on the DNA, trans-acting factors, chromatin structures or epigenetic modifications 
can govern gene transcription, indicating which genes need to be transcribed, to 
which extent or when. However, translational regulation has been less characterized. 
Importantly, each mRNA contains not only its protein-coding sequence but also 
regulatory elements. We know that these elements can govern mRNA translation, 
stability or localization; nevertheless, their impact on protein expression is, in many 
occasions, underestimated. 
In this first part of  the introduction we will summarize the process of  protein 
synthesis, focusing on the lifecycle of  mRNAs and the different regulatory elements 
that can have an impact on the fate of  mRNAs.
1.1. pre-mRNA processing
The first processing events of  pre-mRNAs occur concomitantly with transcription 
(Aguilera 2005). As soon as the first 20-30 nucleotides of  the nascent pre-mRNA 
have been produced, the mRNA is capped at the 5’ end (Topisirovic & Sonenberg 
2011). The mature methylated cap (m7G-cap) is critical for mRNA protection 
from 5’-3’ exonucleases, for mRNA nuclear export, and for cap-dependent mRNA 
translation initiation (Shatkin & Manley 2000),among other functions. These 
regulatory activities are mediated by cap-binding proteins: the nuclear cap binding 
protein complex (nCBC) in the nucleus and eukaryotic translation initiation factor 












Also concomitant with transcription, intronic sequences are removed from pre-
mRNAs by a process named splicing (Papasaikas & Valcárcel 2015). Interestingly, this 
process allows the combinatorial removal of  various intronic and/or exonic regions, 
potentially altering the exon composition of  the mature mRNA. Consequently, 
alternatively spliced mRNA isoforms may differ in their regulation and function, as 
well as their encoded proteins (Fig. 2a). 
Once the polymerase has transcribed the entire gene, the 3’ end of  the pre-mRNA is 
processed. Except for replication-dependent histone mRNAs, this process consists 
of  the endonucleolytic cleavage of  the mRNA and the subsequent addition of  a 
non-templated polyadenosine tract, named the poly(A) tail or poly(A) (Marzluff  
et al. 2008; Di Giammartino et al. 2011; Elkon et al. 2013). The location in the 
mRNA where this process occurs is defined by two specific regulatory elements in 
the pre-mRNA sequence, the polyadenylation signal (PAS, 5’-AAUAAA-3’) and the 
downstream sequence element (DSE, U/GU-rich). These elements, in turn, will be 
recognized by the cleavage and polyadenylation specificity factor (CPSF) and the 
cleavage stimulating factor (CSTF), which together with other cleavage factors, will 
specify the cleavage site, often after a CA dinucleotide. After the cleavage event, a 
poly(A) polymerase (PAP) adds approximately 250 adenosines that will be coated by 
poly(A) binding proteins (PABP) (Fig. 2b). Remarkably, PABPs coating and thus 
the poly(A) tail, is relevant for several mRNA processes: nuclear export, protection 
from 3’-5’ degradation and mRNA translation (Proudfoot 2011; Eckmann et al. 
2011; Jurado et al. 2014).
Importantly, once the tail has been synthesized, the length of  the poly(A) tail can 
be dynamically modulated by deadenylases and polyadenylases (Zhang et al. 2010). 
Therefore, the population of  mRNAs in a cell are heterogeneous in poly(A) tail 
length, ranging from 30 to 250 nucleotides, and modulation of  their poly(A) tail is 
used to regulate mRNA translation and stability. 
It is also worth mentioning that more than one half  of  all mammalian transcripts 
can be cleaved and polyadenylated at various sites, a process known as alternative 
cleavage and polyadenylation (APA). Depending on which site is used, transcripts 
will contain or exclude regulatory elements on their 3’ untranslated region possibly 
altering mRNA behaviour at multiple levels (Elkon et al. 2013) (Fig. 2c).











Figure 2. Pre-mRNA processing. (a) Schematic view of mRNA processing. (b) 
Examples of mRNAs generated by alternative splicing and alternative polyadenylation. 
(c) The PAS and the DSE define the cleavage site where the poly(A) tail will be 
added. 
Finally, and before reaching the cytoplasm, mature transcripts can be enzymatically 
modified on specific nucleotides. More than 100 types of  chemical modifications 
have been described (Peer et al. 2017; Roundtree et al. 2017), however, little is known 
about their biological function and distribution. Some of  these have been shown to 
control mRNA expression and stability, mRNA structure or the susceptibility of  
mRNAs to interact with RNA binding proteins (RBPs) (Fu et al. 2014; Roignant & 






















































It is worth stressing that from the start of  transcription, mRNA processing and 
functions are driven by cis-regulatory elements on the mRNA and the RBPs that 
they recruit. Consequently, cellular mRNAs are not “naked” nucleic acids, but they 
are constantly interacting with RBPs. Moreover, these interactions are dynamic, as 
they evolve during each phase of  the mRNA’s lifecycle. Thus, when we refer to 
mRNAs, we should be aware that we actual mean messenger ribonucleoprotein 
particles (mRNPs). 
1.2. Mature mRNA structure 
After all these processing steps, the mature mRNA body consists of  a coding 
sequence (CDS) flanked by two untranslated regions (UTRs), with a m7G-cap at its 
5’ end and the poly(A) tail at its 3’ end. 
The CDS constitutes the region of  the mRNA that will be translated into a protein 
by ribosomes. It starts with the AUG initiation codon and ends with one of  the three 
stop codons UAA, UAG or UGA. In the last years, several studies have demonstrated 
that codon composition of  the coding region can also impact translation, a concept 
known as codon optimality (Schuller & Green 2018). On the other hand, the 5’ and 
3’UTRs contain structural features or regulatory cis-acting sequences involved in the 
control of  mRNA translation, storage, transport and decay. The 5’ UTR regulatory 
motifs that influence mRNA translation include secondary structures, upstream 
open reading frames (uORFs), internal ribosome entry sites (IRES) and specific 
binding sites for RNA-binding proteins, among others (Leppek et al. 2018). The 3’ 
UTR can also contain specific secondary structures and binding sites for regulatory 
proteins, as well as microRNA (miRNA) binding sites (Fig. 3). 
It is worth highlighting though that each mRNA should be seen as a unit the 
behaviour of  which results from the cooperation or competition of  its distinct 
elements throughout the CDS and UTRs. This concept, known as the combinatorial 
code of  mRNAs, states that all the elements in a given mRNA constitute a unique 
“bar code” that determines mRNA behaviour throughout its life cycle (Piqué et al. 
2008).











Figure 3. Regulatory elements in mature mRNAs. 
The cytoplasmic fate of  mRNAs
After nuclear export, the cytoplasmic fates of  mature mRNAs can be basically 
divided into translation, degradation and localization. In the next sections, we will 
dissect these processes, emphasizing the possible regulatory functions exerted by 
the previously mentioned mRNA features.
1.3. mRNA translation
The translation of  mRNA into proteins is the final step of  protein expression. 
It is a complex energy-consuming process subject to tight regulation. Translation 
of  mRNAs occurs in four phases: initiation, elongation, termination and ribosome 
recycling. 
1.3.1. Translation initiation
Translation initiation represents the most complex and rate-limiting step in 
translation, involving more than 50 proteins in eukaryotes.
Cap-dependent translation initiation is determined by the eIF4F complex, which is 
bound to the 5’ cap and is responsible for recruiting the 43S pre-initiation complex 
to the mRNA (Sonenberg & Hinnebusch 2009; Jackson et al. 2010). The eIF4F 
complex is composed of  eIF4E that binds to the cap, the scaffold protein eIF4G 
that recruits the 43S pre-initiation complex, and the RNA helicase eIF4A that 
favours 43S binding and scanning. The 43S pre-initiation complex consists of  40S 
ribosomal subunit to which the ternary complex (TC) has been recruited. The TC 
is a complex of  the eukaryotic initiation factor 2 (eIF2, a heterotrimer of  α, β and 
γ subunits) bound to GTP and a methionine-charged initiator tRNA (Met-tRNAi). 




















Once the 43S pre-initiation complex binds the mRNA, it scans along the 5’ UTR 
until it recognizes the initiation codon AUG in an appropriate sequence context 
(Kozak 2002). Upon AUG recognition, it will now form the 48S initiation complex 
following which, hydrolysis of  eIF2-GTP takes place and most initiation factors 
are released. Subsequently, the large 60S ribosomal subunit joints and the this 80S 
translationally competent ribosome can start the elongation process (Gebauer & 
Hentze 2004; Hinnebusch & Lorsch 2012). Importantly, eIF4G also interacts with 
PABP at the poly(A) tail, bringing both ends of  the mRNA together in a closed-
loop conformation so that termination and re-initiation of  translation are efficiently 
coupled (Tarun & Sachs 1995).
Alternatively to CAP-dependent translation initiation, some cellular transcripts rely 
on other elements such as internal ribosomal entry sites (IRES) to initiate their 
translation. IRES are RNA elements that through their secondary structure or 
primary sequence, recruit the 40S ribosomal subunit independently of  the cap-
binding factor eIF4E (Shatsky et al. 2018).
Figure 4. Canonical cap-dependent translation initiation. Scheme of the different 
steps during cap-dependent translation initiation. Source: Leppek et al. 2018.











1.3.1.1. Regulation of  translation initiation 
The formation of  the TC is the major checkpoint that the cell uses to regulate global 
protein production. eIF2 is a G-protein that cycles between its active form (GTP-
bound) and the inactive one (GDP-bound). After eIF2-bound GTP hydrolysis upon 
AUG recognition, eIF2-GDP is recycled back to its GTP-bound state, a process 
mediated by the guanine nucleotide exchange factor eIF2B. Since eIF2-GTP is 
the limiting factor for the assembly of  the ternary complex, this recycling step is 
crucial for translation initiation. Indeed, eIF2α phosphorylation, which reduces the 
dissociation rate of  eIF2 from eIF2B, leads to a global inhibition of  translation 
initiation. This process has been shown to occur under certain stress conditions, 
such as viral infection or the accumulation of  misfolded proteins in the endoplasmic 
reticulum (ER) (Pakos-Zebrucka et al. 2016) (Fig. 5a).
As formerly described, some mRNAs contain upstream open reading frames 
(uORF) in their 5’UTRs. Briefly, uORFs are sequences defined by an initiation codon 
upstream of  the main coding region. In normal conditions, uORFs are translated by 
ribosomes, which generally initiate translation on the first available AUG codon. As 
a consequence, uORFs repress the translation of  the main protein-coding sequence 
as fewer ribosomes, if  any, reach its initiation codon. However, uORF-containing 
mRNAs benefit from eIF2α phosphorylation, as low initiation rates favour that 
ribosomes skip uORFs and get to translate the main coding sequence (Barbosa et 
al. 2013) (Fig. 5b).
The cap-binding protein eIF4E is another node of  protein synthesis regulation.  In 
most cells, eIF4E levels are limiting, and thus the regulation of  its activity has a 
strong impact on the translation efficiency of  many mRNAs. For example, eIF4E-
binding proteins (4E-BPs) can inhibit translation by competing eIF4E binding to 
the cap. Extracellular stimuli like mitogens and growth factors can trigger 4E-BPs 
phosphorylation by the mTOR kinases. Phosphorylated 4E-BPs are not able to bind 
eIF4E and translation initiation is enhanced (Richter & Sonenberg 2005; Sonenberg 
& Hinnebusch 2007; Roux & Topisirovic 2018). Alternatively, impairment of  eIF4A 
activity or availability can also lead to translational repression, a strategy that is being 












Figure 5. Regulation of translation initiation. (a) Under stress conditions, eIF2a-
phosphorylation inhibits eIF2-GDP recycling and represses global translation 
initiation. (b) mTOR phosphorylates 4EBPs, inhibiting its binding to eIF4E that will 
bind the CAP and promote translation. Closed-loop model: in this scheme it is also 
shown the circularized mRNA due to the binding of PABP to eIF4G. (c) In stress 
conditions, uORF-containing mRNAs benefit from the low availability of the ternary 
complex (TC) as ribosomes get to translate the main ORF, and are not sequestered 
by uORFs as in normal conditions. Source: (a,c) Adapted from Carpenter et al. 2014. 
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Finally, another factor modulating translation initiation is the previously mentioned 
closed-loop model. The simultaneous interaction of  eIF4G with eIF4E and the 
PABP, which are bound to the cap and the poly(A) tail respectively, brings together 
both ends of  the mRNA resulting in mRNA pseudo-circularization (Imataka et 
al. 1998; Wells et al. 1998). This conformation allows the 5’ cap and the 3’ poly(A) 
tail to synergistically favour the recruitment of  the small ribosomal subunit to the 
mRNA. At least in yeast, this conformation is essential for translation initiation 
and, in other systems, it has also been shown that it can favour ribosome recycling 
or promote mRNA stability (Tarun & Sachs 1995; Sachs et al. 1997; Kahvejian 
et al. 2005). Consequently, any regulation that favours or compromises the cap–
eIF4E–eIF4G–PABP–poly(A) “bridge”, and thus the close-loop structure, can in 
turn stimulate or inhibit translation of  mRNAs (Fig. 5b).
1.3.2. Translation elongation
Translation elongation is the stepwise addition of  amino acids in order to produce 
the codified protein chain. The order of  amino acids is specified by the sequence of  
codons in the mRNA, that tRNAs with the pairing anticodon will recognize bringing 
with them the needed amino acids in the appropriate order. This process is performed 
by the 80S ribosome together with the elongation factors eEF1A and eEF2 and, of  
course, the cellular pool of  charged tRNAs. While translation initiation is directly 
regulated by more than 25 proteins, the elongation and termination processes 
require a minimum number of  them, thereby underscoring the preponderance 
of  the initiation step over the other two (Lackner & Bähler 2008). Nevertheless, 
translation regulation can also occur at the elongation step. For example, eEF2 
phosphorylation by the eukaryotic elongation factor 2 kinase (eEF2K) reduces 
its affinity for ribosomes and therefore represses translation elongation. Among 
others, MAPK (mitogen-activated protein kinase) or mTOR signalling pathways 
can inactivate eEF2K in order to promote eEF2 elongation function (Kaul et al. 
2011). Moreover, in recent years, further elongation-related regulatory mechanisms 
have emerged as new determinants of  protein synthesis. Some examples would be 
acyl-tRNA availability and modifications, ribosome composition and function, and 













Figure 6. Translation elongation. Ribosomes contain three positions for tRNAs: 
an acceptor site (A site), where the aminoacyl-tRNA is placed; the peptidyl site (P 
site), which contains the tRNA with the growing polypeptide; and the exit site (E site), 
where the empty tRNA exits the ribosome. During translation elongation, aminoacyl-
tRNAs are carried to the empty A. Then, a peptide bond is formed between the 
incoming amino acid and the growing polypeptide, which will be now placed in the 
A site. After peptide bond formation, tRNAs are translocated, the empty tRNA is 
positioned in the E site and the peptidyl-tRNA in the P site again. The A site is then 
empty and available for binding the next aminoacyl-tRNA (Kapp & Lorsch 2004; 
Dever & Green 2015). Source: Schuller & Green 2018.
1.3.3. Translation termination and ribosome recycling 
Translation termination is triggered by the appearance of  a stop codon in the A 
position of  the ribosome. In eukaryotes, termination is mediated by two release 
factors (eRF1 and eRF3), which mediate the release of  the synthesized peptide and 
the establishment of  the post-termination complex. This complex, composed of  
the ribosome and eRF1, will facilitate ribosomal recycling. 
Ribosome recycling is the process by which the 80S ribosome splits into its 40S 
and 60S subunits to prepare for another round of  translation. Although eRF1 and 
eRF3 are sufficient to mediate both translation termination and ribosome recycling, 
the latter can also be facilitated by ABCE1 (Preis et al. 2014). Ribosome recycling 
is often described as a key step for the beginning of  initiation, as ABCE1 can also 
associate with several initiation factors. Furthermore, the closed-loop structure of  
mRNAs can also favour the direct re-entry of  ribosomes to the translation initiation 
point, enhancing mRNAs translation efficiency (Nürenberg & Tampé 2013).











However, ribosome recycling does not only occur after completion of  the translation 
process, but can also happen upon failure of  polypeptide synthesis when damaged 
mRNA is encountered, or following the assembly of  empty ribosomes.
Figure 7. Translation termination and ribosome recycling. The first event in 
translation termination is eRF1 recognition of the stop codon. Then, eRF1 binds 
to the ribosome as part of a pre-assembled ternary complex comprising eRF1, 
eRF3 and GTP. Then, eRF3-mediated GTP-hydrolysis induces eRF1 to mediate 
the peptidyl-tRNA hydrolysis and peptide release. Following GTP hydrolysis, the 
RF3-GDP dissociates leaving behind RF1, which remains bound to the ribosome in 
what is known as the post-termination complex until ribosome dissociation occurs, a 
process that can be facilitated by ABCE1. Source: Preis et al. 2014.
1.4. mRNA localization 
After nuclear export, some mRNAs are not directly translated but instead are first 
localized at specific subcellular compartments. Depending on the final localization, 
this process may lead to mRNA storage, degradation or localized translation. For 
example, to achieve localized protein synthesis, some mRNAs are translationally 
repressed, assembled into RBP-motor protein complexes and then transported to 
defined locations such as the endoplasmic reticulum (ER), mitochondria or neuronal 












On the other hand, mRNAs can be also maintained in translationally inactive 
mRNPs. These mRNPs can assemble into membrane-less cytoplasmic organelles 
named mRNP granules. Localization of  mRNAs to these granules is a way to either 
store them translationally inactive or to promote their decay. The best characterized 
mRNP granules in somatic cells are processing bodies (P-bodies) and stress granules 
(Parker & Sheth 2007; Decker & Parker 2012).
P-bodies are present in non-stressed cells and are characterized by the accumulation 
of  proteins involved in translational repression and mRNA decay. Thus, P-bodies 
are mainly thought to be centres for mRNA decay. On the other hand, stress granule 
(SG) formation is enhanced upon cellular stresses, such as ER stress, heat-shock 
or arsenite treatment. They not only contain proteins involved in translational 
repression but also translation initiation factors. Consequently, they are thought to be 
aggregates of  mRNPs stalled at translation initiation, where mRNAs are repressed 
and stabilized during the cellular stress. Noteworthy, P-bodies and SG are dynamic 
structures with partially overlapping functions. In accordance with this some of  
their components are shared and both proteins and mRNAs can cycle between 
P-bodies, stress granules and polysomes (Markmiller et al. 2018; Youn et al. 2018).
Figure 8. Dynamic composition of P-bodies and Stress Granules. Adapted from 
Turner & Díaz-Muñoz 2018.
P-body Stress Granule 











 1.5. mRNA decay
Finally, the last step in a mRNA’s lifecycle is mRNA decay. Individual mRNA half-
lives in a cell vary widely, from more than 24 hours to less than 15 minutes (Kumagai 
et al. 2016). To achieve this, a large cohort of  mechanisms can regulate mRNA 
stability. Broadly, cellular mRNA decay can be divided into two types of  processes: 
basal mRNA decay and quality control decay.
1.5.1. Basal mRNA decay 
Basal mRNA decay consists on the degradation of  mRNAs at the end of  their 
translational life, and it occurs mainly through the exonucleolytic cleavage of  
mRNAs. The previously described 5’ cap, 3’ poly(A) tail or the process of  
circularization, physically prevent the access of  exonucleases to mRNAs ends and 
thus are crucial features that promote mRNA stability. Despite being a multi-step 
process, basal mRNA decay initiates with a gradual shortening of  the poly(A) tail. 
Deadenylation triggers removal of  the 7mG-cap by the decapping complex Dcp1/2 
and its activators (Halbeisen et al. 2008). These events expose the mRNA to rapid 
exonucleolytic degradation, primarily from the 5’ end by Xrn1, and from the 3’ end 
by the exosome and Dis3L2 (Gallouzi & Wilusz 2013).  
1.5.2. Quality control (QC) decay
Cells also need to immediately destroy cytoplasmic mRNAs recognized as aberrant. 
In such cases, mRNAs are usually first cleaved internally by an endonuclease and 
then further degraded by components of  the basal mRNA decay machinery. 
The best-characterized cellular mRNA QC pathway is nonsense-mediated decay 
(NMD), which identifies mRNAs with premature termination codons (PTC) (Popp 
& Maquat 2013). Other RNA QC pathways recognize aberrant translation events, 
such as stalled or non-terminating ribosomes, leading again to mRNA inactivation 












Figure 9. Mechanisms mediating mRNA decay. Source: Abernathy & Glaunsinger 
2015.
1.6. mRNA deadenylation
Importantly, reduction of  the poly(A) tail length is not only the first determinate for 
basal mRNA decay but also the rate-limiting step, as the subsequent exonucleolytic 
decay of  the message body is rapid and irreversible. Therefore, shortening of  the 
poly(A) tail is tightly regulated, in some cases in reversible manners, by multiple 
mechanisms (Schoenberg & Maquat 2009; Eckmann et al. 2011; Weill et al. 2012).
The enzymes responsible for this process are deadenylases. So far, dozens of  
deadenylases have been described in mammals, however, the number is still expanding 
and several details about their specificities and redundancies are still unknown. 
They are usually part of  multi-functional complexes, possessing deadenylase, 
decapping, remodelling and translational repressive activities, and thus controlling 
globally mRNA fate at multiple levels (Goldstrohm & Wickens 2008). One example 
of  such a complex is the CCR4-Not complex. Besides a role in global mRNA 
decay, deadenylases can be recruited to specific subsets of  mRNAs by cis-acting 
elements such as AU-rich Elements (AREs), miRNA binding sites or Cytoplasmic 
Polyadenylation Elements (CPEs), among others (Yan 2014).
AU-rich elements (AREs) consist of  various large clusters of  overlapping AUUUA 
pentamers and UUAUUUAUU nonamers. Approximately 5–8% of  all human 
transcripts contain AREs, which are specifically recognized by over 20 different 
ARE-binding proteins (ARE-BPs) (Beisang & Bohjanen 2012). Among them, 











tristetraprolin (TTP), KSRP and AUF1 recruit deadenylases and downstream 
degradation machinery to their targets, thereby stimulating transcript decay. By 
contrast, when other ARE-BPs bind ARE-containing mRNAs, they can compete 
with the binding of  destabilizing ARE-BPs and thus lead to mRNA stabilization. 
Examples of  these are  the ELAV (family members Hu-antigen R (HuR) and HuD 
(Beisang & Bohjanen 2012).
In the last decade miRNAs have emerged as one of  the major mechanisms mediating 
specific mRNA decay. More than 1,000 miRNAs have been identified in the human 
genome and around 50% of  all mRNAs are predicted to contain miRNA binding 
sites (Huntzinger & Izaurralde 2011a; Kozomara & Griffiths-Jones 2011). Briefly, 
miRNAs are ~21-nucleotide-long non-coding RNAs that are part of  an active 
RNA-induced silencing complex (RISC). At position 2-7 from the miRNA 5’-end, 
miRNAs contain the “seed sequence”, that mediates target mRNA recognition 
through base-pairing. In mammals, usually this pairing is partially complementary, 
leading to mRNA deadenylation and destabilization and/or translational repression. 
Alternatively, few miRNAs can bind to target sites with extensive or perfect sequence 
complementarity, which results in mRNA endonucleolytic cleavage (Huntzinger & 
Izaurralde 2011b).
Figure 10. Elements in the 3’UTR regulate mRNA stability. (a) Recognition of 
AREs by destabilizing ARE-binding proteins, such as tristetraprolin (TTP), stimulates 
mRNA deadenylation and decay. Conversely, the binding of stabilizing proteins — 
such as Hu-antigen R (HUR) — that compete with destabilizing factors inhibits ARE-
mediated RNA degradation. (b) Numerous transcripts contain microRNA (miRNA) 
binding sites in their 3ʹ UTRs. Specific recognition of these sites by the RNA-induced 




















1.7. Cytoplasmic Polyadenylation 
We have seen so far how, after nuclear export, mRNAs can be translated, deadenylated 
and stored, or deadenylated and degraded. Additionally, some mRNAs can be 
re-adenylated in the cytoplasm, a process that allows to de-repress deadenylated 
mRNAs and promote again their translation. This process, named cytoplasmic 
polyadenylation, allows cells to fine tune the location of  protein synthesis. For 
example, in neurons, repressed mRNAs are localized to synapses, where they are 
polyadenylated and locally translated (Miller et al. 2002). Moreover, cytoplasmic 
polyadenylation also contributes to create complex temporal patterns of  protein 
synthesis, like circadian oscillations or the sequential waves of  mRNA activation 
that drive meiosis progression (Kojima et al. 2012; Belloc et al. 2008). Therefore, 
the dynamic regulation of  the poly(A) tail has emerged as another layer to regulate 
protein expression, not only in abundance, but also in timing and space (Eckmann 
et al. 2011).
As nuclear polyadenylation, cytoplasmic elongation of  the poly(A) tail is 
mediated by poly(A) polymerases (PAP). Among them, PAPD4 (Gld2) is the best 
characterized cytoplasmic PAP. Cytoplasmic polyadenylation element (CPE) is the 
most characterized sequence on mRNAs mediating cytoplasmic polyadenylation. 
A few other sequences have been also proposed to mediate this process, but their 
contribution to cytoplasmic polyadenylation is still poorly understood (Charlesworth 
et al. 2013).
CPEs are sequences in the 3’UTR of  mRNAs recognized by the Cytoplasmic 
Polyadenylation Element Binding (CPEB)-family of  proteins. Importantly, CPEBs 
can promote opposite functions on their target mRNAs. Thus, CPEBs binding to 
mRNAs can result in mRNA deadenylation and silencing or polyadenylation and 
translation (Weill et al. 2012; Fernández-Miranda & Méndez 2012). In the next 
sections, we will summarize what is currently known of  CPEBs regulation and 
function.











1.7.1. Cytoplasmic Polyadenylation Element Binding Proteins 
(CPEBs)
In mammals, the CPEB-family is comprised of  four paralogs that, based on sequence 
identity, can be clustered into two subfamilies: CPEB1 and CPEB2-4 (Fernández-
Miranda & Méndez 2012). The four CPEB proteins share common structural 
features. They all contain an unstructured N-terminal regulatory domain (NTD), 
different for each CPEB, and a similar RNA-binding C-terminal domain (CTD) 
comprised of  two RNA recognition motifs (RRMs) and a zinc-binding domain (ZZ 
domain) (Merkel et al. 2013). The RRMs of  CPEB2–4 share 97% sequence identity 
between them, while the RRMs of  CPEB1 shares 48% pairwise sequence identity 
with those of  CPEB2-4 (Hake et al. 1998; Fernández-Miranda & Méndez 2012). 
Despite that it was suggested that all four CPEB family members target the same 
population of  CPE-containing mRNAs, these differences in their RRMs can confer 
certain specificities to the two subfamilies. In accordance with this, the structures 
of  the C-terminal domains of  hCPEB1 and hCPEB4 C-terminal domain that were 
recently solved show that the these two proteins interact differently with the fifth 
position of  the CPE motif  (Afroz et al. 2014).












← Figure 11. CPEB family of RNA-binding proteins. Unrooted phylogenetic tree 
of the most representative CPEB proteins based on a multiple sequence alignment 
using complete protein sequences. Distances between orthologs are significantly 
closer than those between parologs. CPEB1 vertebrate orthologs (red balloon) are 
the most distant members of the family; whereas vertebrates CPEB2 (blue), CPEB3 
(green) and CPEB4 (yellow) are closely related and placed in the same branch. 
Source: Fernández-Miranda & Méndez 2012. 
1.7.2. Cytoplasmic Polyadenylation Elements (CPEs) 
The consensus CPE (CPEc) sequence has been defined as UUUUA1-2U (Richter 
2007). However, there is still controversy on how to define a CPE. First, based on 
in vitro selex experiments, it was proposed that CPEB3-4 recognize a U-rich loop 
motif  (Huang et al. 2006). Second, CPE variations such as UUUUACU were also 
found to be functional and were named non-consesus CPEs (CPEnc) (Piqué et al. 
2008). Finally, cross-linking and immunoprecipitation (CLIP) experiments showed 
different CPE-binding motifs for Orb and Orb2b, the orthologs of  the subfamilies 
CPEB1 and CPEB2-4 in Drosophila melanogaster (Stepien et al. 2016). The latter 
work defined UUUUA and UUUU as the motifs preferentially bound by Orb and 
Orb2b, respectively. Moreover, they also found an enrichment of  UUUUG motifs 
in targets of  Orb2b,  but not of  Orb (Stepien et al. 2016). Altogether, these data 
suggests thatCPEBs can bind more elements besides CPEc and that, despite sharing 
overlapping targets, some mRNAs might be preferentially bound by one CPEB 
subfamily.
It has been shown that, to be functional, CPEs need to be located at an appropriate 
distance from the polyadenylation signal (Piqué et al. 2008). Based on functional 
CPEc and CPEnc, bioinformatic predicts that up to 20% of  human genome 
transcripts are potential CPEBs targets (Belloc & Méndez 2008; Novoa et al. 2010). 
However, this percentage could be actually higher if  other CPE definitions were 
included. Therefore, CPEB-mediated translational control seems to be a widespread 
mechanism to regulate protein production in metazoans.
 
 











1.7.3. Regulation of  CPEBs activity 
In contrast to their conserved RNA-binding domain, the N-terminal regulatory 
domain (NTD) of  CPEB proteins is highly variable and subject to specific post-
translational modifications (PTMs). Importantly, these PTMs can determine if  
CPEBs act as translational repressors or translational activators (Mendez, Murthy, 
et al. 2000; Mendez, Hake, et al. 2000; Drisaldi et al. 2015). It is worth stressing 
that distinct pathways and mechanisms regulate each CPEB. Therefore, in a given 
context, even if  their targets partially overlap, each CPEB might be performing 
opposite functions. 
CPEB1 activity is modified via phosphorylation by Aurora A, and it undergoes 
rapid degradation through CDK1- and PLK1-mediated phosphorylation (Mendez, 
Murthy, et al. 2000; Mendez, Hake, et al. 2000). When unphosphorylated, CPEB1 
represses mRNAs by recruiting the deadenylase PARN or inhibiting the formation 
of  the eIF4F complex (Fernández-Miranda & Méndez 2012). On the other hand, 
upon phosphorylation by Aurora A, CPEB1 binds CPSF, which displaces PARN and 
allows Gld2 to extend the poly(A) tail of  the mRNA (Mendez, Murthy, et al. 2000; 
Kim & Richter 2006). Importantly, besides Aurora A-mediated phosphorylation, the 
arrangement and number of  CPE-elements within the 3’ UTR can also determine 
the effectiveness of  CPEB1 repressor activity (Piqué et al. 2008). Finally, beyond 
cytoplasmic polyadenylation, CPEB1 is also able to participate in alternative cleavage 
and polyadenylation of  mRNAs in the nucleus (Bava et al. 2013).
For CPEB2, no post-translational modifications have been described so far. However, 
it has been proposed to repress transcript translation by interacting with eEF2 and 
inhibiting the elongation phase (Chen & Huang 2012). Alternatively, although the 
molecular mechanisms are not clear, CPEB2 can also activate the translation of  
target mRNAs (Hägele et al. 2009; Pascual et al., under review).
CPEB3 has been shown to act as a repressor, but after undergoing modifications 
like monoubiquitination, N-terminal cleavage or deSUMOylation, it can switch its 
function and promote the translation of  its targets (Pavlopoulos et al. 2011; Wang & 
Huang 2012; Drisaldi et al. 2015). It has also been described that CPEB3 is regulated 
by PKA- and CamKII-mediated phosphorylation (Kaczmarczyk et al. 2016). Unlike 












activity is determined by a change from a soluble to an aggregate state (Drisaldi et al. 
2015). Moreover, data on CPEB3 localization suggests that it could have a nuclear 
function not related to cytoplasmic polyadenylation (Chao et al. 2012).
Finally, CPEB4 activity is regulated via ERK2- and CDK1-mediated 
hyperphosphorylation of  the NTD. These phosphorylation events additively 
maintain CPEB4 in its monomeric state, promoting mRNA polyadenylation and 
translation. In contrast, unphosphorylated CPEB4 separates into liquid-like droplets 
where mRNA is stored but not polyadenylated (Guillén-Boixet et al. 2016). Moreover, 
it has also been proposed that CPEB4 may act as a repressor of  translation during 
terminal erythroid differentiation through an interaction with eIF3 that represses 
translation globally (Hu et al. 2014).
Figure 12. Post-translational modifications modify CPEB activity. (a) Upon 
AurKA-mediated phosphorylation, CPEB1 interacts with different partners and 
changes from a repressor to an activating function. For CPEB2, no PTMs have been 
described so far. CPEB3 polyadenylating function is determined by modifications like 
monoubiquitination and SUMOylation, which determine its soluble or aggregate state. 
CPEB4 activity is regulated by ERK2 and Cdk1 kinases. Upon hyperphosphorylation, 
CPEB4 disassembles the liquid like droplets and its found on its monomeric active 
state, where it can promote mRNA polyadenylation. 
a











1.7.4. CPEBs biological function
Regarding the biological functions exerted by CPEBs, they have been studied mainly 
during Xenopus laevis oocyte maturation and early developmental stages, in contexts 
where transcription is absent and post-transcriptional control of  gene expression is 
particularly important. However, in recent years, data unveiling CPEB functions in 
somatic cells have started to emerge. 
Concerning meiotic progression, it has been shown that CPEB1 is required for 
the repression and storage of  maternal mRNAs in arrested oocytes. Upon meiotic 
resumption, CPEB1 and CPEB4 drive sequential waves of  translational activation at 
different steps of  the cell cycle (Igea & Méndez 2010). Interestingly, in this context 
it was shown how the arrangement of  CPEs and AREs on the 3’UTR of  mRNAs, 
leads to opposing polyadenylation and deadenylation activities that determine the 
precise activation times of  mRNAs during meiosis progression (Belloc et al. 2008) 
(Figure 13).
In somatic cells, CPEB1, 2 and 4 have been also involved in mitotic cell cycle 
progression (Novoa et al. 2010; Giangarrà et al. 2015). CPEBs repressing and 
activating function has also been shown to participate in mRNA localization and cell 
polarity (Xu et al. 2014). Moreover, all four CPEBs are expressed in the brain and 
especially CPEB3, has been shown to participate in neural functions such as memory 
establishment or thermosensitivity (Peng et al. 2010; Pavlopoulos et al. 2011; Wang & 
Huang 2012; Chao et al. 2013; Huang et al. 2014; Fioriti et al. 2015; Fong et al. 2016; 
Lu et al. 2017). On the other hand, CPEBs are also highly expressed in the liver. It 
has been reported that CPEB1 and CPEB4 sequentially regulate VEGFa expression 
in cirrhotic livers and, in homeostasis, CPEB4 maintains ER and mitochondrial 
homeostasis (Calderone et al. 2016; Maillo et al. 2017). Moreover, CPEBs have been 
studied in some tumour environments, showing for example a tumour-promoting 












Figure 13. Sequential waves of cytoplasmic polyadenylation activate mRNA 
translation during meiosis progression. In immature oocytes, CPE-containing 
mRNAs are deadenylated and stored repressed. Upon progesterone stimulation, 
CPEBs trigger three sequential waves of cytoplasmic polyadenylation, activating 
translation of specific mRNAs at the different stages of meiosis progression. The 
number and relative position of CPEs, AREs and the PAS determines the timing 
when the mRNA is going to be translated, a model known as the combinatorial code. 
Source: Weill et al. 2012 











1.7.5. Mechanisms regulating CPEBs expression
Little is known about the transcriptional mechanisms that control CPEBs expression. 
Cpeb1 gene undergoes epigenetic silencing during gastric cancer progression 
by heavy methylation of  its promoter (Caldeira et al. 2012). Moreover, circadian 
transcriptomics in mouse liver revealed the rhythmic expression of  Cpeb2 and Cpeb4 
mRNAs (Kojima et al. 2012), which was further confirmed for Cpeb4 (Maillo et al. 
2017).
On the other hand, Cpebs mRNAs are subject to several mechanisms of  translational 
control. First of  all, Cpeb2-4 3’UTRs contain CPEs and Cpeb4 mRNA has been 
shown to be regulated by CPEB1 and CPEB4 itself  (Igea & Méndez 2010). All 
CPEB mRNAs also contain multiple predicted miRNA binding sites and miR-
92 and miR-26 have been shown to regulate Cpeb2-4 mRNA stability (Morgan et 
al. 2010) whereas miR-122 controls Cpeb1 mRNA translation (Burns et al. 2011). 
Finally, Cpeb4 translation is also controlled by the unfolded protein response (UPR) 
through uORFs within the 5’UTR (Maillo et al. 2017). This mechanism was shown 
to be CPEB4-specific and not shared by the other CPEBs.
Finally, CPEB function can also be altered by alternative splicing or alternative 
cleavage and polyadenylation of  Cpebs pre-mRNAs (Wang & Cooper 2009; Wang & 












In the second section of  the introduction, we will address macrophage biology. 
We will dissect the molecular mechanisms involved in the development of  an 
inflammatory response and the processes that mediate inflammation resolution. 
Moreover, we will give an overview of  the contribution of  posttranscriptional 
regulatory mechanisms to each phase of  the LPS response.  
2. The Innate immune system
The immune system is a set of  host defence mechanisms against pathogens and 
diseases. It is classically divided into two categories: the innate immune system and 
the adaptive. The innate immune system represents our first line of  defence against 
pathogens and it is composed of  the skin and mucous membranes that form external 
barriers, the complement system and immune cell types such as macrophages, 
dendritic cells, neutrophils or natural killer cells. As a second defence mechanism we 
have the adaptive immune system, which confers a more specific response adapted 
to each antigen, and can provide long lasting immunity. T cells, B cells and their 
produced antibodies are part of  the adaptive immune response. 
The crosstalk between the innate and the adaptive immune system has been 
widely studied. Given that adaptive immune cells displayed complex maturation 
mechanisms to achieve antigen-specific responses, it had long been thought that 
specific adaptive responses (T and B cells) governed the unspecific behaviour of  
innate immune cells (Mills 2015). However, now, it is well established that there is 
an innate control of  adaptive immunity that can drive immune responses towards 
type 1 or type 2 immunity (Iwasaki & Medzhitov 2015). Type 1 immunity consists of  
inflammatory responses developed against microorganisms such as viruses, bacteria, 
fungi and possibly protozoa. Recognition of  pathogens by the innate immune 
system is mediated by pattern-recognition receptors (PRRs), which detect conserved 
pathogen-associated molecular patterns (PAMPs), such as bacterial cell-wall 
components and viral nucleic acids. Briefly, type 1 immune responses lead to rapid 
and effective inflammatory responses to eliminate the pathogen. On the other hand, 
type 2 immune responses are induced by parasitic worms and allergens. In this case, 
innate immunity activation occurs by sensing functional characteristics indicative 
of  a pathogen’s presence, rather than specific structures in those pathogens. The 











sensing pathways responsible for this recognition overlap with pathways responsible 
to sense tissue damage. Therefore, type 2 immunity not only activates pathogen 
clearance mechanisms, but also tissue repair responses. 
In both types of  immunities, first the innate immune system recognizes the damage, 
then it signals to adaptive cells so that they polarize towards type 1 or 2 responses 
and, finally, adaptive cells activate effector cells to perform the needed response. 
Importantly, each type of  immunity uses cell types in common, however secretion 
of  different cytokines allows that they acquire specific functions adapted to the insult 
received. However, it should be taken into account that this useful classification to 
understand immune functions is not always reproduced in vivo, as several pathologies 
damage our organism at multiple levels triggering both types of  immune responses 
at the same time. 
Figure 14. Schematic vision of type 1 and type 2 immunity. Immune responses 
are orchestrated by three categories of cells. Innate immune cells function as 
‘sensors’ that detect pathogens and secrete ‘level 1’ cytokines, the tissue-resident 
lymphocytes that respond to ‘level 1’ cytokines to secrete ‘level 2’ cytokines, and 
the effector cells that respond to ‘level 2’ cytokines to carry out effector functions to 
eliminate the pathogen. Type 1 and type 2 immunity use different cytokines in order 













2.1. The mononuclear phagocytic system (MPS) 
The mononuclear phagocytic system (MPS) (van Furth et al. 1972) comprises 
monocytes, macrophages and dendritic cells (DCs), as well as their respective 
committed bone marrow (BM)-resident progenitors (Geissmann et al. 2010; Yona 
& Gordon 2015). In adult organisms, mature macrophages can be subdivided in 
monocyte-derived macrophages and tissue-resident macrophages. 
Tissue resident macrophages mainly originate from progenitor cells generated 
in the yolk sac during embryogenesis. In some tissues and conditions, resident 
macrophages are long lived and have self-renewing capacity, while in others, 
maintenance of  resident macrophages relies on monocyte infiltration (Perdiguero 
& Geissmann 2016). Tissue-resident macrophages are highly heterogeneous 
as they participate in functions that are specific of  their location, such as bone 
morphogenesis (osteoclast), ductal branching (macrophages in the mammary gland) 
or neural networking (microglia) (Pollard 2009).
On the other hand, monocytes are cells circulating in the blood, bone marrow, and 
spleen that arise from hematopoietic stem cells (HSCs) in the bone marrow. Besides 
the replenishment of  certain populations of  resident macrophages and DCs, under 
inflammatory conditions, monocytes are recruited to the source of  infection or 
damage. Upon tissue infiltration, they differentiate into macrophages and, together 
with resident macrophages, orchestrate the immune response.











Figure 15. Origin of the mononuclear phagocytic system. EMP-derived 
hematopoiesis gives rise to erythrocytes and short-lived myeloid cells (monocytes, 
granulocytes and mast cells) that are replaced by HSC-derived cells late during 
gestation. EMPs-derived fetal macrophages colonize all tissues during fetal 
development, where they specialize to their tissue of residency after birth and 
can persist throughout adult life by local proliferation (circular red arrows indicate 
self-renewal potential). Depending on the age of the organism and environmental 
challenges, HSC-derived cells can contribute to adult tissue-resident populations. 
EMPs: Erythro-myeloid progenitors, HSCs: Hematopoietic Stem Cells. Source: 
Perdiguero and Geissmann 2016. 
2.2. Macrophage function during an inflammatory response
An inflammatory response against a pathogen can be divided into different phases. 
The first phase is mainly aimed at destroying the pathogen and, as it uses mechanisms 
that can also damage endogenous tissues, needs to be tightly controlled. Then, a 
clearance phase follows in which dying cells, damaged extracellular matrix material, 
and cellular debris are removed. Finally, there is a recovery phase in which the tissue 












Macrophages play key roles in several of  these steps. Following infection or tissue 
injury, they participate in pathogen recognition and they express proteins that are 
involved in direct antimicrobial functions, such antimicrobial peptides or inducible 
nitric oxide synthase (iNOS); or cytokines and chemokines, like TNFα, IL-6, and IL-
1b, which lead to increased endothelium permeability and promote early recruitment 
of  other innate immune cells. Moreover, being antigen-presenting cells, they can 
also contribute to T cell differentiation and activation of  the adaptive immune 
response. Finally, macrophages are also essential in resolving inflammation by the 
phagocytosis of  dead cells, secreting anti-inflammatory cytokines, and facilitating 
wound-healing and repair mechanisms (Serhan et al. 2008; Murray & Wynn 2011; 
Lavin & Merad 2013).
2.3. Macrophage activation by LPS
To recognize pathogens, macrophages express several classes of  PRRs, including 
Toll-like receptors (TLRs), RIG-I-like receptors (RLRs), NOD-like receptors (NLRs) 
and C-type lectin receptors (CLRs) (Arthur & Ley 2013). All PRRs mentioned above 
activate both MAPK and nuclear factor-κB (NF-κB) pathways, which are crucial to 
generate immune responses. In addition, certain PRRs can also promote activation 
of  other pathways like the inflammasome or interferon regulatory factors (IRFs) 
(Kawasaki & Kawai 2014).
TLRs were the first PRRs to be identified and are the best characterized. The TLR 
family comprises 10 members (TLR1–TLR10) in human and 12 (TLR1–TLR9, 
TLR11–TLR13) in mouse. TLRs localize to the cell surface or to intracellular 
compartments such as the ER, endosome or lysosome, and they recognize distinct 
or overlapping PAMPs and DAMPs (danger-associated molecular patterns, such as 
HMGB1, endogenous RNA and DNA) (Figure 16). Each TLR is composed of  
an ectodomain that mediates PAMPs recognition, a transmembrane domain, and a 
cytoplasmic Toll/IL-1 receptor (TIR) domain that initiates downstream signalling 
(Kawasaki & Kawai 2014). TLRs are expressed by innate and adaptive immune cells 
(macrophages, neutrophils, DCs, NK cells, mast cells, T- and B-lymphocytes); as 
well as by some nonimmune cells, such as epithelial and endothelial cells. 











Lipopolysaccharide (LPS) is the major component of  the outer membrane of  
Gram-negative bacteria and one of  the most immune-stimulatory glycolipid. Many 
pathogenic bacteria such as Pseudomonas aeruginosa, Neissera gonorrhoeae, Chlamydia 
trachomatis or Yersinia pestis are gram-negative bacteria. In mammals, LPS recognition 
is mediated by TLR4. 
Figure 16. Toll like receptor (TLR) family of pattern-recognition receptors. TLRs 
plays a central role as sensors of infection. Different TLRs recognize distinct types of 
conserved microbial structure, thus endowing the innate response with a degree of 
specificity. Source: Hajishengallis & Lambris 2010.
2.4. TLR4 signalling pathway
LPS recognition by TLR4 does not occur directly. LPS first needs to bind soluble 
LPS-binding protein (LBP), and then the LPS-LBP complex bind the cell-surface 
receptor CD14, which associates with TLR4 and the accessory protein MD-2 (Fan 
& Cook 2004). Then, upon LPS binding, TLR4 triggers an intracellular response. 
TLR signalling is mediated through their cytoplasmic TIR domains, which interact 
with adaptor proteins following agonist stimulation. TLR4 signals via two adaptor 












BOX 1. MAPK SIGNALLING CASCADES
Mitogen-activated protein kinases (MAPKs) are a superfamily of proline-directed 
serine/threonine protein kinases that are activated in front of several stimuli such 
as hormones and growth factors, cytokines, or environmental stresses (Roux & 
Blenis 2004). MAPKs pathways consist of a series of at least three kinases: a 
MAPK kinase kinase (MAP3K) that activates a MAPK kinase (MAP2K), which in turn 
phosphorylates and activates the MAPK. Mammalian cells express 14 MAPKs that, 
based on their pathways, can be subdivided into different families: the extracellular 
signal-regulated kinases (ERK1/2), p38 MAPKs (p38α, p38β, p38γ and p38δ), Jun 
N-terminal kinases (JNK1/2/3) and the ERK5 MAPK. The remaining MAPKs are 
ERK3/4/7/8 and Nemo-like Kinase (NLK), although their function and regulation 
have been less characterized. In figure 17, it can be seen how each MAPK can be 
activated by several MAP2K and MAP3K, depending on the stimuli and cell type. 
Downstream each MAPK pathway, several kinases, transcription factors or RNA-
Binding proteins are regulated. Moreover, it is worth mentioning that the different 
MAPK can also cross-regulate each other’s function. 
Figure 17. MAPKs signalling cascade. Source: Arthur & Ley 2013.











2.4.1. MyD88-dependent signal transduction
Following ligand binding to TLRs, MYD88 adaptor-like protein (MAL) mediates 
MYD88 recruitment to TLR4 TIR domains. Then, MYD88 interacts with and 
activates the kinases IRAK1/2 and IRAK4, which in turn activate the E3 ubiquitin 
ligase TRAF6. TRAF6, along with ubiquitin-conjugating enzyme UBC13 and 
UEV1A, promotes K63-linked polyubiquitination of  TRAF6 itself  and the MAP3K 
TAK1, inducing TAK1 activation and the subsequent activation of  both p38 and 
JNK pathways. 
The IKK complex is composed of  the catalytic subunits IKKα and IKKβ and the 
regulatory subunit NEMO (also called IKKγ). Once ubiquitinated, through its K63-
Ub chains, TAK1 also binds to the IKK complex, promoting that the IKK complex 
phosphorylates the NF-κB inhibitory protein IκBα. Unphosphorylated IκBα 
masks the nuclear localization signal of  NF-κB retaining it in the cytoplasm. Upon 
phosphorylation, IκBα undergoes proteasome degradation, allowing NF-κB nuclear 
translocation to induce pro-inflammatory gene expression. IκBα degradation also 
releases the inhibition of  TPL2 , a MAP3K that will activate the ERK1/2 pathway 
(Arthur & Ley 2013; Kawasaki & Kawai 2014).
2.4.2. TRIF-dependent signal transduction
In addition to the early MyD88-dependent signals, TLR4 triggers a delayed signal 
cascade through the adaptor TRIF. For this to happen, TLR4 is internalized into 
endosomes and, via TRIF-Related Adaptor Molecule (TRAM), activates TRIF-
dependent pathways. In this case, TRIF activates the kinase TBK1 to promote 
phosphorylation of  the interferon regulatory factors IRF3 and IRF7, which induce 
the expression of  type I interferons (IFNα and IFNβ). 
Moreover, TRIF also interacts with the previously mentioned TRAF6. In this case, 
TRAF6 recruits the kinase RIP-1, which in turn activates again TAK1, leading to 
second wave of  NF-κB and MAPKs activation (Liu et al. 2016; Bode et al. 2012; 












Figure 18. TLR4 signalling pathway. Upon LPS binding, TLR4 triggers an 
intracellular responses, which are mediated via two adaptor proteins, MYD88 and 
TRIF. Both pathways lead to the activation of the NF-κB and MAPKs pathway.
 
2.4.3. Role of  MAPK in LPS response: p38, ERK, JNK
Once activated, the three main MAPKs families can mediate both pro- and/or anti-
inflammatory functions during LPS-driven macrophage activation (Arthur & Ley 
2013; Bode et al. 2012). The JNK family has mainly a pro-inflammatory function, 
via c-Jun/c-Fos heterodimers (which form AP-1) that activate the transcription of  
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On the other hand, p38αα and ERK1/2 pathways can mediate both pro- and 
anti-inflammatory functions. For example, ERK1/2 participate in TNFα and IL-
1β expression, but negatively regulate the production of  IL-12, IFNβ and iNOS. 
Via MK2, p38α also promotes the expression of  inflammatory cytokines, such as 
TNFα, IL-12 and IL-18. One mechanism is by regulating their mRNA stability, but 
it can additionally regulate cytokine expression via transcription factors such as C/
EBPβ, among others.
However, as previously mentioned, ERK1/2 and p38α also activate anti-inflammatory 
pathways, mainly by phosphorylating and activating MSKs. In macrophages, the 
predominant role of  MSKs is the transcriptional induction of  genes involved in 
inflammation inhibition such as IL-10, IL-1 receptor antagonist protein (IL-1RA), 
or DUSP1. This process is mediated by phosphorylation of  the transcription factor 
CREB1, among others.
2.4.4. NF- κB
NF-κB is a dimeric transcription factor generated from combinations of  Rel, p65, 
RelB, p50/NFκB1 and NFκB2 (Hayden & Ghosh 2011; Tugal et al. 2013). The 
prototypic NF-κB consists of  a heterodimer of  p50 and p65 and is classically 
held in an inhibitory IKK complex. As previously mentioned, downstream TLR4 
activation, IκBα degradation allows that NF-κB translocates to the nucleus and 
activates the transcription of  genes containing a DNA-binding motif  known as a 
κB-binding site (Hoffmann & Baltimore 2006).
NF-κB regulates the expression of  a large number of  inflammatory genes including the 
cytokines TNFα, IL-1β, IL-6 and IL-12p40; the chemokines CXCL1 and CXCL2; or 
other inflammatory mediators such as cyclooxygenase 2 (COX2), hypoxia-inducible 
factor 1α (HIF1α) and iNOS. Mechanistically,  NF-κB transcriptional activation 
has been linked to chromatin modification. During macrophage activation, p65 is 
phosphorylated, enabling the recruitment of  histone acetyl transferases (HATs) such 
as CBP/p300. The subsequent histone acetylation induces chromatin relaxation and 












2.4.5. Autocrine loops in LPS response
TLR4 signalling triggers the expression of  cytokines that, once secreted, can signal 
in an autocrine manner on macrophages, initiating new signalling cascades that will 
also contribute to the inflammatory response (Figure 19). 
Secreted type I interferons α and β bind to the type I interferon receptor 
(IFNAR) with consequent activation of  the kinase JAK1, which phosphorylates 
the transcription factors STAT1 and STAT2. P-STAT1/2 proteins dimerize and 
translocate to the nucleus, activating the expression of  interferon-responsive genes, 
such as the chemokines CXCL9 and CXCL10 (Moynagh 2005; Hu et al. 2008; Wang 
et al. 2014).
IL-10 induces an anti-inflammatory response via IL-10 receptor (IL-10R)-JAK1-
mediated activation of  STAT3. P-STAT3 homodimers translocate to the nucleus 
and activate the expression of  anti-inflammatory genes such as IL-10 itself, SOCS3, 
DUSP1 or TTP. These molecules inhibit NF-κB and other inflammatory pathways 
through different mechanisms (Saraiva & O’Garra 2010; Hutchins et al. 2013). 
Interestingly, IL-6 also activates STAT3 through the IL-6 receptor (IL-6R), in this 
case to mediate a pro-inflammatory response. However, IL-6-dependent STAT3 
activation is more transient than the one mediated by IL-10, explaining the different 
functions of  STAT3 in response to each cytokine (Bode et al. 2012).
Macrophages also respond to TNFα, which promotes an inflammatory positive-
feedback loop by stimulating JNK activation and AP-1 activity (Tugal et al. 2013). 
Finally, other LPS-induced proteins also signal back to macrophages in a more indirect 
manner. For example, COX2 expression leads to the production of  prostaglandins 
(PG), which have pro-inflammatory effects but also induce negative feedback loop 
that favours the expression of  anti-inflammatory molecules such as DUSP1 (Tugal 
et al. 2013; Tang et al. 2017). Alternatively, iNOS-mediated production of  reactive 
oxygen species (ROS) can activate ASK1 MAP3K leading again to p38 and JNK 
activation (Arthur & Ley 2013).  











Figure 19. Autocrine loops during inflammatory responses. During the LPS 
response, macrophage synthesize and secrete cytokines like type I IFNs, IL-1, TNFα 
IL-6 and IL-10. Once secreted, they can be recognized by their receptors activating 
again different signalling cascades. 
2.5. Inflammation resolution: TLR4 and NF-κB negative regulators
TLR4 activation also induces the expression of  inhibitors of  the inflammatory 
signalling cascades (Bode et al. 2012). This negative feedback mechanisms use 
different strategies to inhibit inflammatory pathways: dephosphorylation, protein 







































Dual-specificity protein phosphatases (DUSPs, also known as MKPs) are enzymes 
that can dephosphorylate threonine and tyrosine residues in the activation loop 
of  MAPKs, thus inactivating them. DUSP1 and DUSP2 are the main DUSPs 
upregulated following TLR4 activation. DUSP1 predominantly targets p38α and 
JNKs, while DUSP2 targets only JNKs. DUSP4 and DUSP5 function is still unclear, 
although they have been suggested to dephosphorylate ERK1 and ERK2 (Arthur 
& Ley 2013). Other protein-tyrosine phosphatases (PTPs, such as SHP-1, SHP-2, 
CD45, PIP1B) dephosphorylate receptors at the plasma membrane and thereby 
block TLR signalling (Lawrence & Fong 2010).
Suppressors of  cytokine signalling (SOCS) proteins are also inhibitors of  inflammatory 
pathways. Through their SOCS domain they function as E3 ubiquitin ligases and 
mediate protein degradation. For example, SOCS1 facilitates the ubiquitylation and 
degradation of  the p65 subunit of  NF-κB and the adaptor MAL (Wilson 2014). 
Besides mediating protein degradation, SOCS1 and SOCS3 also inhibit JAK1 by 
working as pseudosubstrates (Yoshimura et al. 2007). Through this mechanism, 
SOCS1 directly inhibits JAK1, IFNAR and the IFNγ receptor (IFNGR) (Schneider 
et al. 2014; McCormick & Heller 2015). Moreover, SOCS1 might also inactivate 
JNK and p38 MAPK pathways by binding to ASK1 MAP3K (Yoshimura et al. 
2007). On the other hand, SOCS3-mediated inhibition of  JAK1 strongly inhibits 
IL-6R but not IL-10R, explaining STAT3 transient activation in response to IL-6, 
but sustained in response to IL-10. Moreover, SOCS3 can also inhibit the activation 
of  TRAF6 and TAK1 (Yoshimura et al. 2007; Tugal et al. 2013).
A20/TNFAIP3 is a ubiquitin ligase and deubiquitin enzyme (DUB) that can inhibit 
TLR signalling in several manners. On the one hand, it adds K48-polyubiquitin 
chains to the mediators RIP1 and UBC13, leading to their degradation. On the 
other hand, it removes K63–polyubiquitin chains to disrupt the interactions created 
during early TLR activation between IRAK1/4, RIP1, TAK1 and the IKK complex. 
Importantly, other ubiquitin ligases and DUBs are also involved in inflammation 
resolution (Wertz & Dixit 2010; Das et al. 2018).











Other proteins have been shown to use different mechanisms to inhibit the TLR 
cascade, such as blocking receptors or interactions. In this category we can find 
MyD88s, an alternative spliced form of  MyD88 that blocks the TLR receptor; 
Interleukin-1 receptor antagonist (IL-1RA), that blocks IL-1 receptors without 
inducing any intracellular response; or IRAK-M, which blocks the dissociation of  
IRAK1-4 from MyD88 (Lawrence & Fong 2010; Wertz & Dixit 2010).
Finally, some mechanisms specifically limit NF-κB function. On the one hand, NF-
κB triggers the synthesis of  its inhibitor IκBα, which retains NF-κB again in the 
cytoplasm (Hoffmann & Baltimore 2006). Moreover, different combinations of  NF-
κB subunits can also disrupt its inflammatory activity. For example, homodimers 
of  the p50 subunit, heterodimers containing RelB or containing unphosphorylated 
p65, bind to repressive histone deacetylases (HDACs) suppressing transcription of  
NF-κB target genes (Oakley et al. 2005).
Figure 20. Negative inhibitors of the inflammatory pathways mediate 
inflammation resolution. Suppression of the TLR4 pathways by multiple inihbitory 
molecules, shown in red. These negative regulators can also inhibit IL-6, Type I IFN, 
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2.6. Post-transcriptional control during the LPS response
The TLR signalling pathway is also subjected to extensive translational regulation. 
Here, we will give a brief  overview of  the translational landscape during the LPS 
response.
2.6.1. mRNA decay during the LPS response
One piece of  data showing the relevance of  translational control in immune 
responses comes from the analysis of  transcription and mRNA decay dynamics 
during the LPS response. After LPS stimulation, the increase in RNA levels are 
mainly due to changes in transcription rates. However, the duration of  these 
responses. particularly those that are rapid and transient,  is mainly determined by 
RNA decay (Carpenter et al. 2014).
As previously mentioned, AU-rich elements (AREs) in mRNAs are highly involved 
in the regulation of  its stability. Numerous inflammatory factors undergo ARE-
mediated regulation, including IL-6, TNFα, IL-1β, GM-CSF, iNOS and IL-10. 
Tristetraprolin (TTP) is an AREs binding protein whose function during the 
LPS response in macrophages has been widely characterized. Importantly, TTP 
destabilizing activity is crucial to limit the expression of  inflammatory cytokines.
In unstimulated macrophages, unphosphorylated TTP interacts with the CCR4-
NOT deadenylase complex promoting the destabilization of  its target mRNAs 
(Fabian et al. 2013). In this context, TTP also destabilizes its own mRNA and it is 
subjected to proteasomal degradation, therefore TTP mRNA and protein levels are 
maintained low. Upon LPS stimulation, MK2 downstream p38α phosphorylates TTP 
triggering several effects. On the one hand, it promotes the assembly of  TTP:14-3-3 
complexes, which prevent the interaction between TTP and the deadenylase complex 
(Stoecklin et al. 2004; Clement et al. 2011). Moreover, TTP phosphorylation also 
prevents its proteasomal degradation leading to an accumulation of  TTP protein 
(Hitti et al. 2006; Brook et al. 2006). Finally, TTP phosphorylation reduces its ARE-
binding affinity (Hitti et al. 2006). In the case of  TNFα mRNA, this reduction 
in TTP affinity shifts the competitive AREs-binding equilibrium towards HuR, 
another ARE-binding protein that contributes to the stabilization and expression 
of  TNFα (Tiedje et al. 2012). Altogether, these processes inhibit TTP-mediated 











deadenylation of  mRNAs, promoting the stabilization of  TTP targets. Moreover, 
this mechanism contributes to the rapid expression of  inflammatory cytokines upon 
macrophage activation. However, during the resolutive phase of  the LPS response, 
p38 activity its inhibited, favouring Protein Phosphatase 2A (PP2A)-mediated 
removal of  phosphate groups from TTP (Sun et al. 2007; Smallie et al. 2015). Thus, 
unphosphorylated TTP destabilizes again cytokine mRNAs, favouring the reduction 
in cytokine expression during inflammation resolution (Figure 21). 













































Despite the extended characterization of  this mechanism, there are still pieces that 
are poorly understood. For example, genome-wide studies have shown that not all 
TTP targets are destabilized in the same way during the LPS response, nor are they 
all regulated by the competition between TTP and HuR as is Tnf  (Sedlyarov et 
al. 2016). Moreover, HuR depletion leads to exacerbated inflammatory conditions 
(Yiakouvaki et al. 2012), which undermines its function as a translational activator 
of  inflammatory cytokines, and suggests it also has anti-inflammatory roles, either 
as a translational activator of  anti-inflammatory molecules or as a transcriptional 
repressor due to its nuclear functions. In this line, HuR nucleo-cytoplasmic shuttling 
is controlled by several pathways, including the p38-MK2 axis. In this manner, HuR 
function might be modified along the different phases of  the LPS response (Doller 
et al. 2008)
Finally, other ARE-BPs are also expressed during the LPS response, such as AUF1 
and TIA1. These two proteins also target Tnf mRNA; AUF1 destabilizes it while 
TIA1 represses its translation. The competition between these proteins and HuR 
and TTP could also account for the differential behaviour between ARE-containing 
mRNAs. 
It is worth mentioning that transcript stability can be also affected by non-ARE 
regulatory elements. Among others, EDEN-like sequences, constitutive decay 
elements (CDEs) or other stem loop structures can promote mRNA decay, while 
for example UC-rich sequences can mediate mRNA stabilization (Bode et al. 
2012; Carpenter et al. 2014; Mino et al. 2015; Fu & Blackshear 2017). Additionally, 
abundant evidence has revealed the importance of  miRNAs in the initiation and 
termination of  inflammation, as they can target crucial molecules and thus participate 
in macrophage polarization into pro- or anti-inflammatory functions (Kawasaki & 
Kawai 2014; Lu et al. 2014; Essandoh et al. 2016). 
The interplay between all these regulatory elements that control mRNA decay will 
determine the duration of  mRNA expression during the LPS response.











2.6.2. Translational regulation during the LPS response
Upon LPS stimulation, several translational regulatory mechanisms are also activated 
affecting the development of  the inflammatory response. 
As previously mentioned, eIF2α phosphorylation leads to global translational 
repression of  most mRNAs and, moreover, prolonged eIF2α phosphorylation 
can lead to apoptosis. LPS response triggers eIF2α phosphorylation, however it is 
compensated by the dephosphorylation of  eIF2B via TRIF, which stimulates eIF2B-
mediated recycling of  eIF2. This mechanism allows the maintenance of  efficient 
mRNA translation and cell survival, even if  eIF2α remains phosphorylated (Woo et 
al. 2009; Woo et al. 2012; Cláudio et al. 2013; Carpenter et al. 2014).
In addition, eIF4E activity and availability is also regulated during the LPS response. 
For example, TLR-triggered eIF4E phosphorylation has been shown to enhance the 
translation of  mRNAs such IκBα (Herdy et al. 2012). LPS activates mTOR (Lopez-
Pelaez et al. 2012), which via 4E-BP phosphorylation favours eIF4E availability. 
This process mainly enhances translation of  5’TOP (terminal oligopyrimidine) 
mRNAs and mRNAs with highly structured 5´UTR, some of  which are key 
inflammatory genes such as IRF7, TNFα, IL6 or CXCL1. Although this would 
point towards mTOR having a pro-inflammatory function, mTOR inhibition can 
lead to increased expression of  inflammatory markers. As the mTOR pathway is 
involved in multiple other functions such as metabolism regulation, further studies 
are needed to understand mTOR contribution to both pro- and anti-inflammatory 
processes (Weichhart et al. 2015; Turner & Díaz-Muñoz 2018).
Alternative mechanisms of  regulating translation upon LPS stimulation have been 
also described: inhibition of  eIF4A activity, mRNA localization to stress granules 
and/or P-bodies or regulation of  translation elongation. Furthermore, long non-
coding RNAs are an emerging field that may potentially regulate macrophage 
activation both at the transcription and post-transcriptional levels (Carpenter et al. 












2.6.3. CPEBs in LPS response
The contribution of  CPEBs to macrophage activation by LPS remains largely 
unexplored. For CPEB1, it has been described that KO MEFs and macrophages 
show enhanced NF-κB activation and cytokine expression, indicating that CPEB1 
has a repressor function on cytokine mRNAs such as Il6, Il12, or the upstream NF-
κB activator Tak1 (Ivshina et al. 2014; Groppo & Richter 2011). For the CPEB2-4 
subfamily, their function in macrophages is unknown, although it has been shown in 
other contexts that they can regulate the mRNAs of  inflammatory mediators such 
as Hif1a, tPA or Vegf (Hägele et al. 2009; Chen & Huang 2012; Ortiz-Zapater et al. 
















The aim of  this project is to unveil the contribution of  Cytoplasmic Polyadenylation 
Element Binding Proteins (CPEBs) to macrophage physiology. 
Particularly, we focused on the contribution of  CPEB4-mediated translational 
control to the development and resolution of  inflammatory processes in response 
to LPS stimulation. 
The specific goals that we have pursued are the following:
- Characterization of  the regulatory mechanisms that control CPEB4 
expression and activity upon LPS stimulation in macrophages.
- Definition of  CPEB4 target mRNAs in quiescent macrophages and during 
the late phase of  the LPS response. 
- Understanding the relevance of  CPEB4 function in quiescent macrophages 
and during the LPS response. 
- Understanding the relevance of  CPEB4 expression in myeloid cells in vivo, 













1. CPEB4 is upregulated upon LPS stimulation in macrophages 
Macrophages are immune cells that belong to the innate immune system. Thus, they 
need to rapidly respond to a great variety of  challenges and activate the appropriate 
gene expression program in order to orchestrate effective immune responses. For 
example, macrophages develop antimicrobial functions upon encounter with bacteria, 
while upon sensing of  immunomodulatory cytokines like IL4 they acquire properties 
to promote tissue repair (Martinez & Gordon 2014). Multiple transcriptional and 
translational mechanisms are involved in the regulation of  the duration, extent 
and resolution of  inflammatory responses. Importantly, both positive and negative 
inputs are needed in order to create transient oscillatory responses. CPEBs have 
the unique property of  being able to repress as well as activate translation through 
the regulation of  the poly(A) tail of  mRNAs. Thus, multiple studies have shown 
CPEBs contribution to rapid responses in response to stimuli, such as neuronal 
activation after synaptic stimulation or the resumption of  meiotic progression upon 
progesterone sensing. However, whether CPEBs contribute to the development of  
inflammatory responses remains unexplored. 
Therefore, we decided to study if  CPEBs are involved in inflammatory responses. For 
this, we obtained Bone Marrow Derived Macrophages (BMDMs) and characterized 
CPEBs expression in different situations.  First, we observed that under basal 
conditions, Cpeb2 mRNA was the most abundant one, followed by Cpeb4 (Fig. 22a). 
Next, we stimulated macrophages with LPS, the main membrane component of  gram 
negative bacteria, or with IL-4, an immunomodulatory cytokine. As expected, these 
two stimuli triggered opposite polarizations in macrophages, which also involved 
dramatic changes in CPEBs expression. During the LPS response, Cpeb4 mRNA 
was strongly upregulated, Cpeb3 showed a smaller peak, but the other members of  
the CPEB family were virtually unaffected (Fig. 22b). On the contrary, after IL4 
stimulation, Cpeb1 levels increased, Cpeb2 and Cpeb3 remained stable, and Cpeb4 was 
slightly downregulated (Fig. 22b). These results suggested that the expression of  
Cpebs in BMDMs is regulated by independent mechanisms and that each CPEB 
might be involved in distinct functions, as they are expressed at different stages of  
macrophage polarization.  








Of  these observations, we decided to further study the upregulation of  Cpeb4 
mRNA after LPS stimulation by assessing the expression of  CPEB4 protein. As 
shown in figure 22c, CPEB4 protein was also upregulated upon LPS stimulation. 
Again, the increase in CPEB4 levels was LPS-specific, as IL-4 or IFNγ did not cause 
a similar effect (Fig. 22c). Finally, we also confirmed that the alterations in CPEB3 
levels after LPS treatment were much weaker (Fig. 22c). 
Altogether, these results encouraged us to further study the role of  CPEB4 during 
the LPS response. Specifically,  we decided to characterize its regulation and function 
in this context.    
Figure 22. CPEB4 is upregulated upon LPS stimulation in Macrophages. →
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← Figure 22. CPEB4 is upregulated upon LPS stimulation in Macrophages. 
(a) Cpeb1-4 mRNA expression in untreated BMDM, normalized to Tbp. (b) BMDMs 
were stimulated with LPS or IL4 (10ng/ml) for the indicated times and Cpeb1-4 
mRNA was measured. After normalization to Tbp, relative levels were calculated 
by setting expression of untreated samples as 1 for each gene. (c) Immunoblot 
analysis of CPEB4 and CPEB3 in BMDMs stimulated with LPS, IFNγ or IL-4 (10ng/
ml) for the indicated times. Retina protein extracts from wild type and Cpeb3KO 
mice were used as control for CPEB3 antibody. Vinculin served as loading control. 
(a,b) Data are shown as mean ± s.e.m. Untreated and LPS: data show at least three 
independent experiments. IL4: data show at least two replicates/timepoint for Cpeb1 
and Cpeb4. N=1 for Cpeb2 and Cpeb3. 
2. CPEB4 mRNA stability is regulated during the LPS response 
via p38a-HuR-TTP1
One of  the main features of  macrophage response to inflammatory stimuli is that, 
in very short periods of  time, they are able to increase dramatically the expression 
of  inflammatory genes, but in a transient manner. Thus, the expression of  these 
molecules is usually restricted to defined temporal windows. One of  the most 
characterized systems to limit cytokine expression during the LPS response involves 
the MAPK p38α and two ARE-binding proteins, HuR and TTP, which regulate the 
stability of  ARE-containing mRNAs.   
Briefly, LPS stimulation activates p38α, which promotes TTP phosphorylation, and 
therefore inhibits TTP-mediated mRNA destabilization (Hitti et al. 2006; Brook et 
al. 2006). This process favours that ARE-containing mRNAs are bound by HuR, 
which mediates their stabilization and upregulation (Tiedje et al. 2012; Ke et al. 
2017). However, this state is transient as, during the late LPS response, TTP recovers 
its activity, favouring again mRNA decay and driving the downregulation of  ARE-
containing mRNAs (Sun et al. 2007). Among others, cytokines like Tnf and Il10 
harbour AREs in their 3’UTR and have been shown to be regulated by this system. 
We observed that Cpeb4 expression during the LPS response followed this pattern 
of  transient up- and downregulation (Fig. 22b). Moreover, Cpeb4 contains multiple 
AREs in its 3’UTR  (Fig. 23a). Therefore, we decided to study if  Cpeb4 expression 
was also regulated by this system. 
1These results were mainly obtained by the Dr. Annarita Sibilio.








First, we assessed p38α contribution to Cpeb4 expression. For that, we obtained 
BMDMs from myeloid-specific p38α Knock-Out mice (p38αMKO) (Youssif  
et al. 2018) and stimulated them with LPS. Interestingly, we observed that Cpeb4 
upregulation was reduced in p38αMKO macrophages (Fig. 23b). Moreover, wild 
type macrophages treated with the p38 inhibitor PH797804 showed the same 
phenotype (Fig. 23c), indicating that p38α kinase activity mediates the increase in 
Cpeb4 levels during the LPS response. To assess whether p38α-mediated control of  
Cpeb4 occurred through mRNA stability, we performed an Actinomycin D chase 
assay after 1 hour of  LPS treatment. As shown in figure 23d, Cpeb4 mRNA decay 
was significantly faster in p38αMKO BMDMs, indicating that p38α indeed stabilizes 
Cpeb4 mRNA during the early LPS response. Finally, we also examined how p38α-
mediated regulation of  Cpeb4 mRNA affected CPEB4 protein levels. As for Cpeb4 
mRNA, we observed that after 3 hours of  LPS treatment CPEB4 protein levels 
were significantly lower in the absence of  p38α (Fig. 23e). 
It is worth mentioning, though, that after 9 hours of  LPS stimulation, both 
the mRNA and protein levels of  CPEB4 were comparable between wild type 
and p38αMKO macrophages (Fig. 23b-c, e). Therefore, these results suggest 
that, during the late LPS response, CPEB4 expression was regulated by a p38α-
independent mechanism.  Given that Cpeb4 mRNA levels are already downregulated 
at 9 hours, when CPEB4 protein peak, we hypothesize that this second mechanism 
regulating CPEB4 expression probably involved translational control. According to 
published data, one possibility could be that CPEB4 itself, once it has been partially 
upregulated, mediates an autoregulatory loop where it promotes the translation of  
its own mRNA and, thus, progressively upregulates its own levels (Igea & Méndez 
2010; Calderone et al. 2016; Maillo et al. 2017).
Having seen that Cpeb4 mRNA stability was regulated by p38α, we next wanted 
to assess whether HuR and TTP were mediating this process. First, we stimulated 
BMDMs with LPS for 3 hours and performed HuR RNA immunoprecipitation and 
qPCR (RIP-qPCR, Fig. 24a). As for Tnf mRNA, we observed that HuR binding 
to Cpeb4 mRNA binding to HuR was strongly enriched upon LPS treatment (Fig. 
24b). Furthermore, in p38αMKO macrophages this process was reduced (Fig. 
24b), suggesting that HuR mediates Cpeb4 mRNA stabilization downstream p38α, 









Figure 23. Cpeb4 mRNA stability is regulated during the LPS response via 
p38α. (a) Schematic representation of Cpeb4 3’UTR showing its AREs domains. 
(b) BMDMs obtained from wild type or p38αMKO mice were stimulated with LPS 
(10ng/ml) for the indicated times and gene expression was analysed by RT-qPCR. 
(c) BMDMs were treated with the p38 inhibitor PH797804 (1uM) and LPS (10ng/
ml). After the indicated times, gene expression was analysed by RT-qPCR. (d) 
BMDMs obtained from wild type or p38αMKO mice were stimulated with LPS (10ng/
ml) for 1h and then treated with Actinomycin D (10ug/ml). At the indicated times, 
gene expression was analysed by RT-qPCR. (e) Immunoblot analysis of CPEB4 
in Wild type or p38αMKO BMDMs stimulated with LPS (10ng/ml) for the indicated 
times. Vinculin served as loading control. Quantification of triplicate experiments is 
shown. Ratio paired t-test pv *pv<0,05. (b-d) Data are shown as mean and s.e.m. 
of duplicate experiments. mRNA expression is normalized relative to Gapdh (b,c) or 
18S (d). Statistics Two-way ANOVA *pv<0.05 **<0.01.
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Finally, to study whether Cpeb4 mRNA is regulated by TTP during the late LPS 
response, we took advantage of  a recent publication that studied TTP function in 
LPS-stimulated BMDMs from wild type and TTP myeloid-KO mice (TTPMKO) 
(Sedlyarov et al. 2016). Remarkably, Cpeb4 mRNA followed again the same pattern 
as Tnf. First, analysis of  their iCLIP data showed that TTP binds both Tnf and Cpeb4 
mRNA after 6 hours of  LPS treatment (Fig. 24c, Tnf not shown). Second, the decay 
rate of  both mRNAs was significantly slower in TTPMKO macrophages, suggesting 
that TTP is indeed promoting their destabilization (Fig. 24d). Finally, consistent 
with a reduced Cpeb4 destabilization, after 9 hours of  LPS treatment, TTPMKO 
macrophages presented increased levels of  Cpeb4. This difference, though, was 
much weaker for Cpeb4 than for Tnf  (Fig. 24e). These results indicate that TTP 
mediates Cpeb4 mRNA destabilization during the late LPS response.
Altogether, we have shown that the MAPK p38α regulates Cpeb4 mRNA stability 
during the LPS response. Downstream of  p38α, HuR and TTP regulate Cpeb4 through 
the AREs in its 3’UTR. At early timepoints, HuR mediates Cpeb4 stabilization and 
upregulation, and during the late LPS response, TTP mediates its downregulation 
by destabilization.  
→ Figure 24. Cpeb4 mRNA is regulated by HuR and TTP during the LPS 
response.  (a-b) BMDMs obtained from wild type or p38αMKO mice were stimulated 
with LPS (10ng/ml) for 3h, and immunoprecipitation (IP) with anti-HuR antibody or 
IgGs was performed. (a) Immunoblot analysis of HuR IP. (b) RNA was extracted and 
analysed by RT-qPCR. Data are shown as mean and s.e.m. of duplicate experiments. 
mRNA expression is normalized relative to Gapdh. (c) BMDMs were treated with 
LPS for 6h and TTP PAR-iCLIP was performed. Coverage plots represent the 
number of crosslink sites detected in each position of Cpeb4. Binding sites to Cpeb4 
Transcription Start Site (TSS) and their scores are indicated in the table. (d) Cpeb4 
and Tnf decay rates in wild type and TTPMKO BMDMs stimulated for 6 h with LPS. 
(e) Cpeb4 and Tnf expression profile in wild type and TTPMKO BMDMs treated 
with LPS for the indicated times. Differential expression analysis was performed 
using DESeq2 software. **qvalue= 0.00891 (c-e) LPS treatment 10ng/ml. Data was 









← Figure 24. CPEB4 mRNA is regulated by HuR and TTP during the LPS 
response.
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3. CPEB4 is phosphorylated during the LPS response
While studying the increase in CPEB4 protein levels upon LPS exposure, we observed 
that CPEB4 migrated as a doublet (Fig. 25a), suggesting that CPEB4 was post-
translationally modified. Indeed, we confirmed by lambda phosphatase treatment 
that the upper band in this doublet was phosphorylated CPEB4 (P-CPEB4) (Fig. 
25b). 
In Xenopus laevis oocytes, CPEB4 hyperphosphorylation is mediated by ERK1/2 and 
CDK1 kinases, a process that regulates CPEB4 activity (Guillén-Boixet et al. 2016). 
When unphosphorylated, CPEB4 assembles phase-separated structures, where its 
target mRNAs are stored. However, upon hyperphosphorylation, these structures 
are disassembled and CPEB4 is able to promote the polyadenylation and translation 
of  its target mRNAs (Guillén-Boixet et al. 2016).
In macrophages, ERK1/2 MAPKs are known to be activated after LPS stimulation 
(Weinstein et al. 1992). Importantly, ERK1/2 kinetics of  activation were compatible 
with ERK1/2 being responsible for CPEB4 phosphorylation (Fig. 25b). On the 
other hand, the main function of  CDK1 is to control cell cycle progression during 
M phase (Malumbres & Barbacid 2009). LPS stimulation, though, induces cell cycle 
arrest at early G1 (Vairo et al. 1992; Xaus et al. 1999), as we could confirm based on 
Cyclin D1 expression (Fig. 25c). Consequently, CDK1 is expected to be inactive 
during the LPS response. Therefore, we predict that ERK1/2 MAPKs mediate 
CPEB4 phosphorylation in LPS-activated BMDMs. 
So far, we have seen how multiple mechanisms regulate CPEB4 expression and 
activity upon LPS stimulation. Consequently, during the later timepoints of  the LPS 
response, CPEB4 reaches its highest levels and is mainly found phosphorylated, 
thus being able to promote the polyadenylation and translation of  its target mRNAs. 










Figure 25. CPEB4 is phosphorylated during the LPS-response. (a) Immunoblot 
analysis of CPEB4 in control or LPS-treated macrophages. α-Tubulin served 
as loading control. Quantification of normalized CPEB4 and P-CPEB4 signal is 
shown. (b) Immunoblot analysis of CPEB4 in control and LPS–primed BMDMs. 
Protein extracts were treated with λPhosphatase when indicated. Quantification of 
normalized P-CPEB4 signal is shown. (c) Immunoblot analysis of Phospho-ERK1/2 
in control or LPS-treated BMDMs. (d) Immunoblot analysis of CPEB4 and CyclinD1. 
Lanes 1-4 are samples obtained during the differentiation of Bone Marrow Progenitor 
cells to BMDMs in the presence of M-CSF (time indicated in days). Lanes 5-6 are 
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4. Defining CPEB4 function during the late LPS response in 
BMDMs
4.1. CPEB4 regulates negative feedback inhibitors of  the LPS 
response2
To define CPEB4 target mRNAs, we applied CPEB4 RNA-immunoprecipitation and 
sequencing (RIP-seq) to wild type BMDMs, in untreated conditions and at 9 hours 
after LPS stimulation. BMDMs from Cpeb4KO mice (Maillo et al. 2017) were used as 
controls (Fig. 26a, b). CPEB4 targets were defined as those significantly enriched in 
wild type CPEB4 IP compared to the corresponding IP in Cpeb4KO BMDMs (Peak 
calling analysis, pvalue<0,02 or peak score>500). Hence, we identified 1079 and 
1782 mRNAs associated with CPEB4 in untreated and LPS conditions, respectively 
(Appendix I, II). We defined as the “BMDMs transcriptome” those transcripts 
detected in our input wild type samples in untreated or LPS conditions. As shown in 
figure 26c, CPEB4 targets represented the 10-15% of  the BMDMs transcriptome 
and 797 genes were identified as targets in both conditions. As a quality control, we 
observed that the 3’UTRs of  the identified mRNAs were enriched in CPE motifs 
as expected of  CPEB4 targets (Chi Square test pv<0,0001; Piqué et al. 2008) (Fig. 
26d, see Box 2). Moreover, previously described CPEB4 targets such as Txnip or 
Vegfa were identified, while negative controls such as Gapdh were not (Fig. 26e).
→ Figure 26. Identification of CPEB4 targets in LPS-primed BMDMs. (a) 
Immunoblot for CPEB4 from inputs and immunoprecipitated fractions with anti-
CPEB4 antibody in BMDMs obtained from Wild type or Cpeb4KO mice (n=1); 
Vinculin served as a loading control. (b) RNA integrity was evaluated with an 
Agilent 2100 BioAnalyzer with the RNA 6000 Pico kit. (c) Percentage of CPE-
containing transcripts in RIP-seq defined CPEB4 targets and Mus musculus/BMDMs 
transcriptome. Statistics with Fisher’s exact test.****pv<0.0001. (d) Read coverage 
of Vegfa, Txnip and Gapdh mRNAs in RNAseq (Input) or RIP-seq samples (IP). 
Detected peak enrichments in wild type (WT) versus Cpeb4KO (KO) IP are shown. 
Image obtained using integrated genomic viewer (IGV) with a minimum range of 
0-20 arbitrary units (AU). 
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BOX 2. REVISITING CPEs DEFINITION 
As shown in figure 26d, according to the CPE motif defined by Piqué and colleagues 
(which we will refer as CPE-As), 60% of CPEB4 targets contained functional CPE-As 
in their 3’UTRs (Piqué et al. 2008). Recent publications though, suggest that CPEB4 
could bind other CPE motifs that were not included in Piqué’s analysis. For example, 
a CPE-G motif (UUUUG) was found to be bound by Orb2, the Drosophila ortholog of 
CPEB2-4 (Stepien et al. 2016; Afroz et al. 2014). Therefore, we decided to explore 
if CPEB4 targets were enriched in CPE-G motifs in their 3’UTRs that could explain 
CPEB4 binding. 
First, we defined the CPE-G-containing mRNAs as those with UUUUGU sequences 
in their 3’UTR within the same functional distances from the PAS established in 
Piqué’s script (<100bp). We found that around 20% of the mRNAs in the mouse 
transcriptome contained CPE-Gs, a similar proportion as mRNAs containing CPE-
As (Fig. 27a). Therefore, considering both CPE-A- and CPE-G-containing mRNAs, 
the total percentage of potential CPEBs targets increased to 36%. 
Next, we evaluated whether CPE-G containing mRNAs were enriched in different 
sets of CPEB4 targets: two published sets in erythroblast and hepatocytes (Hu et al. 
2014; Maillo et al. 2017) and our sets in untreated or LPS-stimulated macrophages. 
Interestingly, all lists of CPEB4 targets displayed a significant increase in the 
proportion of CPE-G containing mRNAs (Fig. 27b). Indeed, after combining 
the CPE-A and CPE-G definition, the proportion of CPE-containing targets in 
macrophages increased to almost 80% (Fig. 27c). 
Based on these results, we decided to consider both CPE-G- and CPE-A-containing 
mRNAs as putative CPEBs targets. 











































































← Figure 27. Analysis of CPE-G presence in CPEB4 targets. (a) Percentage 
of CPE-A, CPE-G and CPE-A&G containing transcripts in Mus musculus 
transcriptome. (b) Percentage of CPE-G-containing transcripts in RIP-seq 
defined CPEB4 targets (Hep=Hepatocytes, Ery=Erythroblast, Un=Untreated) 
and Mus musculus/BMDMs transcriptome. Statistics with Chi-Square with Yates’ 
correction.****pv<0.0001.(c) Percentage of CPE-A, CPE-G and CPE-A&G-
containing transcripts in RIP-seq defined CPEB4 targets in macrophages and 
Mus musculus/BMDMs transcriptome. 
To gain more insight into the targets that were bound by CPEB4 in untreated and 
LPS conditions, we performed gene ontology analysis using DAVID Bioinformatic 
Database (Huang et al. 2009b; Huang et al. 2009a). Interestingly, both sets of  targets 
were enriched in MAPK signalling pathways genes (Fig. 28a). Having seen that the 
MAPKs p38α and ERK1/2 regulate CPEB4 expression and function in this context, 
these results indicate that CPEB4-mediated translational control signals back to its 
own regulators generating a feedback regulatory circuit (Fig. 28b). Inflammatory 
responses typically follow oscillatory patterns (Ferrell & Ha 2014b; Turner & Díaz-
Muñoz 2018). For that to occur it is necessary to generate circuits where multiple 
positive and negative feedback loops cross-regulate each other. Therefore, it is highly 
relevant that CPEB4 regulates multiple of  its regulators, as it will contribute to the 
oscillatory behaviour of  gene expression during the LPS response.
Among CPEB4-regulated mRNAs, we also identified several inhibitors of  the 
inflammatory signalling cascades, such as Socs1, Socs3, Dusp1, Tnfaip3, Il1rn, Ppp2ca 
or Zfp36 (TTP mRNA) (Fig. 28c). We have previously seen how CPEB4 expression 
and polyadenylating activity peak during the late phase of  the LPS response, when 
inflammation resolution occurs. Therefore, these results suggest that CPEB4 could 
participate in inflammation resolution by promoting the expression of  these anti-
inflammatory molecules. Importantly, decreased expression of  these proteins can 
lead to hyperinflammatory conditions, which have been linked to multiple diseases. 








Figure 28. Inflammation feedback inhibitors are regulated by CPEB4 during 
the late LPS response. (a) Top 5 Gene Ontology KEGG categories enriched in 
CPEB4 targets in BMDMs (Untreated/9h LPS). Statistics with Benjamini adjusted 
p-value. (b) Schematic representation of CPEB4 targets involved in MAPK pathway. 
Modified from Arthur & Ley 2013. (c) Read coverage in Inputs and IPs of selected 
CPEB4 targets. Image obtained using IGV with a minimum range of 0-50 AU. 
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4.2. Assessing CPEB4 function in BMDMs by ribosome profiling3
Previous studies on CPEB4 have described how its polyadenylating function 
increases the translation efficiency of  its target mRNAs (Ortiz-Zapater et al. 
2012; Calderone et al. 2016; Maillo et al. 2017). However, not all CPEB4 targets 
are affected by CPEB4 function to the same extent. To describe in a genome 
wide manner which target mRNAs showed decreased translation efficiency rates 
in the absence of  CPEB4 we performed ribosome profiling. As in our RIP-seq 
experiment, we compared wild type and Cpeb4KO BMDMs, in untreated conditions 
and after 9 hours of  LPS stimulation. Ribosome profiling experiments calculate 
translation efficiency (TE) differences by measuring ribosome density on mRNAs. 
For that, ribosome-protected fragments (RPF) are isolated and ribosome abundance 
is corrected by the corresponding mRNA levels. Importantly, before calculating TE 
rates, it is necessary that the RPF libraries meet certain quality standards to ensure 
that the RPF isolation was successful. 
With this aim, we first measured the proportion of  reads aligned to the CDS and 
UTRs of  transcripts. As expected, RPF had a much higher proportion of  CDS-
aligned reads than their corresponding RNAseq datasets (Fig. 29a). Next, we 
calculated RPF length, expecting ribosomes to protect fragments between 28 and 
33 nucleotides. In our case, we observed that most RPF had between 32 and 34 
nucleotides, suggesting that the RNA digestion had been incomplete (Fig. 29b). 
Finally, we measured RPF read position relative to the CDS start (Fig. 29c). As 
expected, an increase in RPF density was found around twelve nucleotides upstream 
the start site, and the RPF profile was not flat but followed a three-nucleotide 
periodicity (Fig. 29d). 
3Ribosome profiling was performed in collaboration with dr. Vittorio Calderone. 
Bioinformatic analysis was perfomed in collaboration with Dr. Oscar Reina (Quality 
control) and Dr. Ivan Dotu (Replicates, DiffExp, DT, TE).








Figure 29. Ribosome profiling quality control. (a) Relative distribution of the 
reads obtained between the CDS and UTRs of the reads obtained by Ribosome 
Profiling (RPF) or RNA sequencing (RNAseq). (b) Size distribution of RPF reads. (c) 
Coverage around start AUG codon (A/red) of RPF data. (d) In-frame RPF/RNAseq 
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This periodicity should peak at nucleotides in codon position 0, as ribosomes stay 
for longer times in this position until the appropriate tRNA is charged. In our case, 
though, periodicity peaked at position +2, probably due to the inefficient RNA 
digestion. Finally, as the last quality control, we observed that the four RPF biological 
replicates had a good correlation coefficient (Fig. 29e). Overall, these results suggest 
that we efficiently isolated RPF, even if  some unprotected nucleotides remained 
undigested. Therefore, we decided to continue with the analysis and calculate the 
mRNA TE, as well as compare mRNA expression (RNAseq) and translation (RPF) 
levels between wild type and Cpeb4KO conditions. 
Unexpectedly, in untreated conditions, only Stard13 mRNA showed a significant 
decrease in TE in the absence of  CPEB4 (Fig. 30a). Moreover, few genes showed 
differential expression or translation levels between wild type and Cpeb4KO 
macrophages. As a positive control, we could find Cpeb4 mRNA as one of  the genes 
with significantly decreased RPF. In the same line, in LPS conditions, no mRNAs 
had significant TE differences and few genes displayed different expression or 
translation levels (Fig. 30b). Among those, we observed increased Cpeb2 translation 
in Cpeb4KO macrophages, suggesting a compensatory mechanism between these 
two CPEBs. Crossing this data with our previously defined CPEB4 targets, we could 
not find any CPEB4 target that presented reduced translation efficiency rates in the 
absence of  CPEB4 (Fig. 30a, b).
On the one hand, these results suggest that CPEB4 absence does not alter 
substantially the macrophage gene expression landscape in untreated conditions or 
after 9 hours of  LPS stimulation. However, considering the data we had obtained 
by RT-qPCR and immunoblots, these ribosome profiling results contained multiple 
false negatives. Thus, to further test the sensitivity of  our experiment, we compared 
the two wild type samples, untreated and with LPS, knowing that LPS has a dramatic 
effect on macrophage transcriptome. Indeed, by doing this comparison, we were 
able to detect thousands of  significant changes, both at the mRNA and RPF level 
(Fig. 31a). 








Figure 30. Few differences between wild type and Cpeb4KO macrophages by 
ribosome profiling. (a-b) Differential expression and translation analysis comparing 
RNAseq and RPF data from wild type and Cpeb4KO BMDMs untreated (a) or 
stimulated with LPS (10ng/ml) for 9h (b). Corresponding translation efficiency data 
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As expected, Il1rn and Socs3 were among the most strongly induced with LPS, as 
they are highly upregulated during the late LPS response to mediate inflammation 
resolution. Despite these major changes in expression or translation, only 6 genes 
showed increased translation efficiency after 9h of  LPS stimulation and none of  
these was included in our sets of  CPEB4 targets. It was remarkable though, how the 
TE of  multiple histone mRNAs decreased upon LPS treatment, probably as part of  
the cell cycle arrest induced by LPS. 
Next, we took advantage of  this comparison to check how the expression and 
translation of  CPEB4 targets was affected by LPS stimulation (Fig. 31b). For this, 
we divided the mRNAs into four categories: those associated with CPEB4 only in 
LPS or untreated conditions, those associated in both situations and the rest of  
mRNAs, which are not considered CPEB4 targets. Interestingly, mRNAs associated 
with CPEB4 after LPS stimulation were mostly upregulated during the LPS response, 
both at the expression and translation level.
Altogether, these results suggested that the function of  CPEB4 in macrophages, 
at least after 9h of  LPS treatment, was most likely not related to increasing the 
translation efficiency of  its target mRNAs. Nevertheless, we hypothesize that 
CPEB4 could be involved in the upregulation of  its target mRNAs during the LPS 
response. 








Figure 31. Main changes during the LPS response occur at the expression 
level.  (a) Differential expression and translation analysis comparing RNAseq, RPF 
and TE data from wild type untreated or stimulated with LPS (10ng/ml) for 9h. Only 
differences with pvalue<0.05 are shown. In differential expression and translation 
plots, only two “CPEB4 targets LPS” are shown in red. (b) mRNAs in (a) were 
separated in four categories according to their association to CPEB4 (Un=untreated). 
Percentage of up/downregulated transcripts upon LPS treatment is shown. 
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4.3. Distinct behaviours of  CPEB4 targets in Cpeb4KO BMDMs 
Ribosome profiling analysis did not detect strong differences between wild type 
and Cpeb4KO macrophages. However, being aware that we had false negatives, we 
selected some high confidence CPEB4 targets and assessed their expression during 
the LPS response by RT-qPCR and immunoblot analysis. Interestingly, we observed 
that the expression of  some of  these genes was indeed affected in the Cpeb4KO 
conditions. 
First, we detected a dramatic reduction in the levels of  the anti-inflammatory protein 
SOCS1 (Fig. 32a). These results were in accordance with the hypothesis that 
CPEB4 favours the expression of  negative feedback inhibitors of  the inflammatory 
pathways. Then, we observed a strong upregulation of  the HIF1α protein, also 
during the later timepoints of  the LPS response (Fig. 32a). As HIF1α has been 
linked to pro-inflammatory functions, we speculated that in Cpeb4KO BMDMs the 
resolution of  inflammation was impaired, causing increased levels of  inflammatory 
markers like HIF1α. In the same line, after 9 hours of  LPS we detected a reduction 
of  TTP levels together with an increase of  COX2 expression (Fig. 32b). Even if  
these alterations were weaker, these results supported our hypothesis, since TTP 
and COX2 have anti- and pro-inflammatory functions, respectively. Finally, despite 
its anti-inflammatory function, the levels of  the NF-κB inhibitor IκBα were also 
increased in Cpeb4KO macrophages (Fig. 32b).  
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← Figure 32. Altered expression of CPEB4 targets in Cpeb4KO BMDMs at the 
protein level. (a-c) Immunoblot analysis of the indicated proteins in wild type or 
Cpeb4KO BMDMs treated with LPS for 0-24h. Vinculin served as loading control. 
Signal intensity was normalized to wild type 9h LPS. Data from duplicate (TTP, IκBα, 
COX2; Statistics: multiple t-test) and triplicate (SOCS1, HIF1α; Statistics: Two way 
ANOVA) experiments. *pv<0.05; ** pv<0.01.
Next, we measured the expression of  the corresponding mRNAs, to understand 
if  these changes were occurring at the mRNA level or resulted from translation 
efficiency rates. As shown in figure 33a, alterations in mRNA of  Socs1 and Hif1a 
could explain their altered protein expression. On the contrary, levels of  TTP, COX2 
and IκBα mRNAs (Zfp36, Ptgs2 and Nfkbia, respectively) were overall comparable 
between wild type and Cpeb4KO macrophages (Fig. 33b). Thus, these results suggest 
that the expression of  SOCS1 and HIF1α was dysregulated at the mRNA level, 
while for TTP, COX2 and IκBα this process occurred at their TE rates. Importantly, 
as we had seen in the ribosome profiling data, differences were much stronger in 
mRNA expression than in translation rates. 
Consequently, we decided to focus on how CPEB4 polyadenylating function 
regulated the expression of  mRNAs like Socs1 or Hif1a. First we considered that, to 
explain the dual behaviour of  these targets, other proteins need to be involved in 
their alterations. These could be for instance transcription factors or regulators of  
the mRNA stability.
As previously mentioned, TTP is one of  the major regulators of  mRNA stability 
during the LPS response. Moreover, both Socs1 and Hif1a mRNAs were considered 
TTP targets in Sedlyarov datasets (Sedlyarov et al. 2016). Having seen that TTP and 
CPEB4 cross regulate each other mRNAs, we hypothesized that the phenotypes we 
were observing in Cpeb4KO macrophages could be caused by a disruption in the 
interplay between these two proteins, which could affect the stability and levels of  
mRNAs like Socs1 and Hif1a. 








Figure 33. Altered mRNAs levels of CPEB4 targets in Cpeb4KO BMDMs. (a-b) 
Wild type or Cpeb4KO BMDMs were stimulated with LPS (10ng/ml) for 0-24h and 
mRNA was measured. Tbp was used to normalize and relative levels to untreated 
wild type were calculated. Data are shown as mean and s.e.m.; n=6. Statistics: Two-
way ANOVA **pv<0.01; *** pv<0.001; ****pv<0.0001. 
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4.4. Interplay between CPEB4 and TTP during the LPS response
At this moment, it is worth recapitulating the information we have seen so far. We 
have shown that CPEB4 is upregulated and phosphorylated during the late LPS 
response (Fig. 25), which has been shown to promote its polyadenylating function 
(Guillén-Boixet et al. 2016). Moreover, we have seen how TTP-mediated mRNA 
destabilization is recovered during the late phase of  inflammation. Mechanistically, 
TTP recruits the CCR4-NOT complex to its target mRNAs, promoting their 
deadenylation and consequent destabilization (Lykke-Andersen & Wagner 2005). 
Additionally, our ribosome profiling data suggests that, between untreated and 9 
hours of  LPS stimulation, gene expression changes mostly occur at the mRNA level 
but not at translation efficiwency. And finally, most CPEB4 targets are upregulated 
during this timing of  the LPS response.    
Taking all these observations together, we hypothesized that, as opposed to TTP 
action, CPEB4 polyadenylating function could be favouring mRNA stability instead 
of  mRNA TE in this context. If  true, it seemed also possible that during the late 
LPS response, when both TTP and CPEB4 are active, their opposite deadenylating 
and polyadenylating functions could compete to regulate target mRNAs that they 
have in common. 
It is important to mention that during meiosis progression a similar situation was 
described for CPEB1 and C3H4, another ARE-BP that recruits the CCR4-NOT 
complex. In this case, their opposite polyadenylating and deadenylating functions 
determined the kinetics of  translational activation of  mRNAs upon progesterone 
stimulation (Belloc et al. 2008; Belloc & Méndez 2008). Moreover, it was recently 
shown how in LPS-stimulated macrophages, TTP binding to mRNAs was not 
always related to mRNA destabilization. In some cases, the competition with HuR 
for these mRNAs could explain this behaviour, but other factors were needed to 
explain mRNA kinetics during the LPS response (Sedlyarov et al. 2016). 








4.4.1. Key genes of  the inflammatory response are regulated by 
TTP and CPEB4 
To study the possible interplay between TTP and CPEB4, the first question we 
addressed was if  these two RNA binding proteins shared common target mRNAs 
during the late LPS response. Thus, we compared our set of  CPEB4 targets in the 
presence of  LPS with the iCLIP-defined TTP targets defined by Sedlyarov and 
colleagues (Fig. 34a) (Appendix III, Sedlyarov et al. 2016). Interestingly, we found 
that CPEB4 was associated with 50% of  TTP targets (Fig. 34b). Among the common 
regulated genes, we found crucial inflammatory mediators, like Il6, Il1a, Cxcl1 or 
Nos2, but also multiple of  the previously mentioned negative feedback inhibitors, 
like Socs3, Dusp1 or Il1rn. Remarkably, not only Socs1 and Hif1a, but also Zfp36, Ptgs2 
and Nfkbia were targets of  both CPEB4 and TTP. Thus, this was a common feature 
of  all the mRNAs whose proteins were altered in Cpeb4KO macrophages. 
Figure 34. Overlap between CPEB4 and TTP target mRNAs during late  LPS 
response. (a-b) TTP targets (184 mRNAs) were defined by iCLIP in BMDMs treated 
for 6h with LPS (10ng/ml) (Sedlyarov et al. 2016). CPEB4 targets (1782 mRNAs) 
were defined by RIP-seq  after 9h of LPS treatment. LPS (10ng/ml). Pie chart shows 
the % of TTP targets that are also considered CPEB4 targets. (b) List of common 
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Next, to further study TTP and CPEB4 interplay, we selected some of  these common 
target mRNAs and assessed their expression during the LPS response in TTPMKO 
and Cpeb4KO conditions (Fig. 35a-d). Although there were some exceptions, we 
could observe consistent trends in their behaviours. The expression of  a first group 
of  genes, including Cxcl1, Cxcl2 and Il1a, showed  significant alterations in TTPMKO 
macrophages but not in Cpeb4KO (Fig. 35a). Genes in the second group were 
affected in both KOs, but we could distinguish two patterns. While Ccl2 and Il6 were 
affected at overlapping timepoints (Fig. 35b), Socs3 and Nos2 presented alterations 
at different moments in each KO (Fig. 35c). Finally, the third group included Hif1a 
and Socs1, which showed a surprising behaviour in TTPMKO BMDMs. Instead of  
being upregulated, as one would expect in the absence of  TTP-destabilizing activity, 
they were downregulated or unaffected (Fig. 35d). Interestingly, these were the 
genes that were more altered in Cpeb4KO conditions (Fig. 33a). On the one hand, 
these observations suggest that not all common mRNAs are subjected to the same 
extent to TTP- and/or CPEB4-mediated control. On the other hand, the observed 
inverse correlation between the alterations in each KO suggested that the mRNAs 
that are highly regulated by one of  these proteins are not subjected anymore to 
control by the other. Thus, these results strengthen the hypothesis that TTP and 
CPEB4 compete to regulate their common mRNA targets. 
Additionally, it also drew our attention to the fact the peak of  expression after LPS 
also tended to correlate with the alterations we observed. While early expressed 
genes tended to be more affected by TTP absence, intermediate and late genes were 
generally altered in both TTP- and CPEB4-KO conditions. Interestingly, this pattern 
mirrored CPEB4 regulation as CPEB4 protein levels and activity peak during the 
late LPS response. 








Figure 35. Opposite alterations in LPS response in TTPMKO and Cpeb4KO 
BMDMs. (a) Overlap between TTP target and CPEB4 target mRNAs in BMDMs 
after 6h or 9h of LPS stimulation, respectively. (b-e) Wild type or Cpeb4KO BMDMs 
were stimulated with LPS (10ng/ml) for 0-24h and mRNA was measured by RT-
qPCR. Tbp was used to normalize and relative levels to untreated wild type were 
calculated. Data are shown as mean and s.e.m.; n=6. Statistics: Two-way ANOVA 
*pv<0.05; **pv<0.01; *** pv<0.001; ****pv<0.0001. Wild type or TTPMKO BMDMs 
were stimulated with LPS (10ng/ml) for 0-9h, mRNA was isolated and sequenced. 
Expression is shown as mean FPKM. Statistics: *qv<0.05; **qv<0.01; *** qv<0.001; 
****qv<0.0001. Source TTPMKO expression and statistics: Sedlyarov et al. 2016. →
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4.4.2. An ARE/CPE score predicts mRNA behaviour during the 
LPS response 
In section 2, we have seen how the competition of  HuR and TTP for ARE-
containing mRNAs regulates Tnf and Cpeb4 expression upon LPS stimulation. 
Moreover, results in section 4.4.1. suggest that during the late LPS response, CPEB4 
and TTP also compete for their target mRNAs. These two processes lead us to 
hypothesize that the combined regulation of  these three RNA binding proteins, 
and their corresponding effects on mRNA stability, could be key to determine the 
expression profiles of  multiple mRNAs during the LPS response. 
To test this idea we decided not to use our RIP-seq data of  CPEB4 targets or 
the published sets of  TTP- and HuR-targets, as they were restricted to certain 
timepoints, and also subjected to experimental limitations. Alternatively, we thought 
that the strength and number of  AREs and CPEs present in a given mRNA could 
be key to determine if  this mRNA is more susceptible of  being regulated by HuR 
and TTP, by CPEB4 or by all three of  them. Therefore, as a first approach, we 
decided to calculate an ARE/CPE score for multiple mRNAs and check if  mRNAs 
with similar scores clustered in similar expression patterns. 
Thus, we selected 62 mRNAs known to be upregulated during the LPS response 
and calculated their ARE/CPE score. Briefly, this ARE/CPE score was based on 
the total number of  AREs and CPEs in the 3’UTR of  each mRNA, considering the 
transcript with longest 3’UTR for each gene (Fig. 36a). Of  the 61 mRNAs, 13 were 
considered to be CPE-dominant (score<-1) and 14 ARE-dominant (score>0.8), 
leaving 34 mRNAs in the intermediate category (Fig. 36b, Appendix IV). Taking 
advantage again of  the publication of  Sedlyarov et al., we looked for the expression 
levels of  these mRNAs in wild type BMDMs after 0, 3, 6 and 9 hours of  LPS 
treatment. After normalizing each gene to its peak of  expression, we calculated 
the expression pattern of  each category as the mean of  all the included genes. 
Interestingly, as seen in figure 36c, each mRNA category presented a significantly 
different expression pattern, which was consistent with the expression and regulation 
of  HuR, TTP and CPEB4 during the LPS response. For example, the expression 
of  ARE-dominant genes like Cxcl1, Tnf and Il10, peaked at 3h and was rapidly 









TTP, respectively. Alternatively, CPE-dominant mRNAs like Cpeb4, Nfkbia or Il1rn, 
presented a later upregulation and a more sustained expression during the late LPS 
response, resembling CPEB4 activity. Finally, intermediate genes showed features of  
both groups, as they were upregulated at early timepoints but also showed sustained 
expression at 9 hours. Examples of  this category are Il6, Hif1a or Socs3 mRNAs. 
Altogether, these results show how the combination of  CPEs and AREs is key to 
define the expression pattern of  crucial players of  the LPS response. 
Additionally, the categories obtained with the ARE/CPE score helped us to explain 
why some CPEB4 or TTP targets are not altered in the expected direction upon 
the depletion of  these proteins. For example, we have seen previously that Cxcl1 
and Cxcl2 are highly upregulated in TTPMKO macrophages but unaltered in 
Cpeb4KO (Fig. 35a). These two mRNAs belong to the ARE-dominant category 
and, consequently, they are not altered in CPEB4 absence because they are mainly 
regulated by TTP. Accordingly, Tnf and Il10 also follow the same pattern (Fig. 23e, 
37a). On the contrary, the CPE-dominant category included the two mRNAs that 
were more dramatically downregulated in Cpeb4KO conditions, Ccl2 and Socs1 (Fig. 
34a, 36c). Finally, although the data in Cpeb4KO conditions is not available yet, 
we confirmed that other ARE- or CPE-dominant mRNAs behaved as expected in 
TTPMKO conditions (Fig. 37b).
Importantly, this result suggest that CPEB4 polyadenylating function could be 
responsible for the stabilization and expression of  CPE-dominant mRNAs, a 
function that has never shown for CPEB4. Moreover, all these observations 
establish a link between the ARE/CPE score and the specific functions of  TTP and 
CPEB4. Thus, they support that these proteins are indeed responsible for defining 
the different expression waves of  the LPS response (Fig. 36c). 








Figure 36. An ARE/CPE score can predict mRNA expression pattern during 
the LPS response.  (a) Formula to calculate the ARE/CPE score. The number of 
AREs/CPEs was assessed on the transcript with the longest 3’UTR. (b) 61 mRNAs 
were divided in three categories based on the ARE/CPE score. mRNAs in bold 
only had CPEs or AREs in their 3’UTRs. (c) Wild type BMDMs were stimulated with 
LPS (10ng/ml) for 0-9h, mRNA was isolated and sequenced. Expression data was 
normalized to each peak of expression and the of the 62 mRNAs were clustered 
as shown in (b). Data are shown as mean and s.e.m. Statistics: Two-way ANOVA 
*pv<0.05; **pv<0.01. Statistics in graph compare CPE dominant Vs ARE dominant. 
Additional significant comparisons: 3h pv** (CPE dominant Vs CPE&ARE); 9h pv* 
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Figure 37. ARE-dominant mRNAs showed increased dependency on TTP-
mediated decay. (a) Wild type or Cpeb4KO BMDMs were stimulated with LPS (10ng/
ml) for 0-24h and mRNA was measured by RT-qPCR. Tbp was used to normalize 
and relative levels to untreated wild type were calculated. Data are shown as mean 
and s.e.m.; n=6. Statistics: Two-way ANOVA *pv<0.05. (a-b) Wild type or TTPMKO 
BMDMs were stimulated with LPS (10ng/ml) for 0-9h, mRNA was isolated and 
sequenced. Expression is shown as mean FPKM. Statistics: *qv<0.05; **qv<0.01; 
*** qv<0.001; ****qv<0.0001. Source TTPMKO expression and statistics: Sedlyarov 
et al. 2016.
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4.5. Transcriptional control of  the LPS response in Cpeb4KO 
BMDMs 
As previously mentioned, the observed alterations at the mRNAs level in Cpeb4KO 
macrophages could also have been caused by alterations in transcriptional rates. 
Thus, we assessed the activity of  NF-κB and STAT1, the main factors regulating 
Hif1a and Socs1 transcription, respectively. 
To assess NF-κB activity, we performed immunofluorescence against the p65 subunit 
and evaluated its nuclear localisation. In untreated conditions, NF-κB is retained in 
the cytoplasm by its inhibitor IκBα. LPS stimulation triggers IκBα degradation, 
allowing NF-κB nuclear shuttling. However, once in the nucleus, NF-κB limits its 
own activity by promoting the transcription of  Nfkbia (IκBα mRNA). In this way, 
IκBα levels are restored and NF-κB is retained again in the cytoplasm (Kawasaki & 
Kawai 2014). As expected, 1h after LPS treatment p65 nuclear levels increased, and 
this was partially reverted at 9h (Fig. 38a). Even if  this process occurred in a similar 
manner in wild type and Cpeb4KO conditions, we observed a slight but significant 
reduction of  p65 nuclear levels in Cpeb4KO BMDMs 1h after LPS exposure, and 
a similar tendency at 9h. We had seen previously how Cpeb4KO macrophages 
expressed increased levels of  IκBα protein after 9-16h of  LPS treatment (Fig. 32b). 
Therefore, the reduction in NF-κB nuclear localization could be explained by an 
increased cytoplasmic retention mediated by IκBα. 
To assess STAT1 activation, we measured P-STAT1 levels and detected that Cpeb4KO 
BMDMs presented decreased levels during the late LPS response, especially after 9 
hours of  LPS treatment (Fig. 36b).  
These results suggest that Cpeb4 absence in macrophages may also affect their 
transcriptional landscape. However, we had not observed a global decrease in the 
mRNA levels of  their controlled genes. Therefore, further experiments are needed 









Figure 38. Transcriptional alterations in Cpeb4KO BMDMs. (a) p65 NF-kB 
immunofluorescence (green) of wild type or Cpeb4KO BMDMs stimulated with LPS 
(10ng/ml) for 0-1-9h. Nuclear localization was assessed by comparing with DAPI 
(blue). Mean nuclear intensity signal for each animal is shown, >100cells/animal/
condition. Statistics: Welch’s t test *pvalue<0,05 (b) Immunoblot analysis of P-STAT1 
in wild type or Cpeb4KO BMDMs treated with LPS for 0-24h. Vinculin served as 
loading control. Normalized signal intensity is shown as FC to untreated wild type. 
Data are shown as mean and s.e.m. of duplicate experiments. Statistics: Multiple 
t-test **** pv<0.0001.
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5. CPEB4 function in quiescent BMDMs 
In addition to study CPEB4 function during the LPS response, we also characterized 
whether CPEB4 contributed to macrophage basal homeostasis. As previously 
mentioned, to obtain BMDMs we culture bone marrow hematopoietic progenitors 
in media containing M-CSF. This factor not only induces progenitors cells to 
differentiate into macrophages but also stimulates their proliferation. As shown in 
figure 39a, during this process CPEB4 was also transiently upregulated. In this 
context, CPEB4 upregulation occurred when macrophages were highly proliferative, 
according to CyclinD1 expression (Fig. 39a). Thus, we hypothesized that CPEB4 
expression was linked to its function during mitotic cell-cycle progression (Novoa et 
al. 2010). However, we did not observe differences in the number of  cells obtained 
from wild type or Cpeb4KO progenitors (data not shown). 
Next, we decided to assess if  CPEB4 contributed to macrophage differentiation. 
For this, we analysed the expression of  different myeloid markers by flow cytometry. 
Interestingly, Cpeb4KO BMDMs tended to express higher levels of  the major 
histocompatibility complex class II (MHC class II) (Fig. 39b). MHC class II 
expression in macrophages is mainly driven by the transcription factor CIITA (Ting 
& Trowsdale 2002; LeibundGut-Landmann et al. 2004). Hence, we measured Ciita 
mRNA levels as well as the mRNAs of  the MHC class II subunits I-A and I-E. 
Again, all of  these were upregulated in Cpeb4KO conditions (Fig. 39c), suggesting 
that the increase in MHC class II levels in Cpeb4KO BMDMs was caused by an 
increase in CIITA-mediated transcription.
Neither Ciita nor MHC class II mRNAs were CPEB4 targets according to our 
RIP-seq experiment (Appendix I), suggesting that CPEB4 depletion affected the 
expression of  these proteins in an indirect manner. Therefore, we looked in the 
literature which mechanisms had been described to regulate Ciita expression. Out 
of  these mechanisms, Histone Deacetylase 1 (HDAC1) seemed a good candidate to 
explain our phenotype. HDAC1 is an enzyme that catalyses the removal of  acetyl 
groups. Among other functions, it can trigger histone deacetylation, an epigenetic 









Through this mechanism, HDAC1 has been shown to inhibit Ciita expression, 
consequently affecting MHC class II levels (Zika et al. 2003; Cycon et al. 2013). 
Interestingly, we found that Hdac1 mRNA is associated with CPEB4 in untreated 
conditions (Fig. 39d). Thus, we hypothesize that by polyadenylating Hdac1, CPEB4 
could favour HDAC1 expression, which limits Ciita and MHC class II levels. 
Figure 39. Increased MHC class II expression in Cpeb4KO BMDM. (a) 
Immunoblot analysis of CPEB4 and CyclinD1 during the differentiation of Bone 
Marrow Progenitor cells to BMDMs in the presence of M-CSF (time is indicated in 
days). Two biological replicates are shown. Vinculin was used as a loading control. 
(b) Mean expression of myeloid markers was analysed by flow cytometry. Mann-
Whitney t-test. (c) Gene expression of unstimulated BMDMs obtained from Wild type 
or Cpeb4KO was analysed by RT-qPCR. Tbp was used to normalize and relative 
levels to untreated wild type were calculated. Data are shown as mean and s.e.m.; 
n=6. Statistics: Wilcoxon match-pairs signed rank test *pv<0.05 (d) Read coverage 
of Hdac1 mRNAs in RNAseq (Input) or RIP-seq samples (IP). Peak enrichment in 
wild type (WT) versus Cpeb4KO (KO) IP is shown. Image obtained using integrated 
genomic viewer (IGV) with a range of 0-30 arbitrary units (AU). (e) Diagram 
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Additionally, while studying this mechanism, we found that in a lymphoblast cell 
line, it had been described that CIITA was associated to Cpeb4 promoter, possibly 
regulating its expression (Scharer et al. 2015; Kuleshov et al. 2016). Thus, we could 
establish a regulatory circuit between CIITA, HDAC1 and CPEB4. In this case, 
CIITA would induce the expression of  CPEB4, which by promoting the upregulation 
of  the feedback inhibitor HDAC1 would limit the expression of  CIITA and the 
MHC class II complex (Fig. 39e). Interestingly, increased levels of  MHC class II 
have been linked to macrophages having a more pro-inflammatory phenotype (Van 
Overmeire et al. 2014). Also, high MHC class II expression has been associated 
to autoimmune disorders (Reith et al. 2005). Thus, this potential CPEB4 function 
could also contribute to limit inflammatory responses. 
Finally, given that HDAC1 function had been also involved in inflammation 
resolution (Gupta et al., 2016), we wondered whether CPEB4 also regulated HDAC1 
expression during LPS response. However, this was not the case, as Hdac1 was not 
included among our sets of  CPEB4 targets in LPS-stimulated BMDMs (Appendix 
II). Morever, Cpeb4KO macrophages presented a normal HDAC1 upregulation after 
LPS stimulation, which was also accompanied of  the consequent downregulation on 
Ciita and MHC class II mRNAs (Fig. 40a, b). Thus, HDAC1 upregulation during 
LPS response occurred in a CPEB4-independent manner. 
Overall, these results suggest that, in unstimulated macrophages, CPEB4 could 
regulate MHC class II expression by promoting HDAC1 expression. As seen in 
figure 40a, unstimulated Cpeb4KO macrophages showed a trend to have reduced 
HDAC1 levels. However, further experiments are needed to validate the interplay 









Figure 40. CPEB4-independent upregulation of HDAC1 during the LPS 
response. (a) Immunoblot analysis of HDAC1 in wild type or Cpeb4KO BMDMs 
treated with LPS for 0-24h. Vinculin served as loading control. Signal intensity was 
normalized to wild type 9h LPS. Data from triplicate  experiments is shown. (b) 
Wild type or Cpeb4KO BMDMs were stimulated with LPS (10ng/ml) for 0-24h and 
mRNA was measured by RT-qPCR. Tbp was used to normalize and relative levels 
to untreated wild type were calculated. Data are shown as mean and s.e.m.; n=6. 
Statistics: Two-way ANOVA *pv<0.05; **pv<0.01; *** pv<0.001; ****pv<0.0001. 
***
*
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6. CPEB4 function in macrophages in vivo 
Finally, we wanted to assess the relevance of  CPEB4 expression in macrophages 
in vivo. With this aim, we generated a myeloid-specific Cpeb4KO mouse model 
(Cpeb4MKO); crossing Cpeb4lox/lox mice (Maillo et al, 2017) with transgenic mice 
expressing Cre-recombinase under Lyz2 promoter (Clausen et al. 1999) (Fig. 41a). 
For their characterization, wild type Cpeb4+/+ CreT/+ were used as controls. 
We took advantage of  the reporter cassette Tomato-GFP (Muzumdar et al. 2007) 
to have a read-out of  Cre recombination activity. As shown in figure 41b, GFP was 
effectively expressed in tissues such as spleen, lung, liver or kidney following the 
pattern of  the myeloid compartment. Moreover, we also obtained BMDMs from 
Cpeb4MKO mice and confirmed that CPEB4 depletion was effective, both during 
the differentiation process and after LPS stimulation (Fig. 41c, d). 
→ Figure 41. Generation of a myeloid-specific CPEB4 KO mouse model 
(Cpeb4MKO). (a) Scheme of the alleles used to create Cpeb4MKO mouse model. 
(b) GFP Immunohistochemistry of tissues obtained from Cpeb4MKO mice. Scale 
bar 250 µm. (c-d) BMDMs obtained from wild type or Cpeb4MKO mice. Immunoblot 
analysis of CPEB4 at different days of differentiation (c) or during LPS stimulation (d) 
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6.1. Myeloid-specific Cpeb4KO mice in homeostasis 
When maintained in a specific pathogen-free (SPF) facility, Cpeb4MKO mice were 
born at the expected Mendelian male/female ratios (Fig. 42a) and young adult mice 
(10-18weeks) had normal body weight and did not display any obvious pathology 
regarding growth, fertility or mobility (Fig. 42b). Moreover, no visible change in 
the major organs (e.g., liver, spleen, lung, thymus, heart, kidney) was noted, neither 
at their normalized weight (Fig. 42c,d) nor during their histological analysis (data 
not shown).
Chronic inflammation is a common pathological basis for age-associated diseases. 
Thus, we let a group of  mice age until 80 weeks of  age. We observed a certain 
tendency among Cpeb4MKO males to have greater body weight (pv=0,0571), but 
overall the parameters we evaluated (organ weight and appearance) were comparable 
between wild type and Cpeb4MKO mice (Fig. 42e-g). 
In order to challenge their immune system, a group of  Cpeb4MKO adult mice was 
transferred for three months to a non-SPF animal house until they were 30 weeks 
of  age. Again, no major differences in their weight or major organs were found 
between non-SPF wild type and Cpeb4MKO mice (Fig. 42h-j) (histological analysis 
not shown). 
Finally, we also performed complete blood counts for the previously mentioned 
groups of  mice: adults (in this case 30 weeks old), aged (80 weeks) and non-SPF (30 
weeks). As shown in figure 43a, we observed significant alterations between adult 
and aged wild type mice that did not occur in aged Cpeb4MKO mice. Nevertheless, 
we did not find any differences between Cpeb4MKO mice and their corresponding 
controls. 
Overall, these results indicate that, under homeostatic conditions, CPEB4 depletion 









Figure 42. No major abnormalities in Cpeb4MKO mice in homeostasis. (a) % of 
mice of the indicated phenotype born from Cpeb4+/+ or Cpeb4lox/lox matings. (b,e,h) 
Total animal body weight. (c,d,f,g,I,j) Normalized organ weight. (b-d) 10-18weeks 
old adult mice maintained in a specific pathogen-free  (SPF) facility (e-g) 80weeks 
aged mice maintained in a specific pathogen-free  (SPF) facility (h-j) 30weeks old 
adult mice maintained in a non-specific pathogen-free  facility. Statistics Mann-










































































































































































































































Figure 43. Normal blood counts of Cpeb4MKO mice in homeostasis. (a) 
Complete blood counts from adult (30weeks), aged (80 weeks) and non-SPF mice 
(30 weeks). 95% interval for 8-10weeks C57BL/6 mice is shown (Charles River®). 
Abbreviations: WBC (White Blood Cells), LYM (Lymphocytes), MID (Monocytes), 
GRA (Granulocytes), PLT (Platelets), RBC (Red Blood Cells). Statistics: One-way 






















































































6.2. Decreased survival of  Cpeb4MKO mice to LPS-induced 
homeostatic shock 
Next, based on our previous results on CPEB4 function during the LPS response, 
we challenged Cpeb4MKO mice with an intraperitoneal dose of  LPS. This protocol, 
known as LPS-induced endotoxic shock, models the systemic inflammatory 
process that occurs during sepsis.  We evaluated Cpeb4MKO mice survival upon 
LPS-induced endotoxic shock and observed that Cpeb4MKO mice had increased 
sensitivity to LPS (Fig. 44a), as they showed decreased survival rates despite having 
received comparable LPS doses (Fig. 44b). Thus, CPEB4 expression in the myeloid 
compartment is needed for LPS-induced endotoxic shock survival.
Upon LPS-induced endotoxic shock, mice suffer a dramatic weight loss that can lead 
to life-threatening conditions. In our case, Cpeb4MKO mice lost weight at earlier 
timepoints and, in higher proportions than wild type mice, lost more than 20% of  
their initial weight (Fig. 44c), a factor of  poor prognosis even if  their mean body 
weight loss was comparable to wild type controls (Fig. 44d). 
To better define the origin of  our phenotype, we studied the damage after LPS 
administration for specific organs. Histological analysis revealed that the damage on 
liver, spleen, lung and thymus was comparable between wild type and Cpeb4MKO 
mice (Fig. 45a, see materials and methods for detailed description of  the 
evaluated parameters). Nevertheless, we observed that Cpeb4MKO mice developed 
splenomegaly (Fig. 45b). Importantly, this phenotype has been also described in 
Socs1MKO and Socs3MKO mice, two of  the previously described CPEB4 targets. 
These two KO mice also display decreased survival after LPS challenge and the cause 
of  their phenotypes is the development of  an exacerbated inflammatory response 
(Sachithanandan et al. 2011; Qin et al. 2012). Having seen in vitro that Cpeb4KO 
BMDMs expressed reduced levels of  SOCS1, we hypothesized that the cause of  
our phenotype could also be related to an impairment in inflammation resolution.








Figure 44. Decreased survival of Cpeb4MKO mice to LPS-induced endotoxic 
shock. (a) Kaplan-Meier survival curves after i.p. injection of LPS (10mg/kg body 
weight) (n >7/group/experiment). Results represent three independent experiments. 
*LRT-pv<0.05 (b) Micrograms (ug) of LPS administered to WT and MKO mice. (c) 
Weight loss was evaluated after LPS administration at the indicated hours and 
expressed as % of time zero. (d) Weight loss was calculated as described in c 
and animals were grouped in the indicated categories. (e) Spleen weight is shown 
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Therefore, we decided to measure serum cytokine levels, which overall were 
comparable between wild type and KO mice (Fig. 45c). Looking at wild type animals, 
though, we detected that animals could be clustered between those expressing high 
and low IFNγ (Fig. 45c). Interestingly, in Cpeb4MKO group there was a higher 
proportion of  mice presenting the IFNγhi behaviour, and same happened for IL-1β, 
IL-10 and IL-6 cytokines (Fig. 45d). 
Even if  we did not observe a significant increase in serum cytokine levels, we 
considered that these results were very consistent with the penetrance of  other 
phenotypes such as survival or body weight loss. Altogether, these results suggest 
that, even if  Cpeb4MKO mice responded deficiently to LPS challenge, some mice 
could compensate for the CPEB4 absence and survive, while others could not return 
to the homeostatic state. 
Thus, to look for the origin of  these alterations, we decided to further study the 
spleen of  Cpeb4MKO animals, as splenomegaly development had been so far our 
most penetrant phenotype. As a first approach, we measured cytokine expression in 
total spleen mRNA extracts. Interestingly, we observed increased levels of  several 
cytokines, including Il6, Tnf, Il10 or Il1a (Fig. 46a). These results supported the 
hypothesis that in the absence of  CPEB4 inflammation resolution is impaired. 
However, further studies should address which cellular compartment in the spleen is 
expressing these cytokines. Altogether, in this last section we have seen that CPEB4 
expression in the myeloid compartment is needed for LPS-induced endotoxic shock 
survival and to limit inflammatory responses in splenocytes in vivo.  








→ Figure 45. Cpeb4MKO inflammatory response to LPS-induced endotoxic 
shock. 





























































































































































































← Figure 45. Cpeb4MKO inflammatory response to LPS-induced endotoxic 
shock. Wild Type or Cpeb4MKO mice were sacrificed after an i.p. injection of LPS 
(10mg/kg body weight LPS at the indicated hours. (a) H&E stained sections of the 
indicated tissues were evaluated by scoring several parameters from 0 to 4 (highest 
affectation). Tissue damage for wild type and Cpeb4MKO mice was the result of the 
addition of the different scores. Continues in the next page. (b) Serum cytokines 
levels were measured at the indicated hours after LPS I.P. injection by multiplex 
bead capture assay. n>3 animals/condition. (c) % of Cpeb4MKO displaying serum 
cytokine levels above or below the wild type median.  
 
Figure 46. Increased cytokine expression by Cpeb4MKO splenocytes during 
LPS-endotoxemia. (a) Total RNA was isolated from spleens and cytokine levels 
were measure by RT-qPCR. TBP was used for normalization. n>5 animals/condition. 




































































































In this section, we will discuss different ideas that arise from this work. In the first 
part (points 1-8), we will comment the results of  this study and their biological 
meaning. In the second (point 9), we will address the open questions that remain 
unexplored.
1. Inflammation resolution requires CPEB4-mediated translational 
control 
In this work, we have found that CPEB4 is a novel player in macrophage homeostasis 
and in macrophages response to LPS. We have described how, upon LPS stimulation, 
the MAPK p38α transiently stabilizes Cpeb4 mRNA, a process that is mediated by 
the two ARE-BPs HuR and TTP. We also find a new scenario where CPEB4 protein 
is regulated by phosphorylation, a modification that regulates its activity (Guillén-
Boixet et al. 2016). Downstream CPEB4, we described which are their associated 
mRNAs during the late phase of  the LPS response. Remarkably, our results indicate 
that CPEB4 participates in inflammation resolution by promoting the expression of  
negative feedback inhibitors of  the inflammatory pathways. Indeed, we have also 
demonstrated the relevance of  CPEB4 contribution to inflammation resolution in 
vivo. 
Additionally, we propose that, during the LPS response, TTP and CPEB4 compete 
to deadenylate or polyadenylate the target mRNAs that they have in common. 
Moreover, we have uncovered an association between the number of  AREs and 
CPEs in the 3’UTR of  mRNAs and their expression pattern after LPS stimulation. 
These results suggest that the combined action of  HuR, TTP and CPEB4 is required 
to determine different waves of  mRNA expression during macrophage activation 
by LPS. 









2. CPEB4, a new player in LPS response
Macrophages are constantly exposed to metabolic, homeostatic and immunoregulatory 
signals. Unlike other cells, they are specialized in sensing these stimuli and adapt 
their functions in response to them. For example, upon exposure to danger signals, 
like LPS, they trigger an inflammatory response that aims to eliminate the invaders, 
repair the tissue and restore homeostasis. 
The development and resolution of  inflammatory responses needs to be tightly 
controlled. Importantly, functional defects in the inflammatory or anti-inflammatory 
pathways, can lead to pathogenic situations like infections or auto-immune diseases. 
Thus, macrophages need to carefully balance these two opposite functions. For 
that, they have a complex network of  regulatory mechanisms that control gene 
expression at multiple levels. Importantly, this network is composed by both positive 
and negative circuits that cross regulate each other. This way, inflammatory responses 
present an oscillatory and self-limited behaviour.  
So far, extensive studies have described the signalling pathways that are activated 
in LPS-stimulated macrophages. At the post-transcriptional level, one of  the best 
characterized mechanisms limiting the expression of  cytokines is the induction 
of  mRNA deadenylation and decay. Nevertheless, the function of  cytoplasmic 
polyadenylation in this field remained almost unexplored. 
In this work, we have studied CPEB4 regulation and function during the LPS 
response. We have described how the MAPKs pathways regulate CPEB4 levels and 
activity so that CPEB4 polyadenylating function peaks during the resolutive phase 
of  the LPS response. This way, the expression of  CPEB4-regulated mRNAs is also 
sustained during this period, which is especially relevant for those molecules limiting 
the activation of  the inflammatory pathways. Thus, CPEB4 is a novel player to be 











3. The MAPKs p38α and ERK1/2 regulate CPEB4 levels and 
activity during the LPS response
To study the role of  cytoplasmic polyadenylation in macrophages, we first assessed 
Cpebs expression in macrophages subjected to different stimuli (Fig. 22). We observed 
that Cpeb4 mRNA was transiently upregulated after LPS stimulation. CPEB4 protein, 
however, did not followed the same behaviour, as it was progressively upregulated 
(Fig. 22, 25). These result suggested that Cpeb4 mRNA was post-transcriptionally 
regulated. Additionally, we also detected that CPEB4 was phosphorylated during 
this process, a post-translational modification that enhances CPEB4 polyadenylating 
activity (Guillén-Boixet et al. 2016) (Fig. 25). Thus, these results suggest that distinct 
mechanisms regulate CPEB4 expression and activity in a coordinated manner during 
the LPS response . 
Of  these regulatory mechanisms, we have shown that, indeed, upon LPS stimulation, 
the MAPK p38α and the two ARE-BP HuR and TTP regulate Cpeb4 mRNA. 
Specifically, during the early times of  LPS response, p38α activation stabilizes Cpeb4 
mRNA and promotes its association with HuR (Fig. 21-22), which will probably 
mediate its stabilization. During the late LPS response, though, TTP associated with 
Cpeb4 and promotes its destabilization and downregulation (Fig. 22, Sedlyarov et al. 
2016). Thus, we have described a novel axis that regulates Cpeb4 mRNA at the post-
transcriptional level through the AREs on its 3’UTR. 
Regarding which of  the described kinases mediate CPEB4 phosphorylation, our 
results suggest that ERK1/2 MAPKs could be phosphorylating CPEB4 in this 
context (Fig. 25). Importantly, it has been shown that phosphorylated CPEB4 
can promote the polyadenylation of  its own mRNA, creating a positive feedback 
loop that favours its own expression (Igea & Méndez 2010; Calderone et al. 2016). 
Pressumably, during the late phase of  the LPS response, P-CPEB4 also initiates this 
feedback loop and polyadenylates its own mRNA to upregulate its own levels. 
Importantly, these mechanisms already exemplify that one same mRNA, in this case 
Cpeb4, could be regulated by HuR, TTP and CPEB4 throughout LPS response (Fig. 
47). 









Figure 47. MAPK-dependent regulation of CPEB4 levels and activity during the 
LPS response in BMDMs. In untreated conditions TTP destabilizes ARE-containing 
mRNAs like Cpeb4 (red dashed arrow). Upon LPS stimulation, downstream p38α, TTP 
is phosphorylated, which favours HuR association with these mRNAs, its stabilization 
and upregulation. Downstream TLR4, ERK1/2 MAPKs are also activated, which can 
phosphorylate CPEB4 favouring its polyadenylation activity. Then, CPEB4 activation 
will promote a positive feedback loop where CPEB4 polyadenylates its own mRNA 





























4. Relevance of  CPEB4 hyperphosphorylation for LPS response
As we have mentioned, CPEB4 polyadenylating function is activated by 
phosphorylation during the LPS response. However, unlike other proteins, 
CPEB4 can be hyperphosphorylated in at least twelve sites in its N-terminal 
domain. Moreover, these twelve phosphorylation events additively activate CPEB4 
polyadenylation activity (Guillén-Boixet et al. 2016).
Interestingly, regulation of  proteins through hyperphosphorylation like CPEB4 can 
generate ultrasensitive responses (Guillén-Boixet et al. 2016; Ferrell & Ha 2014a). 
These type of  responses are defined as “a response to an increasing stimulus that 
is described as a sigmoidal dose-response curve. Low levels of  stimulus produce a 
poor response but, as the stimulus level increases, there is an abrupt increase in the 
response to near-maximal levels” (Ubersax & Ferrell 2007). Thus, ultrasensitivity 
allows to create switch-like transitions, where small inputs are initially ignored but, 
if  they surpass a certain threshold, the system responds with a complete output. 
Besides protein hyperphosphorylation, multiple other mechanisms can generate 
ultrasensitive responses, for example feedback loops or cooperativity.
Oscillatory processes like inflammatory responses need to delay the induction of  
inhibitory mechanisms. Thus, they regulate the expression of  these molecules via 
mechanisms that favour this delay, like ultrasensitive responses. In ultrasensitive 
responses generated by hyperphosphorylation, the timing of  the switch is 
determined by several parameters, such as the ratio between activating sites and total 
sites, the levels of  the substrate or the presence of  substrate competitors, among 
others (Ferrell & Ha 2014a). Therefore, it is probably critical for the LPS response 
that CPEB4 is regulated via multiple phosphorylating events instead of  just one. 
This way, CPEB4 switch occurs in a delayed manner, creating different temporal 
windows for the expression of  ARE- and CPE-containing mRNAs or, in a broader 
sense, for the inflammatory and anti-inflammatory phases of  the LPS response. 
It remains to be explored though, which would be the consequences of  an immediate 
activation of  CPEB4 during the early LPS response or the parameters that define 
the ultrasensitive response generated by CPEB4 in this context. 









5. Closing the circuit: CPEB4 targets are enriched in MAPK 
pathway-related genes
To characterize CPEB4 function in macrophages we performed RNA 
Immunoprecipitation and Sequencing (RIP-seq) (Fig. 26-28). Once we had defined 
the mRNAs associated with CPEB4, we observed that the most relevant category 
in the GO analysis was the MAPK signalling pathway. This result established a 
regulatory circuit between the MAPK pathway and CPEB4, which could contribute 
to the oscillatory character of  the LPS response. 
To generate self-sustained oscillations, a single negative feedback is required and 
sufficient (Friesen & Block 1984; Ingolia & Murray 2004; Lomnitz & Savageau 
2014; Novák & Tyson 2008; Ferrell et al. 2011). However, biological oscillators 
are usually organized into more complex networks, which include additional 
elements. Intriguingly, although they are not required to generate oscillations, these 
elements are evolutionary conserved, highlighting the relevance of  their function. 
Among other properties, biological oscillators need to function properly in noisy 
environments or, in other words, need to be robust. Consequently, it has been 
proposed that the function of  these additional elements could be related to the 
oscillator’s robustness (Li et al. 2017). For example, the addition of  self-positive 
feedback loops, in which a node can active itself, significantly increases the robustness 
of  a network (Ananthasubramaniam & Herzel 2014; Gérard et al. 2012; Tsai et al. 
2008). Alternatively, the addition of  nodes receiving incoherent inputs, meaning 
both positive and negative inputs, also increases the oscillator’s robustness (Li et al. 
2017).
Interestingly, both features are found in CPEB4 regulation and function during the 
LPS response. First, CPEB4 is regulated by two incoherent inputs, HuR and TTP. 
Next, CPEB4 can promote its own expression through a positive feedback loop. 
Finally, the described competition between CPEB4 and TTP implies that the target 
mRNAs that they have in common are again subjected to incoherent inputs. Thus, 
thanks to these features, CPEB4 regulation and function could be increasing the 










Additionally, some cellular systems are formed of  multiple interlinked loops rather 
than single positive feedback loops. Dual-switch systems, for instance, combine 
loops with distinct temporal properties. Importantly, this combination of  different 
kinetics confers certain advantages to these systems. First, the output is turned on 
rapidly, as a consequence of  the fast loop, but turned off  slowly, as a consequence 
of  the slow loop. Thus, this duality allows an independent tuning of  the activation 
and deactivation times. More important, although dual-switch systems exhibit high 
noise sensitivity when in off  state, they become much robust once in its on state, as 
a result of  the properties of  its slow loop (Brandman et al. 2005). 
Again, the described circuit between the MAPKs pathway and CPEB4 also benefits 
from these properties. In this system, phosphorylating events between MAPKs 
involve a rapid positive loop, while CPEB4-mediated translational control mediates 
a slower loop. This concept, of  course, also applies to HuR- and TTP-mediated 
translational control. Hence, this properties also support that the interregulation 
between the MAPKs pathway and CPEB4 could increase the robustness of  
macrophage response to LPS.   
Figure 48. LPS activates a regulatory circuit between the MAPK pathway and 
CPEB4. LPS recognition by macrophages activates the MAPK pathways, that 
regulate the levels and activity of HuR, TTP and CPEB4. These three RNA-Binding 
proteins participate in positive feedback loops, cross regulate each other and also 
regulate common mRNAs. The number of AREs and CPEs on mRNAs will determine 
which of these protein preferentially regulate them, thus influencing their expression 
pattern. Finally, the proteins encoded by these mRNAs will provide new positive and 




















6. CPEB4 promotes inflammation resolution during the LPS 
response
Our RIP-seq data also indicated that CPEB4 was associated with the mRNAs of  
multiple feedback inhibitors of  the inflammatory pathways, like SOCS1 and SOCS3, 
MKP1, TTP, A20 or IL1RA (Fig. 28). This result, together with the fact that CPEB4 
activity peaks during the late phase of  the LPS response, suggests that CPEB4 
promotes inflammation resolution by favouring the expression of  these proteins. 
Supporting this idea, Cpeb4KO macrophages presented reduced levels of  SOCS1 
and TTP (Fig. 32). Additionally, although it has not been validated yet, based on the 
ARE/CPE score, IL1RA mRNA (Il1rn) is a good candidate to be highly dependent 
on CPEB4 function, and thus downregulated in Cpeb4KO BMDMs (Fig. 36-37). 
6.1. Decreased survival of  Cpeb4MKO mice to LPS-induced endotoxemia 
To further characterize CPEB4 function in LPS-stimulated macrophages, we 
subjected Cpeb4MKO mice to LPS-induced endotoxic shock. a protocol that models 
the systemic inflammatory response that occurs in sepsis patients. Importantly, this 
response needs to be tightly controlled, as it has been described that both an aberrant 
pro-inflammatory reaction or an extended immune suppression can lead to patient 
death (van der Poll et al. 2017). In our case, we observed that Cpeb4MKO mice 
presented decreased survival capacity upon LPS-induced endotoxemia. Moreover, 
they developed splenomegaly and expressed increased levels of  several cytokines 
in their spleens (Fig. 44-46). Again, these results support that CPEB4 function in 
macrophages is needed to limit inflammatory responses. 
Importantly, the same cytokines which expression was dramatically altered in vivo, 
were expressed normally or weakly altered in BMDMs (Fig. 35, 37, 45). Several 
reasons could account for this difference, such as the distinct features of  each type 
of  macrophage or the contribution of  other cell types in vivo. Regarding this second 
option, it is important to consider that, in vivo, macrophages function as initiators of  
immune responses. Thus, if  macrophages express increased levels of  inflammatory 
cytokines, other immune cell types can sense these signals and overrespond in 
accordance to them, initiating a process that could dramatically magnify the original 
phenotype. Related to this concept, the increased expression of  MHC class II in 










7. AREs and CPEs define the kinetics of  mRNAs during the LPS 
response
While studying CPEB4 target mRNAs, we realized that several of  them had been 
also described to be associated with TTP in LPS-stimulated macrophages. Moreover, 
we detected an inverse correlation between their alterations in TTPMKO and 
Cpeb4KO BMDMs (Fig. 33, 35). These results prompt us to study the AREs and 
CPEs in the 3’UTR of  these mRNAs, to see if  we could predict which of  the two 
RBPs would be predominantly regulating each mRNA. Unexpectedly, considering 
only the number of  AREs and CPEs, we clustered 61 mRNAs in three different 
categories, which followed significantly different expression behaviours during the 
LPS response (Fig. 36). Briefly, while ARE-dominant (AREd) mRNA levels were 
rapidly up- and downregulated, CPE-dominant (CPEd) mRNA levels increased in 
a more progressive manner and they were sustained during the late phase of  the 
LPS response. Finally, the expression of  mRNAs containing both AREs and CPEs 
(A&C mRNAs) presented features of  the two behaviours. Importantly, these results 
uncover the relevance of  ARE- and CPE-mediated translational control to establish 
different temporal mRNA expression patterns during the LPS response (Fig. 49).
7.1. HuR, TTP and CPEB4 define different mRNA expression waves during 
the LPS response
Interestingly, the described behaviour for each group of  mRNAs, was in accordance 
with how the levels and activity of  HuR, TTP and CPEB4 are regulated during 
the LPS response (Fig. 49). Moreover, we observed that the ARE/CPE score 
also clustered mRNAs according to their alterations in TTPMKO and Cpeb4KO 
macrophages. For instance, AREd mRNAs were severely upregulated in TTPMKO 
BMDMs while CPEd mRNAs were barely affected. And, on the contrary, CPEd 
mRNAs were unaltered in TTPMKO conditions but downregulated in the absence 
of  CPEB4 (Fig. 33, 35). 









Altogether, these correlations suggest that HuR, TTP and CPEB4 are indeed the 
RNA binding proteins reading the combinatorial code between AREs and CPEs 
on the 3’UTR of  mRNAs. Moreover, they also highlight the relevance of  the 
coordinated regulation of  the activity and levels of  these proteins, in order to define 
different kinetics of  mRNA expression during the LPS response. Finally, it is also 
worth considering that, by defining these sequential waves of  mRNA expression, the 
function of  HuR, TTP and CPEB4 is probably central to delimit the inflammatory 
and resolutive phases of  the LPS response. 
Figure 49. AREs and CPEs define three temporal waves of mRNA expression 
during the LPS response. The coordinated regulation of the activity and levels of 
CPEB4, TTP and HuR can explain the behaviour of three type of mRNAs. In turn, 
these three classes of mRNAs are defined by the number of AREs and CPEs in the 
3’UTR of mRNAs. Briefly, during the early LPS response, AREd and A&C mRNAs 
are stabilized due to the action HuR. CPEd mRNAs, though, are stabilized and 
upregulated in a more progressive manner, mirroring CPEB4 activity. After 3 hours 
of LPS, AREd mRNAs are rapidly downregulated, due to the destabilizing activity of 
TTP, while the expression of ARE&CPE and CPEd mRNAs is more sustained thanks 
to the polyadenylating function of CPEB4. 
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7.2. CPEB4 polyadenylating function stabilizes CPE-containing mRNAs 
during the LPS response
Given the well-established link between mRNA deadenylation and decay, another 
conclusion derived from these results is that CPEB4-mediated polyadenylation 
stabilizes CPEd and A&C mRNAs. This hypothesis, although needs to be further 
confirmed, is in accordance with the established paradigm that the poly(A) tail 
facilitates mRNA stabilization. If  true, it will provide a new mechanism to positively 
regulate the levels of  a specific subset of  mRNAs.
Remarkably, none of  the published studies on CPEBs function had shown before 
that mRNA polyadenylation could be coupled to its stabilization. The reason for 
that, is that this mechanism is probably more relevant in certain scenarios, for 
example, in cells that display elevated mRNA turnover rates. This is the case of  LPS-
stimulated macrophages, but could also be valid in differentiating or proliferating 
cells. Moreover, the magnitude of  the effect of  CPEBs-mediated polyadenylation 
on mRNA stability will probably vary among different mRNAs. 
7.3. The Combinatorial Code: multiple cis-acting elements collaborate to 
dynamically regulate gene expression 
An emerging idea in the field is that cellular mRNAs could be broadly classified in 
two categories. The first group includes mRNAs that are very abundant, contain 
longer poly(A) tails, a high proportion of  optimal codons and are overall stable. 
These mRNAs are transcribed from highly expressed genes and encode for proteins 
that are needed for basic cellular functions. Thus, their expression does not need 
to be dynamically regulated. The second group of  mRNAs, however, presents the 
opposite qualities. They are expressed at low levels, contain shorter poly(A) tails, 
reduced codon optimality and poor stability. Interestingly, these features make these 
mRNAs highly susceptible to multiple translational regulatory mechanisms, which 
by slightly modifying their properties can change dramatically their behaviour. 
Moreover, by coordinating its distinct regulatory mechanisms, these mRNAs can be 
dynamically regulated.









According with these properties, we would expect that mRNAs in this second 
category are more susceptible to CPEBs function. It is important to consider, 
though, that these mRNAs are also highly predisposed to be regulated by multiple 
other mechanisms. Consequently, to understand how CPEBs regulate its target 
mRNAs, other regulatory elements may need to be considered. Indeed, our study is 
not the first one where the combination of  CPEs and other elements in the UTRs of  
mRNAs can explain complex expression patterns. For example, it has been shown 
that the combination of  AREs and CPEs also determines different temporal waves 
of  activation of  mRNA translation during meiosis progression (Belloc et al. 2008). 
Moreover, the combined action of  uORFs and CPEs was shown to define two 
temporal waves of  translational activation following ER stress (Maillo et al. 2017). 
Altogether, these studies evidence how the combined regulation of  mRNAs by two 
elements in their UTRs can establish different kinetics of  gene expression. However, 
we should consider that mRNAs can contain more than two different elements, that 
some elements are recognized by more than one RNA Binding protein, and that 
each protein is subjected to multiple mechanisms that regulate its expression and 
activity. Hence, the combined regulation of  the cis- and trans-acting elements on 
mRNAs may be able to generate much more complex patterns than the ones that 
have been described so far. 
Finally, we could also think about the biological relevance of  this complexity. It is 
well established that, during animal evolution, the number of  protein-coding genes 
has remained fairly constant; while the length of  3’UTRs and the fraction of  genes 
expressing alternative 3’UTRs have increased substantially (Mayr 2016). Thus, we 
could hypothesize that these two parameters have increased the complexity of  










8. Gene expression is regulated at multiple levels to coordinate 
LPS response
Finally, looking globally at the LPS response, we can see that multiple mechanisms 
are involved in the regulation of  gene expression. These mechanisms act are very 
diverse levels, as they are involved in epigenetic, transcriptional, translational and 
post-translational functions. However, they can be clustered in two groups according 
to their involvement in pro-inflammatory functions or inflammation resolution. 
Importantly, these two groups are not independent from each other, as they are 
activated in a sequential and coordinated manner.
First, during the inflammatory phase of  the LPS response, mechanisms that favour 
the expression of  inflammatory genes are activated. These include the activation of  
signalling pathways via phosphorylation, the degradation of  inflammation inhibitors 
like IκBα, the activation of  transcription factors and induction of  chromatin 
relaxation, and also, mechanisms that favour mRNA stability and translation like 
TTP inactivation, eIF2B dephosphorylation or mTOR activation (appendix III). 
Next, in the anti-inflammatory phase, macrophages activate the second battery of  
mechanisms, which negatively regulate the first ones. Among these, we can find 
mechanisms that inactivate proteins, like the phosphatase DUSP1, that trigger 
their degradation, like SOCS1, that promote mRNA decay, like TTP, or that limit 
translation like mTOR deactivation. 
Altogether, then, LPS response could still be seen an oscillatory circuit composed by 
a single negative feedback loop (Fig. 50). 
Considering this criteria of  positive and negative regulators gene expression, CPEB4 
polyadenylating activity positively regulates mRNAs. Thus, one could expect that is 
was activated during the initial phase of  the LPS response in order to promote the 
expression of  pro-inflammatory molecules. However, CPEB4 is mainly expressed 
and active during the second anti-inflammatory phase. In this context, given the 
global reduction in gene expression, it is critical that the upregulation of  anti-
inflammatory molecules occurs effectively. 









Thus, we propose that CPEB4 function in late LPS response is key to preserve the 
mRNAs coding for anti-inflammatory factors from TTP-mediated deadenylation, 
thus favouring the expression of  a subset of  proteins in an environment where gene 
expression is globally downregulated (Fig. 50). 
Figure 50. Gene expression regulation during the LPS response. Upon LPS 
detection, macrophages activate mechanisms that favour gene expression at 
multiple levels. These mechanisms, besides favouring the expression of inflammatory 
molecules, also promote the expression of negative regulators of the inflammatory 
response. These inhibitors, at later timepoints will inhibit gene expression at multiple 
levels in order to limit the synthesis of pro-inflammatory mediators. During this 
process, however, their expression could be compromised. Thus, we propose that 
CPEB4 function is to favour the expression of the molecules in charge of inflammation 
resolution in this context. 
9. Open questions and future directions
In this second part of  the introduction we will briefly address some questions that 
arise from our results and that, so far, remained unanswered. 
9.1. CPEBs function in macrophages 
In this work we have described CPEB4 function in LPS response. However, several 
aspects of  CPEBs contribution to macrophage physiology remain unexplored. 
For example, CPEB2 function could be relevant for unstimulated macrophages or 



























are involved in macrophages response to other challenges, like infections, tumours 
or metabolic diseases.
Finally, there are still open questions about the contribution of  CPEB1, CPEB2 
and CPEB3 to LPS response. CPEB1 has been proposed to repress Tak1 mRNA 
in LPS-stimulated macrophages, but the exact timings of  its activity or which other 
mRNAs are repressed by CPEB1 is not known (Ivshina et al. 2015). Moreover, Cpeb3 
mRNA was also transiently upregulated after LPS stimulation (Fig. 22). Finally, in 
Cpeb4KO macrophages, Cpeb1, Cpeb2 and Cpeb3 are upregulated (Appendix V). We 
interpret this result as a compensatory mechanism triggered by CPEB4 absence, 
which suggests that they could partially do overlapping functions. Thus, even if  our 
results suggest that CPEB4 is the main CPEB involved in LPS response, it would 
be worth to study their contribution to the regulation of  CPE-containing mRNAs. 
9.2. CPEB4: a stress-response RNA-Binding Protein?
Different stressing stimuli activate the MAPK p38α so that cells adapt their 
functions to their environment. For example, p38α is activated in front of  osmotic 
shock, radiation and oxidative stress, besides LPS and other cytokines. Thus, the link 
we have established between Cpeb4 expression and p38α activation, could actually 
involve that CPEB4 also participates in the cellular response to these other stimuli 
that activate p38α. So far, we have evidence that during mitotic cell cycle progression 
CPEB4 expression is also dependent on the p38α-HuR-TTP axis (data not shown).
In accordance with this, CPEB4 expression and activity has been described in 
scenarios like oocyte meiosis progression or ER stress (Igea & Méndez 2010; 
Maillo et al. 2017). Moreover, in vivo studies in total Cpeb4KO mice suggest that 
CPEB4 expression is critical in response to a challenge but not under homeostatic 
conditions, as we observed in Cpeb4MKO mice (Maillo et al. 2017). Thus, given that 
p38α and other kinases are defined as stress-response kinases, it would be plausible 
to consider CPEB4 a stress-response RNA binding protein.









9.3. Transcriptional regulation of  CPEB4 mRNA
In this work, we have extensively characterized how Cpeb4 mRNA stability 
is regulated upon LPS treatment. However, we have not explored how is Cpeb4 
expression regulated at the transcriptional level. According to different databases, 
the transcription factors PU.1, SMRT, SPI1, CEBPa and CEBPb have been found 
associated to Cpeb4 promoter in macrophages (ChEA 2016, Enrichr; Chen et 
al. 2013; Kuleshov et al. 2016). Moreover, Cpeb4 promoter is predicted to have 
NFKB1 binding sites, one of  the major drivers of  the LPS response. Thus, any of  
these factors could be involved in CPEB4 expression in this context. 
9.4. Non-MAPK -related CPEB4 functions
9.4.1. CPEB4 maintains ER homeostasis (again)
As shown in figure 26, Gene Ontology Analysis revealed that CPEB4 targets were 
enriched in genes related to the MAPK pathway. However, after LPS stimulation 
another category significantly enriched was protein processing at the endoplasmic 
reticulum (ER). The unfolded protein response (UPR) is a pathway that allows cells 
to manage endoplasmic reticulum (ER) stress that is imposed in periods of  high 
ER-protein-folding demand. In this role, the UPR has increasingly been shown 
to have crucial functions in inflammatory responses, which are associated to high 
protein synthesis and secretory charges (Janssens et al. 2014). 
CPEB4 has been shown to activate the translation of  mRNAs encoding for proteins 
that participate in the UPR, a function that is required to overcome ER stress periods 
(Maillo et al. 2017). Therefore, based on the GO data, another function for CPEB4 
during the LPS response could be related to favour the expression of  UPR related 
genes to maintain ER homeostasis. 
9.4.2. CPEB4 translational control regulates mRNA transcription
We tend to think of  gene expression as a linear process where translation acts on 
the mRNAs served by transcription. However, several studies are showing how 
multiple processes such as translation or mRNA degradation can signal back to the 
transcriptional machinery to maintain a balanced proteome. Hence, gene expression 










2016; Das et al. 2017). 
We have shown that CPEB4 regulates the expression of  feedback inhibitors of  the 
inflammatory pathways and thus, to participate in inflammation resolution (Fig. 28). 
However, we also observed some links between CPEB4 function and transcriptional 
regulation. First, Cpeb4KO macrophages presented alterations on NF-κB and STAT1 
activation (Fig. 38). Second, CPEB4 was associated to HDAC1 mRNA, which main 
function is to deacetylase histones and promote chromatin repression (Fig. 39). 
Therefore, it would be really exciting to study if  CPEB4 function could alter certain 
pathways both at the translational and transcriptional level, and contribute to the 
bidirectional regulation of  gene expression. 
9.5. Assessing CPEB4 function by Ribosome profiling
As shown in figure 30, our ribosome profiling data suggests that wild type and 
Cpeb4KO macrophages have almost no differences at TE rates. Further experiments 
should address if  this is due to the fact that we did not met all the quality standards 
(Fig. 29) or because of  the sensitivity of  the technique and the analysis. In the first 
scenario, we should optimize the RNase digestion and monosome selection steps 
of  the ribosome profiling protocol. For the second, being LPS response such a 
dynamic process, a possible solution would be to compare mRNA dynamics across 
different timepoints instead of  a single steady state condition. Nevertheless, with 
the obtained results, it would be worth to further explore the link between CPEB4 
and the genes that were significantly altered in Cpeb4KO BMDMs, like Stard13 (Fig. 
30). 
9.6. Further developing the ARE/CPE Score
9.6.1. Genome wide analysis of  the ARE/CPE score
So far, our ARE/CPE score clustered the expression patterns of  61 mRNAs, 
which included crucial pro- and anti-inflammatory mediators of  the LPS response. 
However, to understand the extent of  this regulatory mechanism, we plan to 
calculate the ARE/CPE score genome wide. 









9.6.2. Including other trans-acting factors in our model
According to the literature several other trans-acting factors also regulate mRNA 
stability during the LPS response. Among them, we can find the miRNA machinery 
as well as RNA binding proteins such as Roquin, Regnase-1, AUF1, hnRNPC, KSRP 
or CELF (Díaz-Muñoz & Turner 2018; Turner & Díaz-Muñoz 2018; Lu et al. 2014; 
Pai et al. 2016; Essandoh et al. 2016). Importantly, some of  the mentioned RBPs 
also recognize AREs and thus, could be contributing to the expression pattern of  
ARE-dominant mRNAs. Thus, it would be great if  future studies included these 
proteins in our model and revealed their contribution to mRNA dynamics.
9.6.3. Increasing the complexity of  the ARE/CPE score 
In the same line, another consideration would be if  by including other cis-acting 
elements in the score, we would be able to better understand mRNA dynamics. To 
tackle this question, we could consider defining a new score computationally. Briefly, 
this would consist in first clustering mRNAs according to their expression patterns 
and then defining which cis-elements are dominant in each category. 
Nevertheless, it is important to consider that, to understand mRNA dynamics, having 
a correlation between a regulatory motif  and an expression pattern is not enough. 
It is also necessary to understand which trans-acting factor recognizes this motif, 
its function, post-translational modifications and expression levels, among other 
features. In our case, a great number of  studies had previously characterized several 
of  these aspects for HuR, TTP and CPEB4. Thanks to them, we could understand 
and interpret many of  our observations and, by putting everything together, get to the 
ARE/CPE score. Thus, even if  we defined a score computationally, characterizing 
each new element would be beyond our capabilities. 
Fifteen years ago The Human Genome project was completed by the collaboration 
of  twenty international institutions and research centres. So far, it is considered 
the world’s largest collaborative biological project. Given the multiple evidence that 
there is a combinatorial code in the UTRs of  mRNAs. Thus, it would be great to 










9.6.4. Considering alternative polyadenylation
Finally, a last consideration on the ARE/CPE score, is that it exclusively considers 
the number of  AREs and CPEs in the 3’UTR of  the longest transcript of  a gene. 
However, mRNAs undergoing alternative cleavage and polyadenylation (APA) can 
generate isoforms with different 3’UTRs, and consequently each 3’UTR should be 
considered separately as it could have a distinct ARE/CPE score. 
As it has been shown that macrophages increase the usage of  shorter 3’UTRs 
in response to bacteria (Pai et al. 2002), it would be really interesting to assess if  
by undergoing APA, mRNAs could switch from a AREd behaviour to a CPEd 
expression pattern. This way, mRNAs would not be forced to be regulated in 
different scenarios by the same elements, but they could either be AREd or CPEd 
according to the context. 
9.7. Mechanistic basis of  the competition between TTP and 
CPEB4
Another question that remains to be explored is the molecular mechanism of  the 
competition between TTP and CPEB4 for the target mRNAs that they have in 
common.
First, it would be possible that TTP and CPEB4 are associated with the same mRNAs, 
where they recruit the deadenylation and polyadenylation machinery, respectively. In 
this case, the competition between the activities of  the recruited complexes would 
determine the final outcome of  the mRNA (Fig. 51a). Alternatively, we could consider 
that either the deadenylation or the polyadenylation machinery can be present on 
an mRNA. In this case, the number of  TTP or CPEB4 molecules associated with 
the mRNA could favour the recruitment of  one or the other complex (Fig. 51b). 
Moreover, we could also imagine that mRNA association with one protein prevents 
that the recruitment of  the other. Consequently, CPEB4 and TTP would not be 
associated with the same mRNAs (Fig. 51c). In this case, it would be interesting 
to address whether the same mRNA molecule can be sequentially associated with 
the most abundant or active protein throughout the different phases of  the LPS 
response. 









Most probably, distinct types of  competitions are possible depending on the mRNA 
features.     
 
Figure 51. Possible mechanisms behind TTP/CPEB4 mRNA competition. (a) 
TTP and CPEB4 are associated with the same mRNA and recruit the deadenylation 
or polyadenylation machinery, respectively. Thus, the final outcome of the mRNA will 
depend on the activities of these complexes. (b) TTP and CPEB4 are associated with 
the same mRNAs. However, one of them preferentially recruits its corresponding 
partners. Then, the bound complex will not allow the recruitment of the other. (c) 
TTP and CPEB4 are associated with different mRNAs. Once the mRNA binds one 
























































9.8. Evaluating the systems used
Finally, I would also like to include a reflexion regarding the systems we have used. 
In vitro, Bone Marrow Derived Macrophages display specific features that may be 
different in monocyte-derived macrophages or tissue-resident macrophages in vivo. 
However, as I have been mentioning throughout this thesis, several mechanistic 
studies on LPS response have also used BMDMs. Importantly, having a common 
accepted and robust system to study macrophage biology facilitates that data 
generated in different laboratories can be contrasted and considered when analysing 
new results. In this line, I would also like to acknowledge the work performed by 
Sedlyarov and colleagues, as it has been crucial to understand several pieces in our 
puzzle (Fig. 24, 34-37). Furthermore, besides their work, their TTP atlas website 
made the access to their data really straightforward. It would be outstanding if  all 
the published data was as accessible as theirs.
Secondly, regarding the in vivo experiments, LPS-induced endotoxemia causes very 
severe damage in multiple organs. For this reason, and in order to minimize animal 
use and suffering, we consider that future studies on the role of  CPEB4 during the 
















The present study provides new insights into the contribution of  CPEB4-mediated 
translational control to the development and resolution of  inflammatory responses 
in LPS-stimulated macrophages. We describe a new mechanism regulating CPEB4 
expression and we propose that CPEB4 function is required for inflammation 
resolution, in vitro and in vivo. Furthermore, we unveiled that the AREs and CPEs 
on the 3’UTR of  mRNAs define different temporal waves of  gene expression 
during the LPS response. 
The main conclusions reached by this work are the following: 
1. The MAPK p38α can regulate Cpeb4 mRNA stability during the LPS response. 
This process is mediated by two ARE binding proteins, HuR and TTP. During 
early LPS response, p38α promotes HuR binding to Cpeb4 mRNA, which probably 
mediates the increase in Cpeb4 stability. At later timepoints, though, TTP promotes 
Cpeb4 mRNA destabilization. 
2. Throughout the LPS response, CPEB4 is post-translationally modified by 
phosphorylation.  
3. In BMDMs, CPEB4 is associated with mRNAs related to the MAPK pathway. 
Thus, during the LPS response, the MAPK pathway and CPEB4 cross regulate each 
other. 
4. During the late phase of  the LPS response, CPEB4 regulates the mRNAs of  
several negative feedback inhibitors of  the inflammatory pathways. By promoting 
the expression of  these molecules, CPEB4 participates in inflammation resolution. 
5. Throughout the LPS response, HuR, TTP and CPEB4 are associated with 
common target mRNAs. The AREs and CPEs in the 3’UTR of  mRNAs can define 
their susceptibility to be regulated by TTP or CPEB4 activities. Moreover, during 
the LPS response, three temporal waves of  mRNA expression can be defined by 
these elements. 
6. CPEB4 expression in myeloid cells is dispensable for overall mice homeostasis. 
However, it is required for LPS-induced endotoxic shock survival. In this context, 






















Animal Studies. To generate a Myeloid-specific Cpeb4 KO mice (Cpeb4MKO), 
conditional Cpeb4 knockout animals (Cpeb4lox/lox (Maillo et al. 2017)) were crossed 
with LysM-CreT/+ (Clausen et al. 1999) transgenic animals obtained from Jackson 
Laboratory. Offspring was maintained in a C57BL/6J background. Routine 
genotyping was performed by PCR. Bone Marrow Derived Macrophages (BMDM) 
were obtained from Wild Type and Myeloid-specific p38α KO mice (p38αMKO) 
(Ref  Elisa) and full CPEB4 KO mice (Maillo et al. 2017). The mice were given 
free access to food and water and maintained in individually ventilated cages under 
specific-pathogen-free conditions (unless otherwise specified). All experimental 
protocols were approved by the Animal Ethics Committee at the University of  
Barcelona. 
LPS-induced Endotoxic Shock. Wild type (CreT/+) and Cpeb4MKO mice were 
injected intraperitoneally with LPS (10 mg/kg; Santa Cruz SC-3535, E. coli 0111:B4). 
Animals were monitored and samples were collected at the indicated times. Mice 
between 2 and 5 months of  age were used, matched for age and sex.   
Cytokine measurement in serum. Serum was collected after centrifuging clotted 
blood at 3000g for 30 min. Cytokine levels were measured with a murine ProcartaPlex 
Assay (Labclinics). 
Histological analysis. Tissues were fixed in 10% neutral buffered formalin and 
stained with H&E. Stained histology sections were visualized with a Nanozoomer 
2.0HT – Hamamatsu and the Nanozoomer Digital Pathology Image Software. 
Disease scores after LPS-induced endotoxic shock were calculated by taking into 
account the following evaluated parameters (Table I). Each of  them was given 
a score between 0 and 4 and the disease score was calculated by the addition of  
individual scores. 
















Cell culture. BMDMs were isolated from the femurs of  adult mice (Celada et al. 
1996). Bone marrow cells were differentiated for 7 days on bacteria-grade plastic 
dishes in DMEM supplemented with 20% (vol/vol) FBS, penicillin (100 units/
ml), streptomycin (100 mg/ml), L-glutamine (5mg/ml) and 20% L-cell conditioned 
medium as a source of  M-CSF. DMEM containing 10% FBS, penicillin (100 units/
ml), streptomycin (100 mg/ml), L-glutamine (5mg/ml), changing its media on 
day 5. For stimulation, BMDM were primed with LPS (10ng/ml, E. coli 0111:B4, 
Santa Cruz SC-3535,), IFNg (low dose 10ng/ml; high dose 100ng/ml, 130-094-
047 Milteny Biotec), IL4 (10ng/ml, 550067 Bd Pharmingen) for the indicated time 
points.
RNA analysis. Total RNA was either extracted by TRIzol reagent (Invitrogen), 
by phenol-chlorofom or using Maxwell. One microgram of  RNA was reverse-
transcribed with oligodT and random primers using RevertAid Reverse Transcriptase 
(ThermoFisher), following the manufacturer’s recommendations. Quantitative real-
time PCR was performed in a QuantStudio 6flex (ThermoFisher) using PowerUp 
SYBR Green Master (ThermoFisher). All quantifications were normalized to an 
endogenous control (TBP or Rpl0).
Liver Necrosis/Apoptosis of isolated hepatocytes randomly distributed
  Small focal areas of hepatocyte necrosis and mixed inflammatory cell infiltrate
  Increase of cellular inflammatory infiltrate (mainly neutrophils) in sinusoids
  Inflammatory infiltrate portal tracts 
  Glycogen depletion
  Gall bladder inflamation
  Hemorrhage (peliosis hepatis)
Lung Diffuse thickening alveolar septum (neutrophils and some macrophages)
  Perivascular and peribronchial edema
  Congestion alveolar capillaries and alveolar septa
  Neutrophils in vascular lumen
Spleen Necrosis/apoptosis lymphocytes and increase size white pulp
  Pyogranulomatous inflammatory cell infiltrate white pulp
  Decreased cellularity in red pulp
  Red pulp congestion
Thymus Necrosis/apoptosis of cortical lymphocytes
  Depletion of lymphocytes in the medulla


















RNA stability. BMDMs from WT and p38αKO mice were stimulated with 
LPS (10ng/ml) for 1h and control cells (time 0) were collected. Fresh medium 
and Actinomycin D (10ug/ml, Sigma Aldrich A9415) were added and cells were 
collected at the indicated times. Total RNA was isolated and cDNA was synthesized 
to perform RT-qPCR analysis, as described below. For each timepoint, remaining 
Cpeb4 mRNA was normalized to Gapdh mRNA levels. The value at time 0 was set 
as 100% and for the rest of  timepoints the percentage of  remaining mRNA was 
calculated. 
Immunoblotting. Protein extracts were quantified by DC Protein assay (Bio-
Rad), and equal amounts of  proteins were separated by SDS-polyacrylamide gel 
electrophoresis. After transfer of  the proteins onto a nitrocellulose membrane 
(GE10600001, Sigma) for 1 h at 100mV, membranes were blocked in 5% milk, 
and specific proteins were labeled with the following antibodies. Quantification was 
done with ImageStudioLite software. 
Immunofluorescence. Cells were fixed with 4% PFA for 10 min followed by 
permeabilization with 0.1% Triton X-100 for 5 min. Then, cells were blocked 
with 10% FBS in 0.03% Triton X-100 for 1 h. Primary antibodies were incubated 
overnight at 4ºC followed by 1 h incubation with the corresponding secondary 
antibody. Images were obtained on an Olympus ScanR - Xcellence – TIRF with 
a 60x water objective lense and a Hamamatsu Orca-ER camera. ScanR acquisition 
software was used. 
RNA-immunoprecipitation-sequencing analysis. Cpeb4KO and wild type 
primary Bone Marrow Derived Macrophages, untreated or stimulated for 9h with 
LPS (10ng/ml), were cultured in DMEM supplemented with 10% FBS, rinsed twice 
with 10 ml PBS, and incubated with PBS  0.5 % formaldehyde for 5 min at room 
temperature under constant soft agitation to crosslink RNA-binding proteins to 
target RNAs. The crosslinking reaction was quenched by addition of  glycine to a 
final concentration of  0.25 M for 5 min. Cells were washed twice with 10 ml PBS, 
lysed with scraper and RIPA buffer [25 mM Tris-Cl pH7.6, 1% Nonidet P-40, 1% 
sodium deoxycholate, 0.1% SDS, 100 mM EDTA, 150 mM NaCl, protease inhibitor 
cocktail, RNase inhibitors], and sonicated for 10 min at low intensity with Standard 
















Bioruptor Diagenode. After centrifugation (10 min, max speed, 4ºC) supernatants 
were collected, precleared, and immunoprecipitated (4h, 4ºC, on rotation) with 10 
μg of  anti-CPEB4 antibody (Abcam), 50 µl of  Dynabeads Protein A (Invitrogen). 
Beads were washed 4 times with cold RIPA buffer supplemented with Protease 
inhibitors (Sigma-Aldrich), resuspended in 100 µl Proteinase-K buffer with 70 ug 
of  Proteinase-K (Roche), and incubated 60 min at 65ºC. RNA was extracted by 
standard phenol-chloroform, followed by Turbo DNA-free Kit (Ambion) treatment. 
Samples were processed at the IRB Functional Genomics Facility following standard 
procedures. Libraries were sequenced by Illumina 50bp single-end and inputs and 
IPs were aligned against the mouse reference genome mm10 with Bowtie2 in local 
mode accepting 1 mismatch in the read seed. Alignments were sorted and indexed 
with sambamba v0.5.1. Putative over-amplification artifacts (duplicated reads) were 
assessed and removed with the same software. Coverage tracks in TDF format 
for IGV were made using IGVTools2. Quality control assessment for unaligned 
and aligned reads was done with FastQC 0.11. Further quality control steps (Gini/
Lorenz/SSD IP enrichment, PCA) was performed in R with the htSeqTools 
package version 1.12.0. rRNA contamination was assessed using the mm10 rRNA 
information available at UCSC for both raw and duplicate filtered reads. A preliminary 
peak calling process was performed for duplicate filtered sequences with the MACS 
1.4.2 software using default options to assess overall enrichment in the sequenced 
samples. The identified peaks (enriched regions) were annotated against the mouse 
reference genome release mm10 using the ChIPpeakAnno package version 2.16.. 
Targets were defined combining 3’UTR enriched Regions from MACS peak calling, 
stablishing as threshold p value < 0,02 and log2(FC) > 1,2. Gene ontology analysis 
was performed using the DAVID Functional Annotation Bioinformatics Microarray 


















BOX 3. OPTIMIZING RIP-SEQ CONDITIONS TO IMPROVE RNA QUALITY
After our first RIP-seq experiment to define CPEB4 targets (n=1, Fig. 26-28), we 
aimed to repeat this protocol to include more biological replicates in our study. 
However, given the high level of RNA fragmentation in the first replicate (Fig. 26), 
we decided to optimize the lysis buffer used for this protocol. As seen in figure 
52a, by adding more RNase inhibitors, specially ribonucleoside vanadyl complex 
(RVC) we could highly improve RNA quality. However, when we tried to repeat 
the RIP-seq experiment with two biological replicates for wild type and Cpeb4KO 
BMDMs, CPEB4 immunoprecipitation was not highly specific (Fig 52b, c). We 
hypothesized that the VRC could be interfering with CPEB4 immunoprecipitation 
and thus, we did an IP test with and without this compound. Unexpectedly, in both 
conditions CPEB4 IP was again highly inespecific, suggesting that VRC was not the 
cause of this problem. Finally, we decided to repeat CPEB4 immunoprecipitation 
using the original buffer with two different batches of CPEB4 antibody (named as 
08 and 12). In parallel, we immunoprecipitated HuR to test if these unspecificity 
was only occurring in CPEB4 IP. We observed that HuR IP was really efficient but 
in the IPs of both CPEB4 antibodies or the IgG an unspecific smear was again 
detected (Fig.52 d). 
Figure 52. RIP-seq optimization process. (a) After BMDMs lysis with different 
buffers, mRNA was isolated and RNA integrity was evaluated with an Agilent 
2100 BioAnalyzer with the RNA 6000 Pico kit. (b) RIP-seq protocol was followed 
as described but using RIPA buffer supplemented with RVC. Immunoblot for 
CPEB4 from inputs and immunoprecipitated fractions with anti-CPEB4 antibody 
in BMDMs obtained from Wild type or Cpeb4KO mice (n=2) is shown; Vinculin 
served as a loading control. Ponceau staining is shown. (c) Immunoblot for 
CPEB4 from inputs and immunoprecipitated fractions with anti-CPEB4 antibody 
in BMDMs obtained from Wild type. RIPA buffer with and without RVC was 
used. IgG served as control. (d) Immunoblot for CPEB4 and HuR from inputs, 
immunoprecipitated and unbound fractions from Wild type BMDMs. Two different 
batches of anti-CPEB4 antibody were used (08 and 12). RIPA buffer with and 
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RIP-seq optimization. Buffers Optimization process: RIPA: 50mM Tris pH=8, 
150mM NaCl, 1mM MgCl2, 1% NP40, 0,1% SDS. POLY: 10mM HEPES pH=7, 
100mM KCl, 5mM MgCl2, 0,5% NP40. RIPA/POLY buffers were supplemented 
with 2mM DTT, Protease inhibitors, Riboblock (200U/ml), SUPErase In (100U/
ml), 0,5mg/ml Heparin and either 25mM EDTA or 10mM VRC. For proteinase 
K treatment, fresh add riboblock, heparin, superase IN and VRC were added. 
Proteinase K was performed for 30min at 42ºC followed by 30min at 65ºC. Befor 
RNA precipitaton, 1ul of  EDTA 0,5M was added.
Script CPE-G. To calculate CPE-G containing mRNAs the following modifications 
were included in the CPE script defined by Piqué and colleagues (Piqué et al. 2008). 
We substituted CPEc definition by TTTTGT, removed CPEnc and PBE and 
maintained the distances to the hexanucleotide. 
Statistics. Data are expressed as means±SEM. Dataset statistics were analyzed using 
the GraphPad Prism software. For two group comparisons, column statistics were 
calculated and based on Standard Deviation and d’Agostino&Pearson normality 
test, parametric t test (assuming or not same SD) or non-parametric t-test (Mann-
Whitney) was performed. For multiple comparisons, one-way ANOVA Kruskal 
Wallis test or two-way ANOVA followed by the Bonferroni post-hoc test were used. 
To asses survival, Kaplan-Meier survival curves were done with Disease Free Survival 
using R2.15 and the survival package version 2.37-2, adjusting by Gender, Weight 
and LPS ug. Fisher’s exact test was used for contingency analysis. Differences under 
p<0.05 were considered statistically significant (*P<0.05, **P<0.01, ***P<0.001). 
For animal studies, same sample size tried to include always more than five mice in 
each group. Animals were grouped in blocks to control for experimental variability. 
Furthermore, wild-type and knockout animals were bred in the same cages whenever 
possible and the experimenter was blinded until the conclusion of  the experimental 
analysis. Experiments were repeated independently with similar results as indicated 
in the figure legends.
Phagocytosis assay. BMDM were incubated with AlexaFluor 594 E. coli 
Bioparticles (ThermoFisher) for 90 min at 37°C. For cytometry analysis, cells were 
washed with PBS to remove free particles, then scraped and collected on ice. Samples 
were run on a Gallios flow cytometer, and data was analyzed using FlowJo software. 
















For microscopy analysis, cells were washed with PBS and fixed with 4% PFA for 10 
min, permeabilized with 0.1% Triton X-100 for 5 min and stained with Dapi. The 
amount of  particle-positive cells was analyzed by fluorescence microscope, with five 
random fields per condition (n > 200).
Lambda protein phosphatase assay (l-PPase). BMDM were lysed with l-PPase 
reaction buffer (New England BioLabs, Ipswich, MA) supplemented with 0.4% 
NP-40 and EDTA-free protease inhibitors (Sigma-Aldrich). l-PPase (New England 
BioLabs) reactions were performed following manufacturer’s instructions.
Ribosome Profiling. Ribosome profiling (RP) was performed as previously 
described (Loayza-Puch et al. 2016; Slobodin et al. 2017). Briefly, sucrose gradients 
for separation of  polysomes were usually prepared by gentle sequential addition of  
2.2ml of  the different sucrose solutions (e.i., 47, 37, 27, 17 and 7% in Tris-HCl pH 
= 7.5 (f.c. 20mM), MgCl2 (f.c. 10mM) and KCl (f.c. 100mM), supplemented with 
2mM DTT, Ribosafe RNase inhibitor (Bioline, 1 ml/ml) and CHX (100 mg/ml) 
into a 12 mL tube (Beckman, 13,2ml 14x89mm) and left overnight at 4ºC to achieve 
continuous gradient prior to the centrifugation. CHX (100 μg/ml) was added to the 
medium of  80-85% confluent BMDM (untreated or after 9h of  LPS) and incubated 
for 5min at 37°C. 10x106 cells were collected in ice-cold PBS and lysed in lysis buffer 
(20 mM Tris-HCl pH 7.8, 10 mM MgCl2, 100 mM KCl, 1% Triton X-100, 2 mM 
DTT, 100 μg/ml CHX, cOmplete protease inhibitors (Roche). An aliquot was kept 
for RNA sequencing. Lysates were passed through a 26G needle (BD bioscience) for 
further homogenization, and centrifuged at 4°C 1300xg for 10 min. Supernatants 
were treated with 2.5U/μl of  RNase I (Ambion) for 45 min at room temperature 
in gentle constant rotation. Lysates were loaded onto a linear sucrose gradient 
(7%–47%,(Slobodin et al. 2017)), and fractionated by ultracentrifugation, using a 
SW-41Ti rotor at 36000 rpm (221632.5g) during 2 hr. The sucrose gradient was 
divided into 14 fractions of  840 μl. The monosome-enriched sucrose fractions (7 to 
10) were collected and treated with proteinase K (PCR grade, Roche), in presence 
of  1% SDS. The so-released ribosome protected fragments (RPFs) were purified 
using TRIsure reagent (Bioline), following the manufacturer’s instructions. RPFs 
between 30 and 33 nucleotides in length were size-selected in 10% acrylamide gel 


















T4 polynucleotide kinase (New England Biolabs) for 6 hr at 37°C in MES-NaOH 
buffer (100mM MES-NaOH, pH 5.5, 10mM MgCl2, 10mM β-mercaptoethanol, 
300mM NaCl). 3’ adaptor (RA3) was ligated using T4 RNA ligase 1 (New England 
Biolabs) for 3.5 hr at 37°C, in absence of  ATP. Ligation products were size selected 
in 10% acrylamide gel, and the 5’ ends were phosphorylated by treatment with T4 
polynucleotide kinase for 30 min at 37°C, in presence of  1mM ATP. 5’ adaptor 
(RA5) was ligated using T4 RNA ligase 1 (New England Biolabs) during 2.5h at 
37°C, and the ligation products were selected in 10% acrylamide gel. Ribosomal 
RNA depletion was performed by biotin-streptavidin affinity purification using 
biotinylated ribosomal RNA probes and streptavidin dynabeads. Retro-transcription 
of  the ligation products into cDNA was performed using Super Script III reverse-
transcriptase (Invitrogen) following the manufacturer’s instructions, and the primer 
RTP. PCR amplification was performed using the forward primer RP1, and the 
reverse primer RPI that contained a hexanucleotide index used to multiplex different 
samples during next generation sequencing (NGS). PCR products were size selected 
by E-Gel electrophoresis (Invitrogen), and submitted to Illumina 50bp single-end 
sequencing. After sequencing, Cutadapt was used to remove Illumina 3’ adapter 
and Bowtie2 local 1 mismatch was performed against rRNA. Non-rRNA reads 
were aligned using bowtie1 (-n1 -m1 -l24)against: CDS+/-18bp(UCSC canonical 
transcripts), 5’UTR +/- 18bp, or 3’UTR +/- 18bp. Non-rRNA reads were also 
aligned against whole genome with STAR2.3.0e (mismatch 0.05, minlength 20). 
Tx- level counts for CDS/UTR reads was imported in R with Rsamtools. CDS/
UTR read proportion, read length and periodicity were checked for all reads and 
for several subsets taking into account different read length (28-31bp). Raw counts 
and periodicity was checked. DESeq2 was used to identify differentially expressed 
transcripts between conditions. The RiboProfiling package was used to perform 
further quality control steps from genome aligned reads.
The sequence of  the nucleotide markers, 3’ and 5’ adapters, RTP, RP1 and different 
RPI primers is shown in Table I).
















Table II. Oligos Ribosome Profiling 
26 nt marker  5′ AGCGUGUACUCCGAAGAGGAUCCAAA 
29 nt marker  5′ AGCGUGUACUCCGAAGAGGAUCCAAAAGC
32 nt marker  5′ GGCAUUAACGCGAACUCGGCCUACAAUAGUGA
35 nt marker  5′ GGCAUUAACGCGAACUCGGCCUACAAUAGUGACGA 
RNA 5’ Adapter (RA5) 5‘ rGrUrU rCrArG rArGrU rUrCrU rArCrA rGrUrC rCrGrA rCrGrA rUrC 
RNA 3’ Adapter (RA3) 5‘ /5rApp/TGG AAT TCT CGG GTG CCA AGG /3ddC/ 
RNA RT Primer (RTP) 5’ GCCTTGGCACCCGAGAATTCCA 
RNA PCR Primer (RP1)
5’ AATGATACGGCGACCACCGAGATCTACACGTTCAGAGTTCTACAGTCCGA
RNA PCR Primer,  Index 1 (RPI1)
5’CAAGCAGAAGACGGCATACGAGATCGTGATGTGACTGGAGTTCCTTGGCACCCGAGAATTCCA
RNA PCR Primer, Index 2 (RPI2) 
5’CAAGCAGAAGACGGCATACGAGATACATCGGTGACTGGAGTTCCTTGGCACCCGAGAATTCCA
RNA PCR Primer, Index 3 (RPI3) 
5’CAAGCAGAAGACGGCATACGAGATGCCTAAGTGACTGGAGTTCCTTGGCACCCGAGAATTCCA
RNA PCR Primer, Index 4 (RPI4) 
5’CAAGCAGAAGACGGCATACGAGATTGGTCAGTGACTGGAGTTCCTTGGCACCCGAGAATTCCA
RNA PCR Primer, Index 5 (RPI5) 
5’CAAGCAGAAGACGGCATACGAGATCACTGTGTGACTGGAGTTCCTTGGCACCCGAGAATTCCA
RNA PCR Primer, Index 6 (RPI6) 
5’CAAGCAGAAGACGGCATACGAGATATTGGCGTGACTGGAGTTCCTTGGCACCCGAGAATTCCA
RNA PCR Primer, Index 7 (RPI7) 
5’CAAGCAGAAGACGGCATACGAGATGATCTGGTGACTGGAGTTCCTTGGCACCCGAGAATTCCA
RNA PCR Primer, Index 8 (RPI8) 
5’CAAGCAGAAGACGGCATACGAGATTCAAGTGTGACTGGAGTTCCTTGGCACCCGAGAATTCCA
 Table III. Antibodies  
Anti-Mouse CD11b FITC    557396  Bd Bioscience
Anti-Mouse F4/80 Antigen PE    12-4801-82 eBioscience
Anti-Mouse MHC Class II (I-A/I-E) PC  17-5321-81 eBioscience
CHOP     SC-575   Santa Cruz
COX2      D5H5  Cell Signalling
CPEB4      Ab83009  Abcam
CyclinD1     SC-8396  Santa Cruz 
Hif1a     10006421 Cayman
IkB-alpha (6A920)    NB100-56507SS-0.025 Novus Biologicals
P-S6     Clon D68F8, 5364  Cell Signaling
Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204)  Clon E10, 9106 Cell Signaling
SOCS1      Ab9870   Abcam
Tubulin     T9026  Sigma



















Gene   Forward   Reverse
dtVNN  ccccccccccccccccccVNN
m18S    cgcccccccacccggccgac gagcgaccaaaggaaccaca
mCcl2  agccgcagcccccgccaccaagc gcgccgaagaccccagggca
mCiita  ccccaggacacccagcccga ggccccagaggcgggcacca
mCpeb1    cgccgcaaagaggcacaggc caaggcaccaacaaacacc
mCpeb2  caccaccagccccccccgaa cccccgcggcgacccccgc
mCpeb3  gaccggagcaggccccacga cgccacccgcccccggacggcgg
mCpeb4  gcacgccccaaaacccaccgg cggaaaccagccgcgaccccaccc
mCxcl1  acccaaaccgaagccacagcc ccgccagaagccagcgccc
mCxcl2  cccgccccgaccccgaagcc ccccggcccccccgccgaggga
mElavl1  accggcgaggccgaacccgc ccacaaaaccgcagcccaag
mH2-Aa    cgccccccgagcccggccaa ggaacacagccgcccgagga
mH2-Ab1    ggcccacacccgccacgcgg cgacgccgcccaacaccccg
mH2-Eb1    cgccacggccgagcggaaag aagcagacgaacagccccgc
mHif1a    ccccggcagcgacgacacag aagcggccccggagcccccg
mIl10  ggccgccaagccccaccgga gagaaaccacgacagcgcc
mIl1a  cgccgcaggccacccaaccaagcg   cgccgcaggccacccaaccaagcg
mIl6  ccacccccacgaccccccagag cgggaccgacgccggcgaca
mNfkbia   gagacccggccccccccaac ccccggagcccaggaccaca
mNos2    aaccccggagcgagccgcgg caggaagcaggcgagggcccg
mPtgs2  tgagtaccgcaaacgcttct cagccatttccttctctcctgt
mRpl0  ccgcaggggcagcagcggc aagcgcgccccggaccgccc
mSocs1   cgccccccggggcccgcc gagaccgcaccgccggcc
mSocs3   agcccccccgcagaccccacg agccagccccgaagcgaaacc
mTbp  agaacaacccagaccagcagca gggaaccccacaccacagccc
mTnf  ccacggcccagacccccacaccc gccggcaccaccagccggccgcccc
mZfp36  cccccccaccaaggccacccg cgacaggccacggcccaccg
   
















Abernathy, E. & Glaunsinger, B., 2015. Emerging roles for RNA degradation in viral replication and 
antiviral defense. Virology, 479–480, pp.600–608.
Afroz, T. et al., 2014. A fly trap mechanism provides sequence-specific RNA recognition by CPEB 
proteins. Genes and Development, 28, pp.1498–1514.
Aguilera, A., 2005. Cotranscriptional mRNP assembly: From the DNA to the nuclear pore. Current 
Opinion in Cell Biology, 17(3), pp.242–250.
Ananthasubramaniam, B. & Herzel, H., 2014. Positive feedback promotes oscillations in negative 
feedback loops. PLoS ONE, 9(8).
Arthur, J.S. & Ley, S.C., 2013. Mitogen-activated protein kinases in innate immunity. Nat Rev 
Immunol, 13(9), pp.679–692.
Barbosa, C., Peixeiro, I. & Romão, L., 2013. Gene Expression Regulation by Upstream Open Reading 
Frames and Human Disease. PLoS Genetics, 9(8), pp.1–12.
Barillot, E. et al., 2012. Computational Systems Biology of  Cancer. Chapman & Hall/CRC 
Mathematical & Computational Biology.
Beisang, D. & Bohjanen, P.R., 2012. Perspectives on the ARE as it turns 25 years old. Wiley 
Interdisciplinary Reviews: RNA, 3(5), pp.719–731.
Belloc, E. & Méndez, R., 2008. A deadenylation negative feedback mechanism governs meiotic 
metaphase arrest. Nature, 452(7190), pp.1017–1021.
Belloc, E., Piqué, M. & Méndez, R., 2008. Sequential waves of  polyadenylation and deadenylation 
define a translation circuit that drives meiotic progression. Biochemical Society Transactions, 
36(4), pp.665–670.
Bhatt, D. & Ghosh, S., 2014. Regulation of  the NF-κB-mediated transcription of  inflammatory 
genes. Frontiers in Immunology, 5(FEB), pp.1–9.
Bode, J.G., Ehlting, C. & Häussinger, D., 2012. The macrophage response towards LPS and its 
control through the p38 MAPK-STAT3 axis. Cellular Signalling, 24(6), pp.1185–1194.
Brandman, O. et al., 2005. Systems biology: Interlinked fast and slow positive feedback loops drive 
reliable cell decisions. Science, 310(5747), pp.496–498.
Brook, M. et al., 2006. Posttranslational Regulation of  Tristetraprolin Subcellular Localization and 
Protein Stability by p38 Mitogen-Activated Protein Kinase and Extracellular Signal-Regulated 
Kinase Pathways. Molecular and Cellular Biology, 26(6), pp.2408–2418.
Brown, T., 2011. Introduction to Genetics: A Molecular Approach, Taylor & Francis Group.
Burns, D.M. et al., 2011. CPEB and two poly(A) polymerases control miR-122 stability and p53 
mRNA translation. Nature, 473(7345), pp.105–8.
Caldeira, J. et al., 2012. CPEB1, a novel gene silenced in gastric cancer: a Drosophila approach. Gut, 
61(8), pp.1115–23.
Calderone, V. et al., 2016. Sequential Functions of  CPEB1 and CPEB4 Regulate Pathologic 
Expression of  Vascular Endothelial Growth Factor and Angiogenesis in Chronic Liver 
Disease. Gastroenterology, 150(4), p.982–997.e30.
Carpenter, S. et al., 2014. Post-transcriptional regulation of  gene expression in innate immunity. 











Nature reviews. Immunology, 14(6), pp.361–76.
Celada, A. et al., 1996. The Transcription Factor PU,1 is Involved in Macrophage Proliferation. 
Journal of  Experimental Medicine, 184(July), pp.61–69.
Chao, H.-W. et al., 2013. Deletion of  CPEB3 enhances hippocampus-dependent memory via 
increasing expressions of  PSD95 and NMDA receptors. The Journal of  neuroscience : the 
official journal of  the Society for Neuroscience, 33(43), pp.17008–22.
Chao, H.W. et al., 2012. NMDAR signaling facilitates the IPO5-mediated nuclear import of  CPEB3. 
Nucleic Acids Research, 40(June), pp.8484–8498.
Charlesworth, A., Meijer, H. a. & De Moor, C.H., 2013. Specificity factors in cytoplasmic 
polyadenylation. Wiley Interdisciplinary Reviews: RNA, 4(August), pp.437–461.
Chen, E.Y. et al., 2013. Enrichr: Interactive and collaborative HTML5 gene list enrichment analysis 
tool. BMC Bioinformatics, 14.
Chen, P.-J. & Huang, Y.-S., 2012. CPEB2-eEF2 interaction impedes HIF-1α RNA translation. The 
EMBO journal, 31(4), pp.959–71.
Chin, A. & Lécuyer, E., 2017. RNA localization: Making its way to the center stage. Biochimica et 
Biophysica Acta - General Subjects, 1861(11), pp.2956–2970.
Chu, J. & Pelletier, J., 2015. Targeting the eIF4A RNA helicase as an anti-neoplastic approach. 
Biochimica et Biophysica Acta - Gene Regulatory Mechanisms, 1849(7), pp.781–791.
Cláudio, N. et al., 2013. Mapping the crossroads of  immune activation and cellular stress response 
pathways. The EMBO journal, 32(9), pp.1214–24.
Clausen, B.. et al., 1999. Conditional gene targeting in macrophage and granulocytes using LysMcre 
mice. Transgenic Research, 8, pp.265–277.
Clement, S.L. et al., 2011. Phosphorylation of  Tristetraprolin by MK2 Impairs AU-Rich Element 
mRNA Decay by Preventing Deadenylase Recruitment. Molecular and Cellular Biology, 31(2), 
pp.256–266.
Crick, F., 1970. Central Dogma of  Molecular Biology. Nature, 227, p.561.
Crick, F.H.C., 1958. On Protein Synthesis. The Symposia of  the Society for Experimental Biology, 
12, pp.138–163.
Cycon, K.A. et al., 2013. Histone deacetylase inhibitors activate CIITA and MHC class II antigen 
expression in diffuse large B-cell lymphoma. Immunology, 140(2), pp.259–272.
Das, S., Sarkar, D. & Das, B., 2017. The interplay between transcription and mRNA degradation in 
Saccharomyces cerevisiae. Microbial Cell, 4(7), pp.212–228.
Das, T. et al., 2018. A20/tumor necrosis factor α-induced protein 3 in immune cells controls 
development of  autoinflammation and autoimmunity: Lessons from mouse models. Frontiers 
in Immunology, 9(FEB).
Decker, C.J. & Parker, R., 2012. P-bodies and stress granules: Possible roles in the control of  
translation and mRNA degradation. Cold Spring Harbor Perspectives in Biology, 4(9).
Dever, T.E. & Green, R., 2015. Phases of  Translation in Eukaryotes. , pp.1–16.
Díaz-Muñoz, M.D. & Turner, M., 2018. Uncovering the role of  RNA-binding proteins in gene 












Doller, A., Pfeilschifter, J. & Eberhardt, W., 2008. Signalling pathways regulating nucleo-cytoplasmic 
shuttling of  the mRNA-binding protein HuR. Cellular Signalling, 20(12), pp.2165–2173.
Drisaldi, B. et al., 2015. SUMOylation Is an Inhibitory Constraint that Regulates the Prion-like 
Aggregation and Activity of  CPEB3. Cell Reports, pp.1–9.
Eckmann, C.R., Rammelt, C. & Wahle, E., 2011. Control of  poly(A) tail length. Wiley Interdisciplinary 
Reviews: RNA, 2(3), pp.348–361.
Elkon, R., Ugalde, A.P. & Agami, R., 2013. Alternative cleavage and polyadenylation: Extent, 
regulation and function. Nature Reviews Genetics, 14(7), pp.496–506.
Essandoh, K. et al., 2016. MiRNA-Mediated Macrophage Polarization and its Potential Role in the 
Regulation of  Inflammatory Response. Shock, 46(2), pp.122–131.
Fabian, M.R. et al., 2013. Structural basis for the recruitment of  the human CCR4-NOT deadenylase 
complex by tristetraprolin. Nature Structural and Molecular Biology, 20(6), pp.735–739.
Fan, H.K. & Cook, J.A., 2004. Molecular mechanisms of  endotoxin tolerance. Journal of  Endotoxin 
Research, 10(2), pp.71–84.
Fernández-Miranda, G. & Méndez, R., 2012. The CPEB-family of  proteins, translational control in 
senescence and cancer. Ageing research reviews, 11(4), pp.460–72.
Ferrell, J.E. & Ha, S.H., 2014a. Ultrasensitivity part II: Multisite phosphorylation, stoichiometric 
inhibitors, and positive feedback. Trends in Biochemical Sciences, 39(11), pp.556–569.
Ferrell, J.E. & Ha, S.H., 2014b. Ultrasensitivity part III: Cascades, bistable switches, and oscillators. 
Trends in Biochemical Sciences, 39(12), pp.612–618.
Ferrell, J.E., Tsai, T.Y.C. & Yang, Q., 2011. Modeling the cell cycle: Why do certain circuits oscillate? 
Cell, 144(6), pp.874–885.
Fioriti, L. et al., 2015. The Persistence of  Hippocampal-Based Memory Requires Protein Synthesis 
Mediated by the Prion-like Protein CPEB3. Neuron, pp.1–16.
Fong, S.W. et al., 2016. CPEB3 deficiency elevates TRPV1 expression in dorsal root ganglia neurons 
to potentiate thermosensation. PLoS ONE, 11(2), pp.1–19.
Friesen, W.O. & Block, G.D., 1984. What is a biological oscillator? The American journal of  
physiology, 246(6 Pt 2), pp.R847–R853.
Fu, M. & Blackshear, P.J., 2017. RNA-binding proteins in immune regulation: A focus on CCCH zinc 
finger proteins. Nature Reviews Immunology, 17(2), pp.130–143.
Fu, Y. et al., 2014. Gene expression regulation mediated through reversible m 6 A RNA methylation. 
Nature Reviews Genetics, 15(5), pp.293–306.
van Furth; et al., 1972. Le systeme phagocytaire mononucleaire: nouvelle classification des 
macrophages, des monocytes et de leurs cellules souches.
Gallouzi, I.E. & Wilusz, J., 2013. A DIStinctively novel exoribonuclease that really likes U. EMBO 
Journal, 32(13), pp.1799–1801.
Gebauer, F. & Hentze, M.W., 2004. Molecular mechanisms of  translational control. Nature Reviews 
Molecular Cell Biology, 5(10), pp.827–835.
Geissmann, F. et al., 2010. Unravelling mononuclear phagocyte heterogeneity. Nature Reviews 
Immunology, 10(6), pp.453–460.











Gérard, C., Gonze, D. & Goldbeter, A., 2012. Effect of  positive feedback loops on the robustness 
of  oscillations in the network of  cyclin-dependent kinases driving the mammalian cell cycle. 
FEBS Journal, 279(18), pp.3411–3431.
Di Giammartino, D.C., Nishida, K. & Manley, J.L., 2011. Mechanisms and Consequences of  
Alternative Polyadenylation. Molecular Cell, 43(6), pp.853–866.
Giangarrà, V. et al., 2015. Global Analysis of  CPEBs Reveals Sequential and Non-Redundant 
Functions in Mitotic Cell Cycle. Plos One, 10(9), p.e0138794.
Goldstrohm, A.C. & Wickens, M., 2008. Multifunctional deadenylase complexes diversify mRNA 
control. Nature Reviews Molecular Cell Biology, 9(4), pp.337–344.
Guillén-Boixet, J. et al., 2016. CPEB4 is regulated during cell cycle by ERK2/Cdk1-mediated 
phosphorylation and its assembly into liquid-like droplets. eLife, 5(Nov 2016), pp.1–26.
Gupta, I. et al., 2016. Translational Capacity of  a Cell Is Determined during Transcription Elongation 
via the Ccr4-Not Complex. Cell Reports, 15(8), pp.1782–1794.
Das Gupta, K. et al., 2016. Histone deacetylases in monocyte/macrophage development, activation 
and metabolism: refining HDAC targets for inflammatory and infectious diseases. Clinical & 
Translational Immunology, 5(1), p.e62.
Hägele, S. et al., 2009. Cytoplasmic polyadenylation-element-binding protein (CPEB)1 and 2 
bind to the HIF-1alpha mRNA 3’-UTR and modulate HIF-1alpha protein expression. The 
Biochemical journal, 417(1), pp.235–46.
Hajishengallis, G. & Lambris, J.D., 2010. Crosstalk pathways between Toll-like receptors and the 
complement system. Trends in Immunology, 31(4), pp.154–163.
Hake, L.E., Mendez, R. & Richter, J.D., 1998. Specificity of  RNA binding by CPEB: requirement 
for RNA recognition motifs and a novel zinc finger. Molecular and cellular biology, 18(2), 
pp.685–693.
Halbeisen, R.E. et al., 2008. Post-transcriptional gene regulation:From genome-wide studies to 
principles. Cell. Mol. Life Sci., 65, pp.798–813.
Hayden, M.S. & Ghosh, S., 2011. NF-κB in immunobiology. Cell Research, 21(2), pp.223–244.
Herdy, B. et al., 2012. Translational control of  the activation of  transcription factor NF-κB and 
production of  type i interferon by phosphorylation of  the translation factor eIF4E. Nature 
Immunology, 13(6), pp.543–550.
Hinnebusch, A.G. & Lorsch, J.R., 2012. The mechanism of  eukaryotic translation initiation: New 
insights and challenges. Cold Spring Harbor Perspectives in Biology, 4(10), pp.1–26.
Hitti, E. et al., 2006. Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor 
necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, 
stability, and binding to adenine/uridine-rich element. Molecular and cellular biology, 26(6), 
pp.2399–2407.
Hoffmann, A. & Baltimore, D., 2006. Circuitry of  nuclear factor κB signaling. Immunological 
Reviews, 210, pp.171–186.
Hu, W., Yuan, B. & Lodish, H.F., 2014. Cpeb4-mediated translational regulatory circuitry controls 
terminal erythroid differentiation. Developmental cell, 30(6), pp.660–72.












Macrophage Activation by Opposing Feedforward and Feedback Inhibition Mechanisms. 
Immunological Reviews, pp.41–56.
Huang, D.W., Sherman, B.T. & Lempicki, R.A., 2009a. Bioinformatics enrichment tools: Paths 
toward the comprehensive functional analysis of  large gene lists. Nucleic Acids Research, 
37(1), pp.1–13.
Huang, D.W., Sherman, B.T. & Lempicki, R.A., 2009b. Systematic and integrative analysis of  large 
gene lists using DAVID bioinformatics resources. Nature Protocols, 4(1), pp.44–57.
Huang, W.-H. et al., 2014. Elevated activation of  CaMKIIÎ± in the CPEB3-knockout hippocampus 
impairs a specific form of  NMDAR-dependent synaptic depotentiation. Frontiers in Cellular 
Neuroscience, 8(November), pp.1–12.
Huang, Y.-S. et al., 2006. CPEB3 and CPEB4 in neurons: analysis of  RNA-binding specificity and 
translational control of  AMPA receptor GluR2 mRNA. The EMBO journal, 25(20), pp.4865–
76.
Huntzinger, E. & Izaurralde, E., 2011a. Gene silencing by microRNAs: Contributions of  translational 
repression and mRNA decay. Nature Reviews Genetics, 12(2), pp.99–110.
Huntzinger, E. & Izaurralde, E., 2011b. Gene silencing by microRNAs: Contributions of  translational 
repression and mRNA decay. Nature Reviews Genetics, 12(2), pp.99–110.
Hurt, J.A. & Silver, P.A., 2008. mRNA nuclear export and human disease. Disease Models and 
Mechanisms, 1(2–3), pp.103–108.
Hutchins, A.P., Diez, D. & Miranda-Saavedra, D., 2013. The IL-10/STAT3-mediated anti-
inflammatory response: Recent developments and future challenges. Briefings in Functional 
Genomics, 12(6), pp.489–498.
Igea, A. & Méndez, R., 2010. Meiosis requires a translational positive loop where CPEB1 ensues its 
replacement by CPEB4. The EMBO journal, 29(13), pp.2182–93.
Imataka, H., Gradi, A. & Sonenberg, N., 1998. A newly identified N-terminal amino acid sequence of  
human eIF4G binds poly(A)-binding protein and functions in poly(A)- dependent translation. 
EMBO Journal, 17(24), pp.7480–7489.
Inada, T., 2013. Quality control systems for aberrant mRNAs induced by aberrant translation 
elongation and termination. Biochimica et Biophysica Acta - Gene Regulatory Mechanisms, 
1829(6–7), pp.634–642.
Ingolia, N.T. & Murray, A.W., 2004. The ups and downs of  modeling the cell cycle. Current Biology, 
14(18), pp.771–777.
Ivshina, M. et al., 2015. CPEB regulation of  TAK1 synthesis mediates cytokine production and the 
inflammatory immune response. Molecular and cellular biology, 35(3), pp.610–8.
Iwasaki, A. & Medzhitov, R., 2015. Control of  adaptive immunity by the innate immune system. 
Nature Immunology, 16(4), pp.343–353.
Jackson, R.J., Hellen, C.U.T. & Pestova, T. V., 2010. The mechanism of  eukaryotic translation initiation 
and principles of  its regulation. Nature Reviews Molecular Cell Biology, 11(2), pp.113–127.
Janssens, S., Pulendran, B. & Lambrecht, B.N., 2014. Emerging functions of  the unfolded protein 
response in immunity. Nature Immunology, 15(10), pp.910–919.
Jurado, A.R. et al., 2014. Structure and function of  pre-mRNA 5′-end capping quality control and 
3′-end processing. Biochemistry, 53(12), pp.1882–1898.
Kaczmarczyk, L. et al., 2016. New phosphospecific antibody reveals isoform-specific phosphorylation 
of  CPEB3 protein. PLoS ONE, 11(2).
Kahvejian, A. et al., 2005. Mammalian poly ( A ) -binding protein is a eukaryotic translation initiation 
factor , which acts via multiple mechanisms. Genes and Development, 19, pp.104–113.
Kapp, L.D. & Lorsch, J.R., 2004. The Molecular Mechanics of  Eukaryotic Translation. Annual 
Review of  Biochemistry, 73(1), pp.657–704.
Kaul, G., Pattan, G. & Rafeequi, T., 2011. Eukaryotic elongation factor-2 (eEF2): Its regulation and 
peptide chain elongation. Cell Biochemistry and Function, 29(3), pp.227–234.
Kawasaki, T. & Kawai, T., 2014. Toll-like receptor signaling pathways. Frontiers in Immunology, 
5(SEP), pp.1–8.
Ke, Y. et al., 2017. PARP1 promotes gene expression at the post-transcriptiona level by modulating 
the RNA-binding protein HuR. Nature Communications, 8.
Kim, J.H. & Richter, J.D., 2006. Opposing Polymerase-Deadenylase Activities Regulate Cytoplasmic 
Polyadenylation. Molecular Cell, 24(2), pp.173–183.
Kojima, S., Sher-Chen, E.L. & Green, C.B., 2012. Circadian control of  mRNA polyadenylation 
dynamics regulates rhythmic protein expression. Genes and Development, 26(24), pp.2724–
2736.
Kozak, M., 2002. Pushing the limits of  the scanning mechanism for initiation of  translation. Gene, 
299(1–2), pp.1–34.
Kozomara, A. & Griffiths-Jones, S., 2011. MiRBase: Integrating microRNA annotation and deep-
sequencing data. Nucleic Acids Research, 39(SUPPL. 1), pp.152–157.
Kuleshov, M. V. et al., 2016. Enrichr: a comprehensive gene set enrichment analysis web server 2016 
update. Nucleic acids research, 44(W1), pp.W90–W97.
Kumagai, Y. et al., 2016. Genome-wide map of  RNA degradation kinetics patterns in dendritic cells 
after LPS stimulation facilitates identification of  primary sequence and secondary structure 
motifs in mRNAs. BMC Genomics, 17(Suppl 13).
Lackner, D.H. & Bähler, J., 2008. Chapter 5 Translational Control of  Gene Expression. From 
Transcripts to Transcriptomes. International Review of  Cell and Molecular Biology, 271(C), 
pp.199–251.
Lavin, Y. & Merad, M., 2013. Macrophages: Gatekeepers of  Tissue Integrity. Cancer Immunology 
Research, 1(4), pp.201–209.
Lawrence, T. & Fong, C., 2010. The resolution of  inflammation: Anti-inflammatory roles for NF-
??B. International Journal of  Biochemistry and Cell Biology, 42(4), pp.519–523.
LeibundGut-Landmann, S. et al., 2004. Specificity and expression of  CIITA, the master regulator of  
MHC class II genes. European Journal of  Immunology, 34(6), pp.1513–1525.
Leppek, K., Das, R. & Barna, M., 2018. Functional 5′ UTR mRNA structures in eukaryotic translation 
regulation and how to find them. Nature Reviews Molecular Cell Biology, 19(3), pp.158–174.
Li, Z., Liu, S. & Yang, Q., 2017. Incoherent Inputs Enhance the Robustness of  Biological Oscillators. 
Cell Systems, 5(1), p.72–81.e4.
Liu, J., Qian, C. & Cao, X., 2016. Post-Translational Modification Control of  Innate Immunity. 
Immunity, 45(1), pp.15–30.
Loayza-Puch, F. et al., 2016. Tumour-specific proline vulnerability uncovered by differential ribosome 
codon reading. Nature, 530(7591), pp.490–494.
Lomnitz, J.G. & Savageau, M.A., 2014. No Title. , (1).
Lopez-Pelaez, M. et al., 2012. Cot/tpl2-MKK1/2-Erk1/2 controls mTORC1-mediated mRNA 
translation in Toll-like receptor-activated macrophages. Molecular Biology of  the Cell, 23(15), 
pp.2982–2992.
Lu, W.H., Yeh, N.H. & Huang, Y.S., 2017. CPEB2 Activates GRASP1 mRNA Translation and 
Promotes AMPA Receptor Surface Expression, Long-Term Potentiation, and Memory. Cell 
Reports, 21(7), pp.1783–1794.
Lu, Y.-C. et al., 2014. ELAVL1 Modulates Transcriptome-wide miRNA Binding in Murine 
Macrophages. Cell reports, 9(6), pp.2330–43.
Lykke-Andersen, J. & Wagner, E., 2005. Recruitment and activation of  mRNA decay enzymes by 
two ARE-mediated decay activation domains in the proteins TTP and BRF-1. Genes and 
Development, 19(3), pp.351–361.
Maillo, C. et al., 2017. Circadian- and UPR-dependent control of  CPEB4 mediates a translational 
response to counteract hepatic steatosis under ER stress. Nature Cell Biology, (January).
Malumbres, M. & Barbacid, M., 2009. Cell cycle, CDKs and cancer: A changing paradigm. Nature 
Reviews Cancer, 9(3), pp.153–166.
Markmiller, S. et al., 2018. Context-Dependent and Disease-Specific Diversity in Protein Interactions 
within Stress Granules. Cell, 172(3), p.590–604.e13.
Martinez, F.O. & Gordon, S., 2014. The M1 and M2 paradigm of  macrophage activation: time for 
reassessment. F1000prime reports, 6(March), p.13.
Marzluff, W.F., Wagner, E.J. & Duronio, R.J., 2008. Metabolism and regulation of  canonical histone 
mRNAs: Life without a poly(A) tail. Nature Reviews Genetics, 9(11), pp.843–854.
Mayr, C., 2016. Evolution and Biological Roles of  Alternative 3 0 UTRs. Trends in Cell Biology, 
26(3), pp.227–237.
Mayr, C., 2017. Regulation by 3 -Untranslated Regions. Annu. Rev. Genet.
McCormick, S.M. & Heller, N.M., 2015. Regulation of  macrophage, dendritic cell, and microglial 
phenotype and function by the SOCS proteins. Frontiers in Immunology, 6(OCT).
Mendez, R., Hake, L.E., et al., 2000. Phosphorylation of  CPE binding factor by Eg2 regulates 
translation of  c-mos mRNA. Nature, 404(6775), pp.302–7.
Mendez, R., Murthy, K.G., et al., 2000. Phosphorylation of  CPEB by Eg2 mediates the recruitment 
of  CPSF into an active cytoplasmic polyadenylation complex. Molecular cell, 6(5), pp.1253–9.
Merkel, D.J. et al., 2013. The C-terminal region of  cytoplasmic polyadenylation element binding 
protein is a ZZ domain with potential for protein-protein interactions. Journal of  Molecular 
Biology, 425(11), pp.2015–2026.
Miller, S. et al., 2002. Disruption of  dendritic translation of  CaMKIIalpha impairs stabilization of  
synaptic plasticity and memory consolidation. Neuron, 36(3), pp.507–519.











Mills, C.D., 2015. Anatomy of  a discovery: m1 and m2 macrophages. Frontiers in immunology, 
6(May), p.212.
Mino, T. et al., 2015. Regnase-1 and roquin regulate a common element in inflammatory mRNAs by 
spatiotemporally distinct mechanisms. Cell, 161(5), pp.1058–1073.
Morgan, M., Iaconcig, A. & Muro, A.F., 2010. CPEB2, CPEB3 and CPEB4 are coordinately regulated 
by miRNAs recognizing conserved binding sites in paralog positions of  their 3’-UTRs. Nucleic 
acids research, 38(21), pp.7698–710.
Moynagh, P.N., 2005. TLR signalling and activation of  IRFs: Revisiting old friends from the NF-κB 
pathway. Trends in Immunology, 26(9), pp.469–476.
Murray, P.J. & Wynn, T. a, 2011. Protective and pathogenic functions of  macrophage subsets. Nature 
reviews. Immunology, 11(11), pp.723–37.
Muzumdar, M.D. et al., 2007. A Global Double-Fluorescent Cre Reporter Mouse. Genesis (New 
York, N.Y. : 2000), 45, pp.593–605.
Novák, B. & Tyson, J.J., 2008. Design principles of  biochemical oscillators. Nature Reviews Molecular 
Cell Biology, 9(12), pp.981–991.
Novoa, I. et al., 2010. Mitotic cell-cycle progression is regulated by CPEB1 and CPEB4-dependent 
translational control. Nature cell biology, 12(5), pp.447–56.
Nürenberg, E. & Tampé, R., 2013. Tying up loose ends: Ribosome recycling in eukaryotes and 
archaea. Trends in Biochemical Sciences, 38(2), pp.64–74.
Oakley, F. et al., 2005. Nuclear factor-kappaB1 (p50) limits the inflammatory and fibrogenic responses 
to chronic injury. The American journal of  pathology, 166(3), pp.695–708.
Ortiz-Zapater, E. et al., 2012. Key contribution of  CPEB4-mediated translational control to cancer 
progression. Nature medicine, 18(1), pp.83–90.
Van Overmeire, E. et al., 2014. Mechanisms driving macrophage diversity and specialization in distinct 
tumor microenvironments and parallelisms with other tissues. Frontiers in immunology, 
5(March), p.127.
Pai, A.A. et al., 2016. Widespread Shortening of  3’ Untranslated Regions and Increased Exon 
Inclusion Are Evolutionarily Conserved Features of  Innate Immune Responses to Infection. 
PLoS Genetics, 12(9), pp.1–24.
Pai, R.K. et al., 2002. Regulation of  Class II MHC Expression in APCs: Roles of  Types I, III, and IV 
Class II Transactivator. The Journal of  Immunology, 169(3), pp.1326–1333.
Pakos-Zebrucka, K. et al., 2016. The integrated stress response. EMBO reports, 17(10), pp.1374–
1395.
Papasaikas, P. & Valcárcel, J., 2015. The Spliceosome: The Ultimate RNA Chaperone and Sculptor. 
Trends in biochemical sciences, 41(1), pp.33–45.
Parker, R. & Sheth, U., 2007. P Bodies and the Control of  mRNA Translation and Degradation. 
Molecular Cell, 25(5), pp.635–646.
Parras, A. et al., 2018. Autism-like phenotype and risk gene mRNA deadenylation by CPEB4 mis-
splicing. Nature, 560(7719), pp.441–446.
Pascual R. et al, under review. The RNA-binding protein CPEB2 regulates mammary hormone 












Pavlopoulos, E. et al., 2011. Neuralized1 activates CPEB3: a function for nonproteolytic ubiquitin in 
synaptic plasticity and memory storage. Cell, 147(6), pp.1369–83.
Peer, E., Rechavi, G. & Dominissini, D., 2017. Epitranscriptomics: regulation of  mRNA metabolism 
through modifications. Current Opinion in Chemical Biology, 41, pp.93–98.
Peng, S.-C. et al., 2010. A novel role of  CPEB3 in regulating EGFR gene transcription via association 
with Stat5b in neurons. Nucleic acids research, 38(21), pp.7446–57.
Perdiguero, E.G. & Geissmann, F., 2016. The development and maintenance of  resident macrophages. 
Nature Immunology, 17(1), pp.2–8.
Piqué, M. et al., 2008. A Combinatorial Code for CPE-Mediated Translational Control. Cell, 132, 
pp.434–448.
van der Poll, T. et al., 2017. The immunopathology of  sepsis and potential therapeutic targets. Nature 
Reviews Immunology, 17(7), pp.407–420.
Pollard, J.W., 2009. Trophic macrophages in development and disease. Nature reviews. Immunology, 
9(4), pp.259–270.
Popp, M.W.-L. & Maquat, L.E., 2013. Organizing Principles of  Mammalian Nonsense-Mediated 
mRNA Decay. Annual Review of  Genetics, 47(1), pp.139–165.
Preis, A. et al., 2014. Cryoelectron microscopic structures of  eukaryotic translation termination 
complexes containing eRF1-eRF3 or eRF1-ABCE1. Cell Reports, 8(1), pp.59–65.
Proudfoot, N.J., 2011. Ending the message : poly ( A ) signals then and now. Genes & development, 
25, pp.1770–1782.
Qin, H. et al., 2012. SOCS3 deficiency promotes M1 macrophage polarization and inflammation. 
Journal of  immunology (Baltimore, Md. : 1950), 189(7), pp.3439–3448.
Reith, W., LeibundGut-Landmann, S. & Waldburger, J.-M., 2005. Regulation of  MHC class II gene 
expression by the class II transactivator. Nature reviews. Immunology, 5, pp.793–806.
Richter, J.D., 2007. CPEB: a life in translation. Trends in Biochemical Sciences, 32(6), pp.279–285.
Richter, J.D. & Coller, J., 2015. Pausing on Polyribosomes: Make Way for Elongation in Translational 
Control. Cell, 163(2), pp.292–300.
Richter, J.D. & Sonenberg, N., 2005. Regulation of  cap-dependent translation by eIF4E inhibitory 
proteins. Nature, 433(7025), pp.477–480.
Roignant, J.Y. & Soller, M., 2017. m6A in mRNA: An Ancient Mechanism for Fine-Tuning Gene 
Expression. Trends in Genetics, 33(6), pp.380–390.
Roundtree, I.A. et al., 2017. Dynamic RNA Modifications in Gene Expression Regulation. Cell, 
169(7), pp.1187–1200.
Roux, P.P. & Blenis, J., 2004. ERK and p38 MAPK-Activated Protein Kinases : a Family of  Protein 
Kinases with Diverse Biological Functions ERK and p38 MAPK-Activated Protein Kinases : 
a Family of  Protein Kinases with Diverse Biological Functions. Microbiology and molecular 
biology reviews : MMBR, 68(2), pp.320–344.
Roux, P.P. & Topisirovic, I., 2018. Signaling pathways involved in the regulation of  mRNA translation. 
Molecular and Cellular Biology, p.MCB.00070-18.
Sachithanandan, N. et al., 2011. Macrophage deletion of  SOCS1 increases sensitivity to LPS and 











palmitic acid and results in systemic inflammation and hepatic insulin resistance. Diabetes, 
60(8), pp.2023–2031.
Sachs, A.B., Sarnow, P. & Hentze, M.W., 1997. Starting at the beginning, middle, and end: Translation 
initiation in eukaryotes. Cell, 89(6), pp.831–838.
Saraiva, M. & O’Garra, A., 2010. The regulation of  IL-10 production by immune cells. Nature 
Reviews Immunology, 10(3), pp.170–181.
Scharer, C.D. et al., 2015. Genome-wide CIITA-binding profile identifies sequence preferences that 
dictate function versus recruitment. Nucleic Acids Research, 43(6), pp.3128–3142.
Schneider, W.M., Chevillotte, M.D. & Rice, C.M., 2014. Interferon-Stimulated Genes: A Complex 
Web of  Host Defenses William. Annual Review of  Immunology, pp.513–545.
Schoenberg, D.R. & Maquat, L.E., 2009. Re-capping the message. Trends in Biochemical Sciences, 
34(9), pp.435–442.
Schuller, A.P. & Green, R., 2018. Roadblocks and resolutions in eukaryotic translation. Nature 
Reviews Molecular Cell Biology, pp.1–16.
Sedlyarov, V. et al., 2016. Tristetraprolin binding site atlas in the macrophage transcriptome reveals a 
switch for inflammation resolution. Molecular systems biology, 12(5), p.868.
Serhan, C.N., Chiang, N. & Van Dyke, T.E., 2008. Resolving inflammation: dual anti-inflammatory 
and pro-resolution lipid mediators. Nature reviews. Immunology, 8(5), pp.349–61.
Shakespear, M.R. et al., 2011. Histone deacetylases as regulators of  inflammation and immunity. 
Trends in Immunology, 32(7), pp.335–343.
Shatkin, A.J. & Manley, J.L., 2000. The ends of  the affair: Capping and polyadenylation. Nature 
Structural Biology, 7(10), pp.838–842.
Shatsky, I.N. et al., 2018. Cap-Independent Translation : What ’ s in a Name ? , pp.1–14.
Shi, Z. et al., 2017. Heterogeneous Ribosomes Preferentially Translate Distinct Subpools of  mRNAs 
Genome-wide. Molecular Cell, 67(1), p.71–83.e7.
Simsek, D. et al., 2017. The Mammalian Ribo-interactome Reveals Ribosome Functional Diversity 
and Heterogeneity. Cell, 169(6), p.1051–1065.e18.
Slobodin, B. et al., 2017. Transcription Impacts the Efficiency of  mRNA Translation via Co-
transcriptional N6-adenosine Methylation. Cell, 169(2), p.326–337.e12.
Smallie, T. et al., 2015. Dual-Specificity Phosphatase 1 and Tristetraprolin Cooperate To Regulate 
Macrophage Responses to Lipopolysaccharide. The Journal of  Immunology, 195(1), pp.277–
288.
Sonenberg, N. & Hinnebusch, A.G., 2007. New Modes of  Translational Control in Development, 
Behavior, and Disease. Molecular Cell, 28(5), pp.721–729.
Sonenberg, N. & Hinnebusch, A.G., 2009. Regulation of  Translation Initiation in Eukaryotes: 
Mechanisms and Biological Targets. Cell, 136(4), pp.731–745.
Stepien, B.K. et al., 2016. RNA-binding profiles of  Drosophila CPEB proteins Orb and Orb2. 
Proceedings of  the National Academy of  Sciences, 113(45), pp.E7030–E7038.
Stoecklin, G. et al., 2004. MK2-induced tristetraprolin:14-3-3 Complexes prevent stress granule 












Sun, L. et al., 2007. Tristetraprolin (TTP)-14-3-3 complex formation protects TTP from 
dephosphorylation by protein phosphatase 2a and stabilizes tumor necrosis factor-α mRNA. 
Journal of  Biological Chemistry, 282(6), pp.3766–3777.
Tang, T. et al., 2017. Macrophage responses to lipopolysaccharide are modulated by a feedback 
loop involving prostaglandin E2, dual specificity phosphatase 1 and tristetraprolin. Scientific 
Reports, 7(1), pp.1–13.
Tarun, S. & Sachs, A.B., 1995. A common function for mRNA 5’and 3’ends in translation initiation 
in yeast. Genes & development, 9(23), p.2997.
Tiedje, C. et al., 2012. The p38/MK2-Driven Exchange between Tristetraprolin and HuR Regulates 
AU-Rich Element-Dependent Translation. PLoS Genetics, 8(9).
Ting, J.P.-Y. & Trowsdale, J., 2002. Genetic Control of  MHC Class II Expression. Cell, 109(2), 
pp.S21–S33.
Topisirovic, I. & Sonenberg, N., 2011. mRNA Translation and Energy Metabolism in Cancer : The 
Role of  the MAPK and mTORC1 Pathways mRNA Translation and Energy Metabolism in 
Cancer : The Role of  the MAPK and mTORC1 Pathways. Cold Spring Harbor Symposia on 
Quantitative Biology, LXXVI, pp.355–367.
Tsai, T.Y. et al., 2008. Robust, Tunable Biological Oscillations from Interlinked Positive and Negative 
Feedback Loops Tony. Science, 321(JULY), pp.126–130.
Tugal, D., Liao, X. & Jain, M.K., 2013. Transcriptional control of  macrophage polarization. 
Arteriosclerosis, Thrombosis, and Vascular Biology, 33(6), pp.1135–1144.
Turner, M. & Díaz-Muñoz, M.D., 2018. RNA-binding proteins control gene expression and cell fate 
in the immune system. Nature Immunology, 19(2), pp.120–129.
Ubersax, J.A. & Ferrell, J.E., 2007. Mechanisms of  specificity in protein phosphorylation. Nature 
Reviews Molecular Cell Biology, 8(7), pp.530–541.
Vairo, G.I.N., Royston, A.K. & Hamilton, J.A., 1992. Macrophage Activation and the Inhibition of  
Macrophage Proliferation by Tumor Necrosis. , 641.
Wang, C.-F. & Huang, Y.-S., 2012. Calpain 2 Activated through N-Methyl-D-Aspartic Acid Receptor 
Signaling Cleaves CPEB3 and Abrogates CPEB3-Repressed Translation in Neurons. Molecular 
and Cellular Biology, 32(August), pp.3321–3332.
Wang, N., Liang, H. & Zen, K., 2014. Molecular mechanisms that influence the macrophage m1-m2 
polarization balance. Frontiers in immunology, 5(November), p.614.
Wang, X.-P. & Cooper, N.G.F., 2009. Characterization of  the transcripts and protein isoforms for 
cytoplasmic polyadenylation element binding protein-3 (CPEB3) in the mouse retina. BMC 
molecular biology, 10, p.109.
Wang, X.P. & Cooper, N.G.F., 2010. Comparative in Silico analyses of  Cpeb1-4 with functional 
predictions. Bioinformatics and Biology Insights, 4, pp.61–83.
Weichhart, T., Hengstschläger, M. & Linke, M., 2015. Regulation of  innate immune cell function by 
mTOR. Nature Reviews Immunology, 15(10), pp.599–614.
Weill, L. et al., 2012. Translational control by changes in poly(A) tail length: recycling mRNAs. Nature 
structural & molecular biology, 19(6), pp.577–85.
Weinstein, S.L. et al., 1992. Bacterial lipopolysaccharide induces tyrosine phosphorylation and 











activation of  mitogen-activated protein kinases in macrophages. J Biol Chem, 267(21), pp.14955–
14962.
Wells, S.E., et al. & al., E., 1998. Circularization of  mRNA by Eukaryotic Translation Initiation 
Factors. Molecular Cell, 2(1), pp.135–140.
Wertz, I.E. & Dixit, V.M., 2010. Signaling to NF- B: Regulation by Ubiquitination. Cold Spring 
Harbor Perspectives in Biology, 2(3), pp.a003350–a003350.
Wilson, H.M., 2014. SOCS proteins in macrophage polarization and function. Frontiers in 
Immunology, 5(JUL), pp.1–5.
Woo, C.W. et al., 2009. Adaptive suppression of  the ATF4-CHOP branch of  the unfolded protein 
response by toll-like receptor signalling. Nature Cell Biology, 11(12), pp.1473–1480.
Woo, C.W. et al., 2012. Toll-like receptor activation suppresses ER stress factor CHOP and translation 
inhibition through activation of  eIF2B. Nature Cell Biology, 14(2), pp.192–200.
Xaus, J. et al., 1999. Interferon α induces the expression of  p21(waf-1) and arrests macrophage cell 
cycle, preventing induction of  apoptosis. Immunity, 11(1), pp.103–113.
Xu, S., Tyagi, S. & Schedl, P., 2014. Spermatid Cyst Polarization in Drosophila Depends upon apkc 
and the CPEB Family Translational Regulator orb2. PLoS genetics, 10(5), p.e1004380.
Yan, Y. Bin, 2014. Deadenylation: Enzymes, regulation, and functional implications. Wiley 
Interdisciplinary Reviews: RNA, 5(3), pp.421–443.
Yiakouvaki, A. et al., 2012. Myeloid cell expression of  the RNA-binding protein HuR protects mice 
from pathologic inflammation and colorectal carcinogenesis. Journal of  Clinical Investigation, 
122(1), pp.48–61.
Yona, S. & Gordon, S., 2015. From the reticuloendothelial to mononuclear phagocyte system - The 
unaccounted years. Frontiers in Immunology, 6(JUL), pp.1–7.
Yoshimura, A., Naka, T. & Kubo, M., 2007. SOCS proteins, cytokine signalling and immune 
regulation. Nature Reviews Immunology, 7(6), pp.454–465.
Youn, J.Y. et al., 2018. High-Density Proximity Mapping Reveals the Subcellular Organization of  
mRNA-Associated Granules and Bodies. Molecular Cell, 69(3), p.517–532.e11.
Youssif, C. et al., 2018. Myeloid p38α signaling promotes intestinal IGF-1 production and 
inflammation-associated tumorigenesis. EMBO molecular medicine, p.e8403.
Zhang, X., Virtanen, A. & Kleiman, F.E., 2010. To polyadenylate or to deadenylate: That is the 
question. Cell Cycle, 9(22), pp.4437–4449.
Zika, E. et al., 2003. Histone Deacetylase 1 / mSin3A Disrupts Gamma Interferon-Induced 
CIITA Function and Major Histocompatibility Complex Class II Enhanceosome Formation. 
















































































































































































































































































































APPENDIX I. CPEB4 target mRNAs in Untreated BMDMs
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We considered as TTP targets the iCLIP-defined TTP targets in BMDMs stimulated for 
3h or 6h with LPS. Only those mRNAs with detected binding sites in its 3’UTR were 
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Figure XX. mTOR activation in wild type BMDMs during LPS response. BMDMs treated
with LPS (10ng/ml) for the indicated hours. Immunoblot analysis of phosphor-S6 as a readout
of mTOR activity, Vinculin is used as loading control.
































































*** *** ******* ** **** *
Figure XX. Increased Cpeb1-3 levels in Cpeb4KO BMDMs. 
Wild type or Cpeb4KO BMDMs were stimulated with LPS (10ng/ml) for 0-24h and mRNA
 was measured by RT-qPCR. Tbp was used to normalize and relative levels to untreated 
wild type were calculated. Data are shown as mean and s.e.m.; n=6. 
Statistics: Two-way ANOVA *pv<0.05 **pv<0.01 ***pv<0.001 ****pv<0.0001. 
Wild Type
Cpeb4KO 
Figure 53. Increased Cpeb1-3 levels in Cpeb4KO BMDMs. Wild type or Cpeb4KO 
BMDMs were stimulated with LPS (10ng/ml) for 0-24h and mRNA was measured by 
RT-qPCR. bp as used to normalize and relative levels to untreated wild type were 
calculated. Data are shown as mean and s.e.m.; n=6. Statistics: Two-way ANOVA 
*pv<0.05; **pv<0.01; *** pv<0.001; ****pv<0.0001. 
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Figure XX. mTOR activation in wild type BMDMs during LPS response. BMDMs treated
with LPS (10ng/ml) for the indicated hours. Immunoblot analysis of phosphor-S6 as a readout
of mTOR activity, Vinculin is used as loading control.
































































*** *** ******* ** **** *
Figure XX. Increased Cpeb1-3 levels in Cpeb4KO BMDMs. 
Wild type or Cpeb4KO BMDMs were stimulated with LPS (10ng/ml) for 0-24h and mRNA
 was measured by RT-qPCR. Tbp was used to normalize and relative levels to untreated 
wild type were calculated. Data are shown as mean and s.e.m.; n=6. 
Statistics: Two-way ANOVA *pv<0.05 **pv<0.01 ***pv<0.001 ****pv<0.0001. 
Wild Type
Cpeb4KO 
Figure 54. mTOR activation during the LPS response. BMDMs wer  treated with 
LPS (10ng/ml) for the indicated hours. Immunoblot analysis of phospho-S6  a 
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Rivas, Ángel Nebreda, Raúl Méndez. Inflammation resolution requires CPEB-mediated translational 
control in macrophages. Manuscript in preparation. 
Annarita Sibilio*, Clara Suñer*, Judit Martín, Toni Berenguer, Ángel Nebreda, Raúl Méndez. CPEB-
mediated translational control in intestinal homeostasis and diseases. Manuscript in preparation.
In this work, we have studied CPEB4 contribution to intestinal homeostasis and disease. Our 
results suggest that CPEB4 could control the immune intestinal environment. Indeed, in stressed-
colitis conditions Cpeb4KO mice present enhanced inflammation and a delay in the recovery 
of  colon epithelia. However, in tumoral circumstances CPEB4-mediated immune compartment 
could help the adaptive tumoral response to struggle against cancer cells, as Cpeb4KO mice show 
less colitis-associated tumorigenesis when treated with chemical carcinogens. 
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Miranda, Yi-Shuian Huang, Roger R. Gomis and Raúl Méndez. The RNA-binding protein CPEB2 
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2. Other projects
Novel functions for CPEB3 in mammalian organisms during homeostasis
Anna Ferrer*, Clara Suñer*, Judít Martín, Neus Prats, Rosa Pascual, Gonzalo Fernández Miranda, 
Raúl Méndez. 
This project aimed to describe new functions for CPEB3 using distinct ubiquitous Cpeb3KO 
mouse models. Given all the literature about CPEB3 function in the nervous system, here we 
focused on the other organs. Interestingly, we observed that CPEB3 was highly expressed in 
testis. Additionally CPEB3 was also expressed in retina, pancreas, prostate, muscle, heart, liver 
and mammary gland. In accordance with that, two Cpeb3KO models, inducible and constitutive, 
showed displayed defects in testis and retina. Importantly, in these two tissues the four members 
of  the CPEB family are expressed, suggesting a possible collaboration between them to regulate 
CPE-containing mRNAs in different cell types or at different stages. 
Interplay between CPEBs functions in mammalian organisms
Judit Martín*, Rosa Pascual*, Clara Suñer*, Neus Prats, Gonzalo Fernández Miranda, Raúl 
Méndez.
This project aimed to study the interplay between the different members of  the CPEB family in 
mammalian organism in vivo. Using an ubiquitous inducible system, we generated and characterized 
the single Cpeb1-4KO mouse models, which overall showed mild phenotypes in homeostasis. 
Moreover, we also combined CPEBs deletions and generated double, triple and quadruple Cpeb1-
4KO mouse models. Interestingly, as we depleted the expression of  more CPEBs, mice developed 
more aggressive phenotypes. These results indicated that CPEBs function partially overlap and, in 
single CpebKO mice, CPEBs can possibly compensate the absence of  one of  them.  
*Equally contributing






Dicen que el cerebro de los niños es como una esponja, que absorbe todo lo que hay 
a su alrededor. En mi experiencia, durante el doctorado tu cerebro vuelve un poco a 
ese estado de absorción y se va empapando de todo lo que te rodea. Por eso es tan 
importante quién te rodea durante esta etapa.
Todos vosotros, los que me habéis acompañado estos años, me habéis enseñado, 
mejorado, llevado a nuevos sitios, corregido, ayudado, divertido…y todo eso es 
mucho más importante que ser doctora. O quizás ser doctora sea eso. Por eso, mil 
gracias. Os admiro de una manera que no podéis imaginar y que, en unas pocas 
páginas, voy a intentar que entendáis.
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En la bahía de Cadaqués descansa el Cucurucú. Para la mayoría, es una roca con forma de aleta. Para 
unos pocos, es la aleta de un pez gigante sumergido. 
Los investigadores a menudo no somos los primeros en observar un fenómeno...
…sino los primeros en ver qué hay debajo del agua.
______________________
A la badia de Cadaqués descansa el Cucurucuc. Per la majoria, és una roca amb forma d’aleta. Per uns 
pocs, és l’aleta d’un peix gegant submergit. 
Els investigadors sovint no som els primers en observar un fenòmen…
    …sinó els primers en veure què hi ha sota l’aigua.
______________________
On Cadaqués bay, lays the Cucurucuc. For most, it is a fin-shaped rock. For a few, it is the fin of  a 
giant submerged fish. 
Researchers are often not the first to observe a phenomenon…
…but the first to see what lays under water.

